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ABSTRACT
Clusterin is a widely distributed and highly conserved secreted mammalian

glycoprotein whose elevated expression has been detected in a number of disease states (e.g.
Scrapie, Alzheimer's and Creutzfeldt-Jakob diseases) that are associated with abnormally
high levels of misfolded and/or precipitated proteins. Clusterin, present at concentrations
ranging from 35-105 ug/ml in human serum, is known to interact with a variety of proteins
and lipids in vitro. These numerous binding interactions have led to a number of biological

functions being proposed for clusterin; these include roles in reproduction, lipid transport

endocrine secretion, apoptosis, and complement regulation. In a recent study, it was reporte

that clusterin has molecular chaperone activity in vitro. Molecular chaperones, as defined b
John Ellis, are proteins that function in vivo to specifically interact with and stabilise
unfolded or partially unfolded proteins, thereby preventing them from potentially
aggregating and precipitating, e.g. during protein folding.
In this study, clusterin was shown to prevent the precipitation of heat-stressed
ovotransferrin and y-crystallin, as well as DTT-reduced ovotransferrin and lysozyme.
Analysis by size exclusion chromatography of samples in which clusterin was co-incubated
with ovotransferrin or lysozyme undergoing stress-induced denaturation revealed the
presence of HMW species in the void volume that was eluted from the column. Subsequent
analysis by SDS-PAGE of these HMW species, confirmed the presence of both clusterin and

the stressed target protein. Results presented in this report also demonstrate that clusteri
protects proteins in (i) diluted human serum from heat-induced precipitation and (ii)
undiluted human serum from DTT-mediated precipitation. Other results presented in this

thesis indicate that clusterin does not have the ability to hydrolyse ATP and hence, perform

V

its chaperone function in an ATP-independent manner. In addition, clusterin was unable to
independently facilitate the reactivation of heat-inactivated ADH and catalase after removal

of stress. However, in the presence of a chaperone with refolding capability (i.e. Hsc70) and
ATP, clusterin-stabilised ADH and catalase were partially refolded. Taken together, these

results raise the possibility that clusterin may inhibit precipitation of human serum protein
in vivo and create a reservoir of inactive protein structures from which folding-competent
proteins can be subsequently reactivated by other refolding chaperones.
Clusterin was shown to inhibit the slow precipitation of y-crystallin and lysozyme,
but was unable to prevent these same target proteins from rapid precipitation. Real-time H
NMR spectroscopic analysis of the interaction between clusterin and a-lactalbumin reveal
that clusterin did not alter the rate of a-lactalbumin reduction but did stabilise the less
ordered intermediately folded form of the protein. These results suggest that (i) kinetic

factors are important in the chaperone action of clusterin and (ii) clusterin binds specifica
to slowly aggregating proteins on the irreversible off-folding pathway.
This thesis also presents results to show that elevated temperature (up to 50 °C) does
not induce significant changes in the oligomerisation state of clusterin nor does it

substantially alter the ability of clusterin to interact with heat-stressed or chemically red

target proteins. In contrast, incubation at mildly acidic conditions resulted in the dissocia
of clusterin oligomers, which led to an increased exposure of hydrophobic regions on
clusterin to solution and a concomitant enhancement of its chaperone action. A phenomenon
known as acidosis occurs at sites of tissue damage or inflammation where the local pH can
drop below 6. Acidosis has been reported to occur at sites of inflammation as well as in
many of the diseases to which clusterin has been associated. Taken together, these results

vi

suggest that under these conditions, the dissociation and enhanced chaperone actions of
clusterin could help to inhibit the aggregation and deposition of inflammatory and/or toxic
insoluble protein deposits which would otherwise exacerbate pathology.
At present, the structural regions responsible for the ligand binding and chaperone
action of clusterin have not been identified. Sequence analysis of clusterin has revealed
several regions that could be functionally important, including three regions of amphipathic
a-helices and two coiled-coil domains. In addition, studies have shown that, despite having
variable truncations at the C-terminus of the a-chain and the N-terminus of the (3-chain,
clusterin expressed by yeast Pichia pastoris has similar chaperone activity to human

clusterin in vitro, indicating that the sites responsible for the chaperone action of cluste
more likely to be located more towards the N-terminal region of the a-chain and the C-

terminal region of the [3-chain. In order to identify the functional sites of clusterin and t

the above statements, five proline-substitution and five truncation clusterin mutants, as wel
as wild-type clusterin, were developed. These mutants, including wild type clusterin, were

expressed in transiently transfected Spodoptera frugiperda (Sf9) insect cells. Sf9 cells were

chosen as the host for the expression of wild type and mutant clusterin due to their reported
ability to express high levels of recombinant proteins and perform post-translational
modifications in a manner that is similar to mammalian cells. However, Western blot
analysis showed that the expressed proteins were not expressed at high levels and had
molecular masses that were approximately 15 kDa smaller than their expected sizes. Since
the Sf9 transfectants were not cloned, the Sf9 cell cultures may have contained a large
number of non-transformants/non-secretors that may have outnumbered secreting
transformants and hence, explain why the yield was so low. The size irregularity can be

vu

explained by incomplete glycosylation of the expressed proteins or by truncations caused by
protease actions. Whatever the case may be, these results clearly indicate that Sf9 insect
cells are unsuitable for producing properly processed wild-type or mutant clusterin.
Therefore, to produce properly processed wild-type and mutated clusterin for the study of
clusterin's structure-function relationship, a different expression system will be required.
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Chapter 1

GENERAL INTRODUCTION

The Role of Clusterin in Protein
Unfolding and Refolding

1.1 GENERAL INTRODUCTION
In 1997, studies conducted by Humphreys et al. (the results were published in
1999) revealed that a secreted mammalian protein called clusterin exhibited chaperonelike activities in vitro similar to those of the small heat shock proteins (sHSPs)
(Humphreys et al, 1999). For the first time, an extracellular mammalian chaperone
protein had been described. As a consequence of this remarkable discovery, current
studies reported herein have been aimed at determining the extent to which clusterin is
involved in protein unfolding and, especially, refolding. This chapter focuses on
introducing the relationship between protein structure, function and folding, and the
importance of chaperone proteins to these processes. In addition, the general properties
of clusterin and the relationship of its molecular chaperone activity to in vivo protein
unfolding and refolding will be discussed in detail.

1.2 PROTEINS
1.2.1 Protein Structure and Function

The secret to the versatility of proteins lies in their complex structure; that is, the wa
in which they are ultimately folded. Central to the study of protein structure and
function is a dogma, which states that, "3D structure is taken to be an obligatory
prerequisite for protein function" (Dunker et al, 2001). This protein structure-function
relationship can be represented by the following as:

Amino Acid Sequence • 3-Dimensional Structure • Function

What this implies is that the shape and function of all proteins is inextricably linked i
such a way that, in order to be biologically active, proteins must adopt a folded three-

2

dimensional structure that is specific for their intended function. Hence, a protein is
rendered functionally useless if it is not folded correctly.
For nearly a century, scientists have sought to discover the underlying
mechanisms by which proteins are transformed into their functionally active
conformation in vivo once they are synthesised. Their success has been noted by a
number of milestones; reviewed in (Dunker et al, 2001) and summarised as follow. In
1929, Hsien Wu postulated that native protein structures are formed by repeated patterns
of folding into a complex three-dimensional shape. In 1931, Anson and Mirsky

demonstrated that haemoglobin folding is reversible and that the renatured form exhibited
a native-like oxygen binding and tryptic digestion pattern. In the 1950s, studies by
Eisenberg and Schwert demonstrated that thermodynamic factors control the processes of
denaturation and renaturation, and that these processes resulted in large changes to the
conformation of the proteins involved. Also in the 1950s, Linus Pauling discovered two
simple but regular arrangements of amino acids (the a-helix and (3-sheet) that were
present in almost every protein (Pauling and Corey, 1951). In 1961, Christian Anfinsen
and his colleagues (Anfinsen and Haber, 1961) showed that denatured bovine pancreatic

ribonuclease (RNase), with reduced disulfide bonds and disrupted tertiary structures, can
spontaneously but slowly revert back to its biologically active structure in vitro. They
had demonstrated for the first time that "no special genetic information, beyond that

contained in the amino acid sequence, is required for the proper folding of a molecule an
for the formation of 'correct' disulfide bonds" (Goldberger et al, 1963; Ruddon and
Bedows, 1997). These and many other scientists have contributed greatly to the current
understanding of protein structure and folding. Their findings have been summarised as
follows.

3

Briefly, protein structure can be broken d o w n into four distinct levels, called

primary, secondary, tertiary and quaternary structures; listed here in the hierarchal or
of increasing structural complexity (van Holde, 1990). Ultimately, as deduced from
Anfinsen's classical RNase experiment (see above), the three-dimensional shape (tertiary

or quaternary structure) of all proteins is determined by the primary structure; that is
sequence of amino acids that make up a particular protein (Anfinsen and Haber, 1961).
All proteins, from bacteria to humans, are constructed from the same repertoire of 20
basic amino acids, each of which has its own unique chemical 'personality' as a direct
result of variations in the molecular composition of their 'side chain' (reviewed in
Branden and Tooze, 1999). Some amino acids favour aqueous environments and are
more likely to be located on the surface of a protein where they can interact with the
surrounding water molecules, whereas those that prefer hydrophobic environments tend
to be located deep within the protein. Some have slightly positive or negative charges
and, therefore, have a greater propensity to repel groups of similar charge. Moreover,

some have a rigid side chain and hence lack flexibility and free rotation about the pepti
bonds, whilst others are bulky due to having long or large side chains. This spectrum of

behaviour, in turn, affects how all amino acids are spatially oriented with respect to ea
other within a mature protein. More importantly, it dictates whether a segment of
polypeptide becomes part of an a-helix, P-sheet or P-turn (secondary structural

elements), as well as dictating the final orientations or topology of these domains in th
three-dimensional (tertiary and quaternary) structure of a folded protein (Branden and
Tooze, 1999).
As a general rule, proteins can exist in one of three major thermodynamic states at
any given moment; these include the native, intermediary "molten globule" (MG) and the

unfolded states (Ohgushi and Wada, 1983). The basis for the classification of a particula
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protein into one of these states lies with the amount of structure that it possesses, as

outlined in Table 1.1. While it would be easier to describe proteins as discrete structur

that exist as homogeneous entities in a given state, the fact is that each state is compr
of an ensemble of different protein conformations with similar properties (Pain, 2000).
Ultimately, all proteins try to fold into the native state - the conformation in which
they are thermodynamically most stable and of the lowest energy. The driving force for
this stability lies with favourable negative enthalpy arising from harmonious
intramolecular side chain interactions (through electrostatic interactions, internal
hydrogen bonding, or van der Waals interactions), and a decrease in structural
randomness, resulting in favourable negative entropy (Branden and Tooze, 1999; Dill,
1990; Shirley, 1992). For globular proteins, favourable entropy also arises from the

burial of hydrophobic groups within the protein, which effectively causes the cessation o
the hydrophobic effect (Branden and Tooze, 1999; Herzfeld, 1991). Finally, for a
number of proteins, structural stability may also arise from the formation of disulfide
bonds between cysteine residues located either on the same polypeptide chain or on
adjacent chains (Creighton, 1997).
It is, however, erroneous to assume that a fully folded protein in its native state
and stabilised by the above-mentioned forces and bonds is static. Random secondary
structural elements as well as whole domains continually undergo movements in space.

Such fluctuations can be caused by individual atoms rotating around their bond axis or by
the collective movement of groups of atoms (Kim and Woodward, 1993). Usually, these
fluctuations are small, a few tenths of an Angstrom, and occur on a picosecond timescale
(Pain, 2000). Occasionally, larger fluctuations can also occur and the regions that

undergo such fluctuations are often referred to by crystallographers as "flexible regions
Structural movements are very important for the function of many proteins, being

5

involved in the processes of enzyme catalysis, receptor-ligand interactions, binding of

antigens to antibodies, energy transductions, and so on. To illustrate this point, c
the enzyme, AK3, a member of the adenylate kinase family. Figure 1.1 depicts the
structures of substrate-free, inactive and activated AK3, with both substrates (AMP
Ap5P) bound (Schulz, 1991).

A

B

Figure 1.1: Structural movements as a result of substrate binding to adenylate kinase 3 (AK3). Only nonhydrogen atoms are shown. (A) A K 3 with no ligand. The 30-residue segment forming the AMP-binding
site is indicated within the red circle. Structural movement of this segment upon A M P binding is shown by
the unfilled arrow. (B) A K 3 with bound substrate A M P . (C) AMP-bound A K 3 rotated by 90 ° around the
vertical axis. The flexible 38-residue domain is indicated within the blue circle. The direction of its
movement upon A p 5 A binding is indicated by the unfilled arrow. (D) A K 3 with bound substrates A M P
and A p 5 A . These images were taken from Shulz, 1991.
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Substrate-free A K 3 is characterised by the presence of a large cleft which forms
the active site, a main body consisting of a parallel P-sheet structure surrounded by a
number of a-helices, a 30-residue segment forming the AMP-binding site, and a highly
flexible 38-residue domain situated at the mouth of the cleft (Dreusicke and Schulz,
1988). As the first substrate (AMP) binds, the main body remains intact while the 30residue segment undergoes a movement of 8 A followed by another 8 A on binding of
ApsP. At this moment, the 38-residue domain at the mouth of the cleft rotates by as
much as 90 ° to form a solid lid, thus shielding the enclosed active site and rendering

enzyme fully active to carry out its function. This is, of course, a reversible process,

nevertheless it does illustrate the significant structural movements required for functi

in certain proteins, as well as the importance of having correctly folded motifs to perm
proteins to function properly.

1.2.2 Protein Folding
Much of the initial understanding of how proteins fold into the native state has

been gained through structural characterisation of the various protein conformations tha

feature in the protein-folding process. Experimental approaches to these studies include
the use of circular dichroism spectroscopy, X-ray crystallography and protein
fluorescence. The structural information gained from these techniques have often been

used, like pieces from a jigsaw puzzle, to piece together folding pathways. The advent o
Nuclear Magnetic Resonance (NMR) spectroscopy and recombinant DNA technology

has allowed the protein-folding process to be further studied at the molecular level. Fo
instance, the ability to measure thermodynamic changes of individual or groups of atoms
over time using NMR spectroscopy has meant that it is now possible to determine the
kinetics of protein folding (Balbach et al, 1996; Creighton, 1997). In addition,
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recombinant D N A technology (see chapter 5) has enabled production of mutants to probe
the folding process and to ascertain the level of involvement of individual amino acids.

Therefore, besides their ability to characterise various protein transition states, thes
powerful, complementary techniques have facilitated substantial elucidation of the
kinetics and thermodynamics that govern protein folding.
As a result of these developments, a number of models have been proposed to
describe the mechanisms and pathways by which unfolded polypeptide chains are folded
into the stable native conformation. In the simplest model, which usually applies to
small, single domain proteins (typically with less than 100 residues), the process of

protein folding is best described as being "two-state"; involving a direct transition fr
the high energy unfolded form to a low energy native state (Figure 1.2 A) (Jackson and

Fersht, 1991). In contrast, folding by larger, more complex proteins occurs via a general
pathway involving an initial collapse of the unfolded state into a partly structured,
intermediate "molten globule" state, followed by further structural remodelling and
packing into the final native form (Sali, 1994). For some proteins, such as chymotrypsin
inhibitor 2 (CI2) and barnase, folding may be achieved through the course of a single
major pathway (Figure 1.2 B) (Jackson and Fersht 1991; Fersht, 1993), whereas the
folding of other proteins, such as lysozyme, may involve numerous but parallel folding
pathways (Figure 1.2 C) (Fersht et al, 1994; Matthews, 1993).

During protein folding, the transition from the unfolded to the molten globule state is
characterised by (i) a substantial development of secondary structural elements such as

helices and P-sheets, (ii) an absence of much of the tertiary structures associated with
native conformation, and (iii) the formation of a loosely packed hydrophobic core that

results in the exposure of hydrophobic surfaces to solvent. This transition is fast, usu
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occurring in a few milliseconds. A s proteins evolve from the molten globule to the native

state, a gradual assembly of persistent native-like tertiary structure (in the form of
subdomains) is observed. This process, mainly driven to completion by the same forces

that govern native protein stability, occurs much more slowly and can last up to 1 sec
(Anfinsen, 1972; Branden and Tooze, 1999; Dill, 1990; Sali, 1994).

(A)

Unfolded
protein

native
protein

(B)

Unfolded
protein

•• intermediate

native
protein

intermediate,

(C)

Unfolded
protein

-• intermediate,

native
protein

intermediate.

Figure 1.2: Schematic representation of the various protein-folding pathways. (A) Two-state model; small,
single domain proteins (typically with less than 100 residues) fold directly from the unfolded state into the
native state via this model. (B) and (C) Folding pathways involving protein intermediates; folding of some
proteins (e.g. barnase) are achieved through the course of a single major pathway (B), whilst others (e.g.
lysozyme) m a y fold via numerous but parallel pathways (C). The protein structures were drawn to indicate
different conformational states; they do not represent any known protein structures. The number of
possible folding pathways as shown in (C) m a y vary between proteins.

9

1.2.3 Protein Unfolding/Misfolding and its Consequences
Protein unfolding is essentially the opposite process to protein folding. It may
involve a partial or full unravelling of the native protein structure to form the molten
globule or the fully unfolded polypeptide, respectively. Triggers for protein unfolding
vary significantly (see below) but the outcome is always the same - they invariably lead
to the weakening of thermodynamic forces that normally stabilise the protein conformer.
The molten globule structure has been a focus of research since it is in this state that
protein misfolding and aggregation are most prevalent. It is now widely believed that the
highly exposed hydrophobic domains of molten globules are partly responsible for
promoting inappropriate protein-protein interactions.
Proteins generally fold quickly, thus reducing the amount of time that is available
for protein intermediates to interact with each other to form large, useless protein
aggregates. Although all proteins are able to fold quickly, Anfinsen demonstrated that
more complex, multidomain, or oligomeric proteins are unable to fold as efficiently as
small, single domain proteins unless they are folded in the presence of additional
proteins, which Laskey termed "molecular chaperones" (Laskey et al, 1978). John Ellis

(Ellis, 1987) later applied this term to include all bacterial and eukaryotic proteins tha
function to prevent illegitimate interactions between different polypeptide chains during

normal protein folding or upon unfolding under altered physiological conditions or stress.
The term stress is often used to describe any conditions that may influence or lead
to protein unfolding and misfolding. Stress can be exerted by a number of factors such as
temperature, pH, oxidation or reduction, and molecular crowding. In addition to these
stresses, protein misfolding can also result from defective genes that encode for the

production of mutated proteins with altered structural characteristics and hence, defectiv
folding abilities. Molecular crowding is a stress factor of particular importance because
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affects all proteins, from newly synthesised polypeptides to mature proteins. Molecular
crowding occurs due to the high concentration of transiently hydrophobic and charged
proteins and other molecular species within the cell. For instance, the total
macromolecular concentration in the cytoplasm of a typical bacterium such as E.coli is
approximately 340 mg/ml (Ellis and Haiti, 1996); this overcrowding is graphically
depicted in Figure 1.3. Overcrowding of molecules promotes "improper interactions"

between nascent proteins, which, like that caused by other stress conditions, often leads
to irreversible formation of non-functional misfolded protein structures or aggregates
(Van den Berg et al, 1999). The breakdown of controlled or regulated protein folding
often leads to cellular malfunctioning and disease (Thomas et al, 1995; Dobson, 1999).
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Figure 1.3: A pictorial representation of the extent of molecular crowding by
macromolecules in a bacterial cell. T h e identity of these macromolecules are indicated to
the right of the picture. This image was taken from Pain, 2000.

M a n y diseases have been linked to the failure of proteins to fold properly or, if
folded, to remain in the native conformation. In most cases, the aggregation of proteins
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into insoluble complexes has been a key characteristic feature of these diseases (reviewed
in Kapito and Ron, 2000; Thomasson, 2001). Some of these diseases include cystic

fibrosis, Alzheimer's disease, Parkinson's disease, cataract, and prion diseases such as
scrapie, bovine spongiform encephalopathy (BSE) and Creutzfeldt-Jakob disease (CJD).

In the case of cystic fibrosis, a single deletion-mutation of a phenylalanine at positio
in the cystic fibrosis transmembrane conductance regulator (CFTR) causes the protein to
misfold, rendering it unable to regulate the transport of CI" ions in epithelial cells
(Ackerman and Clapham, 1997; Kleizen et al, 2000). Cataract, which accounts for 42%
of blindness world-wide, occurs when the aggregation of crystallin proteins, the major
component of the eye, becomes so severe that the lens goes opaque, causing cataract
sufferers to lose their sight. The other diseases listed above all feature extensive

accumulation of amyloid fibrils. Amyloid fibrils are formed as a result of inappropriate

interactions between P-sheets of partially unfolded proteins that polymerise to form lon
unbranched fibrous structures of indefinite lengths (Figure 1.4). In the case of
Alzheimer's disease, the fibrils are mainly comprised of 40-42 residue fragments, AP(140) and Ap(l-42), of the amyloid precursor protein (APP) (Heininger, 1999; McGeer and

McGeer, 1997; Sisodia and Price, 1995). The fibrils that are attributed to prion disease
such as CJD and BSE result from the aggregation of amyloidogenic scrapie prion protein
(PrPsc), which is the mutated isoform of the normal cellular prion protein, PrPc (DandoyDron et al, 1998; Sanada and Vo-Dinh, 2001; Slepoy et al, 2001). Under appropriate
conditions, it appears that virtually all proteins can form fibrils, provided that they
the ability to adopt the P-sheet structure.
The devastating and often irreversible in vivo damage caused by these
amyloidogenic proteins has been well documented and has created an immense challenge
for the development of novel therapeutic solutions to the many diseases associated with
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protein misfolding.

For this reason, elucidation of the mechanisms governing the

formation of amyloid fibrils has been very actively pursued. One approach has been to
investigate the possible roles of molecular chaperones in the prevention of protein

misfolding, since increases in their expression seem to be correlated with these and man

other diseases.

Figure 1.4: Images of amyloid fibrils. (A) Transmission electron microscopy of fibrils formed by the
seven-residue peptide A M 6 - 2 2 , negatively stained with uranyl acetate [38]. (B) Cryo-electron microscopy
model of an amyloid fibril derived from the S H 3 domain of the p85a subunit of bovine phosphatidylinositol-3'-kinase; the stacking arrangement of the b structures is shown in colour (Jimenez et al, 1999).

1.2.4 Molecular Chaperones
The term molecular chaperones was applied by John Ellis to describe a diverse

group of functionally related proteins that function in vivo to assist in protein assemb
specifically interacting with non-native protein structures and inhibiting their

precipitation (Ellis, 1987; Ellis, 1992). It is believed that, during their chaperone acti
molecular chaperones undergo structural changes that result in the exposure on their
surface of hydrophobic regions. These regions allow the chaperones to interact with
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hydrophobic domains of molten globule substrate proteins. In addition, it is believed that
these interactions are promoted by highly flexible regions, which many chaperones
possess.
Of the molecular chaperone superfamily, the best characterised chaperones belong
to the stress-induced proteins that are collectively known as the heat shock proteins
(Hsps). As the name implies, Hsps first came to attention because of their increased
expression in response to elevated temperature (heat shock). Numerous studies have now

shown that, in additional to thermal stress, the increased expression of Hsps can also b
induced by many other stresses (Mehlen et al, 1995; Preville et al, 1999). The five
major heat shock protein families include Hsp 100/104, Hsp90, Hsp70, Hsp60/GroEL,
and the small heat shock proteins (sHsps) (Kabakov and Gabai, 1997). While HsplOO,
Hsp90, and the sHsps (Gething, 1997; Jakob and Buchner, 1994; Sanchez and Lindguist,
1990) are expressed primarily in response to heat shock, Hsp70 and Hsp60 are involved
in protein folding and refolding under normal conditions as well as under heat shock
conditions (Gething, 1997; Haiti, 1996). Some of these heat shock protein families,
notably the sHsps, HSP70 and HSP60/GroEL, will be discussed in more detail in
subsequent chapters.
Many chaperones have been implicated in pathological states including those
mentioned previously (see section 1.2.5; "Protein Misfolding and its Consequences").
Although their function in diseases associated with protein misfolding is not fully

understood, their elevated expression in response to these diseases nevertheless raises

question as to what role chaperone proteins have in disease and whether their presence i
beneficial (slowing the progression of disease) or detrimental (exacerbating disease).
Until recently, all known molecular chaperones were intracellular proteins. At present,
only a small number of extracellular proteins with chaperone-like activity have been
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discovered (Bhattacharyya and Das, 1999; Pavlicek and Ettrich, 1999). O f these, a near-

ubiquitous protein called clusterin became the first reported extracellular molecular
chaperone (Humphreys et al, 1999). For the remainder of this chapter, the general

characteristics of clusterin and its predicted functions in vivo will become the main
of discussion.

1.3 CLUSTERIN
The name "clusterin" was internationally accepted at the first Clusterin Workshop
in 1992 at Cambridge, UK, to describe a protein which has the ability to promote the
aggregation or "clustering" of a variety of cell types, including erythrocytes, renal

epithelial cells, Sertoli and mouse testes TM-4 cells (Figure 1.5) (Blaschuk et al, 19
Rosenberg and Silkensen, 1995). This protein was initially isolated in 1983 from ram
rete testis fluid by conventional methods and by immunoaffinity chromatography
(Blaschuk et al, 1983). Previously, many homologues of clusterin were isolated from

different animal species and with each new discovery a different name was assigned to

the protein (Table 1.2). For example, the human homologue of clusterin, first isolated
1989, was subsequently named apolipoprotein J (apoJ), NA1/NA2 (de Silva et al, 1990a
and b; Matsubara et al, 1995), SP-40,40 (Kirszbuam et al, 1989; Murphy et al, 1988;
O'Bryan et al, 1990), complement cytolysis inhibitor (CLI) (Jenne and Tschopp, 1989),
and PADHC-9 (Rosenberg et al, 1993), depending on the locale in the human body in

which it was discovered. Similarly, the rat homologue of clusterin was given the names
SGP-2 and TRPM-2 (Jenne and Tschopp, 1989; Law and Griswold, 1994; Wong et al,

1993). However, to avoid confusion, in this thesis the protein will simply be referred
as clusterin.

15

1"

•
.

-»=•—»n—
it *

*

•»•m

»%

*

f

£.*

I

» ?
t

%

.*

^ 1

. t

k

L*

'i-im

. vf*

£ •' a
**4

%
!

4

j- ,
- •' *

:

,

*

*»^
'
IT
4

V

: ^

f

.'»

;

A*

Figure 1.5: Microscopy images showing the "clustering" effects of clusterin on T M - 4 cells. (A) In the
absence of clusterin, T M - 4 cells do not aggregate. (B) In the presence of exogenous clusterin, the cells
aggregate extensively (Fritz et al, 1983).

1.3.1 Clusterin Structure and Biosynthesis
The mature clusterin molecule is a secreted 75-80 kDa heterodimer consisting of
two non-identical 35-40 kDa subunits, a and P, that are joined together via a highly
conserved motif containing five disulfide bonds (Choi-Miura et al, 1992). A schematic

representation of this structure is shown in Figure 1.6. Southern blot analysis and cro
hybridisation studies have revealed that a single 1.6-2.0 kb mRNA, transcribed from a
single copy gene located on chromosome 8p 12-21 in humans (Fink et al, 1993);
chromosome 14 in mice (Jordan-Starck et al, 1994); and chromosome 15 in rats
(Goldner-Sauve et al, 1991), is responsible for encoding the polypeptide precursor of
clusterin (Rosenberg and Silkensen, 1995; Rosenberg et al, 1993; Wilson and
Easterbrook-smith, 1996). The precursor is synthesised in tandem with a typical 21-22
amino acid signal peptide, which directs the clusterin polypeptide to the lumen of the

endoplasmic reticulum where the signal peptide is proteolytically removed. The disulfid
bonds that hold the two subunits together are also formed at this point (Burkey et al,
1991).
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To produce the mature clusterin molecule, which consists of 427 amino acid
residues, the polypeptide is further cleaved between residues 205 (arginine) and 206

(serine), resulting in formation of the two subunits. The amino-terminal 205 amino acids
form the a subunit whereas the carboxyl-terminal 222 amino acids constitute the p
subunit. At this stage, the post-translationally processed product now has a molecular
mass of 51 kDa (de Silva, 1990b; Jordan-Starck et al, 1994; Wilson and EasterbrookSmith, 1996), which is 25-29 kDa smaller than the mature clusterin molecule. Chemical

deglycosylation of the clusterin-oc and -ft subunits by de Silva et al. (de Silva et al,

1990c) has revealed that this difference is due solely to extensive N-linked glycosylat
of the mature protein. Rat Sertoli cell-derived clusterin, for example, contains 2330% (w/w) highly sulfated carbohydrates whereas carbohydrate accounts for 30% of
the molecular mass of human clusterin (Griswold et al, 1986; Law and Griswold,

1994). Although it is generally believed that glycosylation helps to solubilise proteins
an aqueous environment, the absence of carbohydrates has no effect on the posttranslational modification and secretion of clusterin. This clearly indicates that
carbohydrates found on the surface of clusterin are not essential for proper clusterin
trafficking and secretion (Wilson and Easterbrook-Smith, 1996). Yet, this
suggestion seems to be contradicted by a recent report which showed that
overexpression of an intracellular lectin called VIP36 stimulated the secretion of a
number of secretory glycoproteins, including clusterin, by interacting with and
facilitating the ER-to-plasma membrane transport of proteins with high mannosetype glycans (Hara-Kuge et al, 2002). Obviously, more research will be needed to
determine the exact role of the carbohydrates found on the surface of clusterin.
Once glycosylated, the mature protein is usually secreted into the extracellular
space. However, apparent exceptions include chicken clusterin which is retained as an

18

uncleaved single chain polypeptide (Mahon et al, 1999) and a truncated form of
clusterin which, following the treatment of CCL64 and HepG2 cells with
transforming growth factor beta (TGF0) (Reddy et al, 1996), was reported to
accumulate in the nucleus of the cells.
The primary sequence of clusterin is known, but the secondary, tertiary and
quaternary structures are yet to be determined. What is known, however, is that 40%
of the total number of amino acids are polar while 41% are non-polar (Blaschuk et
al, 1983). Furthermore, circular dichroism spectroscopy indicates that cc-helices
account for 41% of clusterin structure, whereas P-sheets and turns account for
approximately 19% and 32%, respectively. Structure predictions also suggest that
mature form of the clusterin molecule contains extensive amphipathic oc-helical

regions that are formed by the 76 N-terminal amino acid residues, as well as regions
comprised of residues 150-170, 215-240, 300-350, and 406-420 (Figure 1.6) (Jenne
et al, 1991; Jenne and Tschopp, 1992). The hydrophobic nature of clusterin, which
results in its aggregation with itself to form dimers and tetramers, may arise from
these predicted amphipathic regions (Blaschuk et al, 1983).
The degree of identity in the amino acid sequence of clusterin varies between
species and is strongly correlated with the "phylogenetic distances" between these
species (Figure 1.7). For example, clusterin isolated from mice and rats (both of
which belong to the same phylum) have been shown to share 91% sequence identity
(Wong et al, 1993) whereas human and rat clusterin share 77% sequence identity
(Matsubara et al, 1995). Human and canine clusterin share 78% sequence homology
whereas human and bovine clusterin show 72% homology (Jenne and Tschopp,
1992). Clusterin from two relatively unrelated species (human and quail) show the
least homology in their amino acid sequence, with 46-49% homology (Jenne and
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Tschopp, 1992). However, clusterin from all species contains one region (residues
87-150) which exhibits the greatest degree of conservation with 98% sequence
identity, suggesting that this region may be of structural and/or functional
importance.

a subunit

Y
i

205

3-c

i i

3-N

X

427

206

B subunit
KEY

r

Glycosylation sites

Predicted coiled-coil cc-helices

Mill
I I I I I Disulfide bonds
I I I II

Predicted amphipathic cc-helices

Figure 1.6: Schematic representation of the structure of clusterin. T h e main features of the clusterin
structure shown include glycosylation sites, the disulfide bond motif, and the predicted coiled-coil a-helices
and amphipathic a-helices (see key). T h e amino acid positions at the N-terminus (N-) or C-terminus (-C)
of the two subunits are indicated as numbers. This figure w a s modified from figure 1 of [77].

A search of current protein-sequence databases, such as the Swiss protein
database, revealed no substantial sequence homology between clusterin and other known

proteins. Yet, discrete regions of similarity have been reported between clusterin an

helical coiled-coil proteins such as myosins and desmins (Tsuruta et al, 1990), oc-hel

proteins such as apolipoprotein A-I (Apo A-I) (de Silva et al, 1990c), and the cystein
rich thrombospondin type-I regions in terminal complement components C7, C8, and C9
(Jenne and Tschopp et al, 1992; Tschopp et al., 1993).
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1.3.2 Clusterin Distribution and Binding Interactions
Clusterin is regarded as a near-ubiquitous protein because it is found in
virtually all mammalian tissues, where the levels of expression are very similar
between different species (Wilson and Easterbrook-Smith, 1996). Strong levels of
expression have been detected in the adrenal medulla, brain, anterior and posterior
pituitary, liver, ovary, and testis, with low levels in the lung, lactating mammary
tissue, kidney, spleen, thymus, and the uterus (de Silva et al, 1990b; Duguid et al,
1989; Boggs et al, 1996; Collard and Griswold, 1987; Oda et al, 1994). Recent

reports have also indicated the presence of clusterin in the corneal epithelium, ret

and aqueous humor of the eye (Dota et al, 1999). However, this is not to say that all

cells in these organs express clusterin. For example, in the prostatic ductal system
and the epididymis, only endothelial cells express clusterin mRNA. In addition,
whereas atrial myocytes of the heart and Chief cells of the stomach both produce

clusterin, ventricular myocytes (heart) and parietal cells (stomach) do not (Rosenbe

et al, 1993). In many organs, clusterin is often expressed at fluid-tissue interfaces
this has led to the suggestion that it may serve to protect cell membranes from the
harmful effects of prolonged exposure to "biologically active fluids" such as bile,

gastric juice, pancreatic juice, gland secretions and urine (Jordan-Starck et al, 19
Aronow etal, 1993).
Clusterin is also present in a number of body fluids including breast milk,
cerebrospinal fluid, plasma, semen, and urine (Jenne and Tschopp, 1989; O'Bryan et
al, 1990; Aronow et al, 1993). The concentration of clusterin in human plasma has
been reported to range between 35 and 105 p.g/mL (0.44 - 1.35 uM) (Jenne and
Tschopp, 1989; Murphy et al, 1988). In human seminal fluid, the concentration of
clusterin is approximately 10-fold higher (Matsubara et al, 1995) while in the

22

cerebrospinal fluid (CSF) clusterin concentration varies between 1.2 and 3.6 p.g/mL
(Calero et al, 2000). Serum clusterin is produced by megakaryocytes, which are
also responsible for the synthesis of platelets in the bloodstream. Clusterin is not
actually released from platelets until they degranulate in response to endothelial
damage. The ability of clusterin to promote aggregation of a variety of cell types

including erythrocytes and white blood cells have, in the past, led to suggestions th
clusterin may be involved in cell development and cell adhesion (Silkensen et al,
1999).
Extensive work on mouse clusterin mRNA during various stages of gestation
and organogenesis have shown that the location of clusterin expression or production
may change at different stages of development. For example:

• Clusterin is present in both the atria and ventricles of the foetal mouse heart but
only in the atria of the adult heart (Aronow et al, 1993);
• Clusterin is present in the bronchial tree of the developing human lung but is
absent in the mature lung (Rosenberg and Silkensen, 1995), and;
• Clusterin expression increases in the central nervous system as embryogenesis
progresses towards the postnatal stages of development (Rosenberg and Silkensen,
1995).
The stage-dependent expression of clusterin suggests possible roles in organogenesis
and development.

Clusterin interacts with a variety of proteins and lipids in vitro. Some of the
best known binding partners of clusterin include terminal complement components
C7, C8, and C9 (Boggs et al, 1996; Choi et al, 1989; McDonald and Nelsustuen,
1997), immunoglobulins (Wilson and Easterbrook-Smith, 1992), Alzheimer's
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amyloid beta molecules (Ghiso et al, 1993; Zlokovic et al, 1994; Matsubara et al,
1995; Choi-Miura and Oda, 1996), and a serum protein called paraoxonase (Kelso et
al, 1994). Other binding partners include glutathione S-transferase (GST)
(Hochgrebe et al, 2000), heparin (Pankhurst et al, 1998), myosins and desmins, and
SIC (Streptococcal inhibitor of complement-mediated lysis) (Akesson et al, 1996).
In human blood, clusterin is associated with high-density lipoprotein (HDL) particles
along with another plasma protein called apolipoprotein A-I (apoA-I), which is often
co-purified with clusterin (Jenne and Tschopp, 1989). Clusterin aggregates with
itself under conditions of neutral pH and low salt concentrations to form dimers and
tetramers (Blaschuk et al, 1983; Griswold et al, 1986). In addition to the
hydrophobic nature of clusterin, a combination of non-ionic and weak electrostatic
forces is believed to be responsible for these interactions. It is not known why
clusterin interacts with so many biological molecules or why it binds with itself.

1.3.3 Proposed Biological Functions of Clusterin
For many years, the process of identifying a functional role for clusterin has been

complicated by its near-ubiquitous distribution and its ability to bind to a variety o
proteins and lipids (see above). Numerous biological functions have been proposed for
clusterin, further complicating the quest to find its true function/s. Clusterin has
implicated in the biological processes of reproduction (Blaschuk et al, 1983; Law and
Griswold, 1994); Tenniswood et al, 1998), lipid transport (Jenne et al, 1991),

endocrine secretion (Rosenberg et al, 1993), apoptosis or programmed cell death (Jenne
and Tschopp, 1992; Wong et al, 1993; French et al, 1994; Wilson and EasterbrookSmith, 1996), and complement regulation (Choi et al, 1989; Kirszbuam et al, 1989;
McDonald and Nelsustuen, 1997). Rosenberg and Silkensen (1995) previously raised the
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question of whether clusterin is truly a multifunctional protein or has a single unifying

function that explains its distribution among the various physiological settings in which
has been found. Some aspects of proposed clusterin functions are discussed in detail
below.

1.3.3.1 Clusterin and reproduction
Questions as to the functions of clusterin within the reproductive system were
raised after the initial isolation of this major glycoprotein from ram rete testis fluid.

Clusterin constitutes about 18% of the total protein secreted into the testis fluid and ha

the ability to elicit the clustering of Sertoli cells (Blaschuk et al, 1983). Sertoli cell
provide an appropriate environment for spermatogenesis and the transfer of nutrients to
the developing spermatocytes and spermatids. They are also the major testicular source
of the rat homologue of clusterin, SGP-2, which comprises 50% of all protein secreted by
these cells (Law and Griswold, 1994; Rosenberg and Silkensen, 1995).
Clusterin is present in the male reproductive tract in the cytoplasm of various cell
types, including Sertoli cells and epididymal cells, the late developing spermatids and
released spermatozoa in the testis, and on the surface of maturing sperm cells in the
epididymis (Collard and Griswold, 1987; O'Bryan et al, 1990; Aronow et al, 1993;
Rosenberg and Silkensen, 1995). Due to its high abundance and broad distribution, it has

been suggested that clusterin plays a major role in the generation and maturation of sperm
cells, especially the formation of the cytoskeletal components of sperm tails (Law and
Griswold, 1994). However, this remains to be substantiated. Other suggested functions

of clusterin in the male reproductive tract include lipid transport, mediation of cell-ce
interactions (e.g. of Sertoli cells) and the protection of spermatozoa from harmful and
degradative environments (Rosenberg and Silkensen, 1995). In addition, the localisation
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of clusterin on male germ cells raises the possibility that it m a y protect sperm from
complement lysis in the vagina post-coitus. In females, clusterin mRNA and protein
have been found in the ovary and uterus (Ahuja et al, 1994). Clusterin has been detected
in granulosa cells during the development of the ovarian follicle where it has been
postulated to protect and support the maturation of the ovum.

1.3.3.2 Involvement of clusterin in lipid transport
The highly amphipathic nature of clusterin allows it to bind molecules with

similar properties - hence, the existence of numerous binding partners (see section 1.3.2
As Jenne et al. reported (Jenne et al, 1991), clusterin purified by monoclonal antibodyaffinity chromatography was often isolated in association with a common 28 kDa protein
of human plasma. Partial amino-terminal sequencing revealed the identity of this protein
to be apoA-I. It is now known that the majority of serum clusterin does not circulate as
free globular molecule but rather is associated with high-density lipoprotein (HDL)
particles in the form of clusterin-HDL-apoA-I complexes. These complexes are rich in

free cholesterol but poor in lipids, with lipid composition ranging from as low as 11% (d
Silva et al, 1990c), to a moderate 22% (Jenne et al, 1991). Since clusterin is commonly

associated with apoA-I, it has been suggested that clusterin is involved in lipid transpo
(Rosenberg and Silkensen, 1995), especially the transport of cholesterol from peripheral
tissues to the liver (de Silva et al, 1990c). ApoA-I is an apolipoprotein, the protein
components of micellar complexes of lipoproteins that are responsible for transporting
otherwise insoluble lecithin, triglyceride and cholesterol in vertebrate blood (Stryer,
1995). Supporting the proposal that clusterin is involved with lipid transport is the
observation that levels of cholesterol and clusterin in human plasma are positively

correlated and that clusterin is found at high levels in atherosclerotic plaques (Jordan-
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Starck et al, 1994). A role for clusterin in the uptake and redistribution of lipids from
damaged cells has been proposed which is consistent with evidence showing that
clusterin-HDL-apoAI complexes have an affinity for membranes of damaged, abnormal,
or dying cells (Rosenberg and Silkensen, 1995). Clusterin is a ligand for the lowdensity lipoprotein receptor-related protein-2/megalin/gp330 (LRP-2), an endocytic
receptor of the low density lipoprotein receptor family (Kounnas et al, 1995;
Morales et al, 1996; Hermo et al, 1999). In vivo, LRP-2 has been shown to mediate
the endocytosis of clusterin alone, or clusterin associated with cholesterol-rich
lipoproteins. Since LRP-2 is also believed to play a crucial role in the development

of epithelial cells of the efferent ducts and epididymis as well as in the uptake and

disposal of lipoproteins and cholesterol, it has been suggested that clusterin may ac
as a marker for the disposal of its lipid substrates (Hermo et al, 1999). Human
clusterin has been reported to promote the efflux of cholesterol from macrophage
foam cells of apoE-null mice, suggesting that clusterin may be involved in cellular
cholesterol homeostasis (Gelissen et al, 1998). Furthermore, this report suggested
that, by being able to regulate cholesterol transport, clusterin might have antiatherogenic properties. However, this remains to be established.

1.3.3.3 Clusterin and apoptosis
There are two different ways by which mammalian cells die in vivo (Figure 1.8).
Cell death may be due to necrosis, or accidental cell death, which is a relatively

uncontrolled process usually caused by traumatic physical injuries or chemical chang

the cellular environment (French et al, 1994). Alternatively, cells that are no longe

needed by an organism may die as a result of apoptosis or programmed cell death (PCD)
which is characterised by distinct morphological and biochemical changes. These
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morphological changes include a marked decrease in cell volume (cell shrinkage),
cytoskeletal modification resulting in membrane blebbing, nuclear condensation and
fragmentation, degradation of DNA into oligonucleosomal fragments, as well as the
formation of "apoptotic bodies" (French et al, 1994). In vivo, apoptotic bodies are
always rapidly phagocytosed by macrophages to ensure that any proteolytic and other
lytic enzymes are not released into the extracellular environment, thereby preventing
localised inflammation (Kuby, 1997).
The association between clusterin and apoptosis came about due to reports

showing an elevated expression of clusterin specifically in apoptotic cells. Some of the

reports suggested that clusterin is an apoptotic marker (Buttyan et al, 1989; Danik et a
1991). Clusterin's apparent importance in apoptosis has been highlighted by findings
that in certain diseases, clusterin mRNA is usually upregulated. For instance, in 1989,

Duguid et al reported an increase in clusterin expression in the hippocampus of patients
suffering from Alzheimer's or Pick's disease (Duguid et al. 1989). In the same year,

Bettuzzi et al. reported up-regulation of TRPM-2 (rat clusterin) in involuting prostatic

epithelial cells undergoing apoptosis following chemical or surgical castration (Bettuzz
et al, 1989). Since then, elevated TRPM-2 expression has also been reported in
regressing mammalian glands after weaning, in the renal collecting ducts and distal

tubules after ureteral obstruction, and in a variety of carcinomatous cells undergoing c
death following the removal of trophic hormones which normally sustain their survival
(Wong et al, 1993). More recently, increased clusterin expression has been observed in
populations of photoreceptors undergoing apoptosis in retinal degeneration slow (rds)
mutant mouse retinas (Agawal et al, 1996) and light-induced degenerative rat retinas
(Jomaryeffl/., 1999).
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NECROSIS

APOPTOSIS

Mild convolution
Chromatin compaction
and segregation
Condensation of
cytoplasm

Chromatin clumping
Swollen organelles
Flocculent mitochondria

I
•%J*G}
Disintegration

I

Release of
intracellular
contents

I

Inflammation

i
^J

Nuclear fragmentation
Membrane blebbing
Apoptotic bodies

Phagocytosis

Apoptotic body

Phagocytic cell
(macrophage)

Figure 1.8 : Schematic outline of the comparative morphological differences that occur in necrotic and
apoptotic cells. Necrosis or accidental cell death is characterised by the loss of plasma membrane integrity
and cell rupture, which causes the release of intracellular contents and localised inflammation. Apoptosis
or 'programmed' (non-pathological) cell death involves cytoplasmic and nuclear condensation, membrane
blebbing and formation of apoptotic bodies, followed by phagocytosis. In contrast to necrosis, apoptosis
does not result in inflammation. Source: Kuby, 1997.

N u m e r o u s hypotheses regarding the involvement of clusterin in apoptosis h a v e
been proposed. It has been suggested that clusterin may directly activate an apoptotic
suicide mechanism, enhance the opsonization of cell debris, or even function as a
chemoattractant for phagocytic cells by 'labelling' or marking cell debris for removal
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(Wong et al, 1993; French et al, 1994).

Initial reports suggested that cells over-

expressing clusterin are themselves apoptotic. However, it is important to note that th

not always the case. For instance, cells of the skin, intestinal epithelium, and placent

decidual cells that are constantly undergoing apoptosis do not seem to express clusteri
levels that can be measured (Aronow et al, 1993). In addition, in vitro studies using
human thymus cells have shown that clusterin gene expression occurs much more

prominently in non-apoptotic cells that are in the immediate vicinity of cells undergoi

PCD (French et al, 1994). Therefore, it is reasonable to suggest that clusterin expressi

may not be an initiating factor in apoptosis, but rather appears as a consequence of it.
Indeed, clusterin has been shown to protect a wide range of cells from apoptotic cell

death mediated by various stimuli that include amyloid-p" (1-40) neurotoxicity (Boggs et
al, 1996), oedematous caerulein-induced pancreatitis (Calvo et al, 1998), ultraviolet B
irradiation (French et al, 1994), hypoxia-induced ischemia (Hee Han et al, 2001), TNFoc-mediated cytotoxicity (Humphreys et al, 1997; Sensibar et al, 1995), peroxide
(H2O2)- induced oxidation (Schwochau et al, 1998), heat shock (Viard et al, 1999) and
the withdrawal of growth factors such as pregnant mare serum gonadotropin (PMSG)
(Zwain and Amato, 2000).
The correlation between elevated levels of clusterin mRNA and the survival of
carcinoma cells such as human renal clear cell carcinoma (Parczyk et al, 1994) and
RUCA-I rat endometrial adenocarcinoma (Bora et al, 1993) also led to the suggestion

that clusterin may promote cell survival by suppressing the terminal complement cascade.

If this is true, and if clusterin can truly inhibit complement-mediated lysis in vivo (s

section 1.3.3.4), its expression during cancer development might prove to be a signific
hindrance to possible cancer therapies that sought to utilise the body's own complement
system to target and dispose of the rogue cells.
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1.3.3.4 Clusterin in complement regulation
As a part of the general vertebrate immune system, the complement system

consists of at least 29 different serum and membrane proteins (C1-C9, factors B and D,

and a series of regulatory proteins) and is responsible for causing a variety of immun

responses, such as localised inflammation and lysis of foreign microorganisms (reviewe
in [Kuby, 1997; Holers et al, 1985; Liszewski et al, 1991). The activation of

complement is triggered either by bound antibodies (to initiate the classical pathway)
polysaccharides (the alternative and lectin pathways) on the surface of foreign cells
often causes the dilation of blood vessels and accumulation of phagocytes at sites of

infection. One distinct feature of the complement system is the assembly of complement
proteins (C5b, C6, C7, C8, and C9) into a membrane attack complex (MAC), which,

upon insertion into the cell membrane, is responsible for cell lysis resulting in cell
(Kuby, 1997). The formation of the MAC is highly regulated and if any one of the

complement components fails to associate correctly or bind to the target membrane, all
lysis will not eventuate (Kirszbuam et al, 1989).
The demonstrated ability of clusterin to bind with high affinity to purified
terminal complement proteins C5b, C7, C8 and C9 led to the proposal that it functions
a complement regulator (Murphy et al, 1988; Tschopp et al, 1993). In numerous in
vitro studies, the binding of clusterin to complement proteins was shown to prevent
formation of the MAC, resulting in the inhibition of complement-mediated cytolysis of
variety of cell types. Choi-Miura et al, 1989, reported that the complement-dependent

hemolysis of erythrocytes could be inhibited by the incorporation of clusterin prior t
addition of C7 to C5b6. However, when clusterin was added simultaneously with C5b6,
C7, C8 and C9, complement-mediated cytolysis was enhanced. This observation was
interpreted as evidence that clusterin inhibits complement by masking the membrane-
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binding site of C5b-7 thus preventing its association with the membrane, and hence, cell
lysis. The association of clusterin with C5b-7 may be of significant importance in the
prevention of complement-mediated lysis of healthy bystander cells by fluid phase C5b-7
complexes that have missed their intended targets. In situ experiments conducted by
McDonald and Nelsestuan in 1997 on rat kidneys supported this hypothesis by showing
that complement-induced glomerular injury could be augmented in kidneys that are
perfused with clusterin-depleted plasma. Similarly, glomerular damage in the rat kidney
upon complement activation was enhanced when perfused with human plasma depleted
of clusterin to 30% of the initial concentration (Saunders et al, 1994). Taken together,
the above-mentioned reports suggest that clusterin may function as a complement
regulator to inhibit complement-mediated cytolysis.
In contrast, a recent report challenges the idea that clusterin functions as a
complement regulator by presenting data showing that, at physiological plasma

concentrations (i.e. reported as ranging from 50 - 150 p.g/ml), exogenous clusterin could
not protect (i) sheep or rabbit erythrocytes against classical or alternative complement
pathway mediated lysis, (ii) human erythrocytes undergoing insulin-induced complement
mediated lysis, and (iii) transfected L929 cells from complement-mediated lysis in human
serum (in this model, clusterin was expressed as a cell surface protein) (Vakeva et al,
1993). In the case of undiluted serum, results showed that approximately 30 mg/ml
clusterin was required to protect 50% of sheep or rabbit erythrocytes against lysis
mediated by undiluted serum, which equated to a clusterin concentration at least two
orders of magnitude greater than that in normal human serum. As a result of these

findings, it was concluded that clusterin might not be a physiologically relevant regula
of complement activation. This supported an earlier finding that clusterin colocalised
with the MAC on the surface of damaged cardiomyocytes but was not present on the
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surface of undamaged cardiomyocytes, and that it was unable to protect myocardium
against complement-mediated attack (Hatters et al, 2002). Therefore, a genuine role of
clusterin as a physiological regulator of complement remains to be established.

1.3.3.5 Clusterin as a molecular chaperone
A common theme reflected in the many functions proposed for clusterin is that it
is implicated as a component of the general response to cellular and tissue injuries.
Clusterin has been associated with a variety of disease states including Alzheimer's
disease (May and Finch, 1992; Choi-Miura and Oda, 1996), scrapie (Duguid et al,
1989) renal tubular injury (Rosenberg et al, 1993), atherosclerosis (Fink et al,
1993), epilepsy (Danik et al, 1991), and retinal degeneration (Jomary et al, 1999),
just to name a few. The role played by clusterin in these diseases is still unknown.
However, recent findings suggest that clusterin may be involved in protein unfolding in
vivo and that it may function as a molecular chaperone in the diseases with which it is
associated. Many other chaperones, such as the Hsps, are also associated with the same
disease states as clusterin (section 1.2.6).
As mentioned earlier, in vitro studies conducted by Humphreys et al, 1999,

showed, for the first time, that clusterin has functional similarities to the small hea

proteins, a group of intracellular molecular chaperones which function in vivo to protec

other proteins from stress-induced unfolding, aggregation and precipitation. This repor

highlighted clusterin's ability to interact with, and stabilise, numerous unrelated stre
affected target proteins to form soluble high molecular weight (HMW) complexes. These
substrates included heat-stressed catalase and glutathione S-transferase (GST), and
chemically reduced a-lactalbumin (a-lac) and bovine serum albumin (BSA). Enzymelinked immunosorbent assays (ELISAs) revealed that, like the sHsps, clusterin binds
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preferentially to stressed proteins. Although clusterin was able to inhibit stress-induced

precipitation of test proteins, it was unable to protect catalase and GST against stressinduced loss of activity.
Recently, Hatters et al demonstrated that clusterin, at substoichiometric ratios (1 :
30-100, clusterin:apoC-H) could suppress in vitro amyloid formation by apoC-II, a

lipoprotein lipase activator, but failed to promote fibril dissociation (Hatters et al, 20
This behaviour of clusterin was consistent with the report by McHattie and Edington,
who demonstrated that the in vitro aggregation of the neuropeptide PrP106-126 to form

amyloidal fibrillar structures could be prevented in a dose-dependent manner by clusterin
(Mc Hattie and Edington, 1999). More specifically, 100 u.g/ml of clusterin was able to
suppress the aggregation of PrP106-126 by as much as 90% with only a further 5%
reduction in aggregation in the presence of 1 mg/ml clusterin.
The manner in which clusterin interacts with its substrates is still under

investigation. One suggestion involves the binding of clusterin to its substrates through
hydrophobic interactions, in much the same way as Hsp-substrate binding is believed to
occur. By sequence analysis and ANS binding, clusterin has recently been shown to
contain three flexible, molten-globule-like regions that are highly conserved among the
different mammalian clusterin homologues (Bailey et al, 2001). A prominent feature of
these regions of predicted disorder, approximated to the N- and C-termini of the a- and

|3-subunits, respectively, and the N-terminal region of the ^-subunit, is the presence of

amphipathic a-helices. It is the hydrophobic surfaces of these a-helices that are believe
to be important for clusterin binding to the cell membrane of sperm (Law and Griswold,
1994) and to the various, naturally found or stress-affected ligands, most of which are
predominantly hydrophobic.
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1.4 THESIS OBJECTIVES
The report by Humphreys et al, 1999 highlighted clusterin's ability to stabilise a
wide range of unrelated stress-affected proteins and provided the first step towards an
understanding of the possible role of clusterin in the processes of protein unfolding and
refolding. This project aimed to further characterise the structure-function relationship
clusterin and to address a number of uncertainties relating to its role as a molecular
chaperone. The following questions were addressed:
1) Can the apparent generality of clusterin's chaperone activity be extended further to

include other, previously untested, substrate proteins such as ovotransferrin (also known

as conalbumin), lysozyme, and y-crystallin? This was to firmly establish that clusterin is
a molecular chaperone with broad substrate specificity.
2) What effects do temperature andpH have on the chaperone activity of clusterin? The
action of certain Hsps, such as a-crystallin, is enhanced at elevated temperature; the
effect of pH is unknown.
3) Can clusterin preserve the enzymatic activity of stressed catalase and alcohol
dehydrogenase? Catalase was chosen to confirm previous findings by David Humphreys,

who had shown that clusterin was unable to prevent heat-induced loss of catalase activity.
Alcohol dehydrogenase, on the other hand, had not been tested.
4) Does clusterin possess ATPase activity? If clusterin had ATPase activity it might
indicate that clusterin could refold its substrates, since most chaperones that are
stoichiometrically able to refold proteins require ATP to do so.

5) If clusterin is incapable of refolding its substrates, can it stabilise stressed protei
a state competent for refolding by other chaperones (eg. Hsc 70)?
6) Can recombinant DNA technology be used to identify the structural domains
responsible for the function of clusterin as a molecular chaperone?
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Chapter 2

General
Materials and Methods
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2.1 GENERAL BUFFERS AND SOLUTIONS
Buffers that were used throughout this project include: phosphate buffered saline
(PBS; 137 mM NaCl, 2.7 mM KC1, 1.47 mM KH2P04, 11.6 mM Na2HP04, pH 7.4),
sodium phosphate buffer (50 mM Na2HP04, pH 7.0), and lx heat-denatured casein
(HDC; 1% (w/v) casein, 0.01% (w/v) thimerosal, in PBS, pH7.4). Other less commonly

used buffers and solutions can be found in their respective sections. A list of che

used in this project, along with their full names, abbreviations, corresponding for

and their suppliers, has been placed at the end of this chapter (Table 2.1). The su
of general consumables that are not listed in Table 2.1 are shown in brackets.

2.2 SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS (SDS-PAGE)
2.2.1 SDS-PAGE Buffers and Stains
The compositions of the various buffers and stains used during SDS-PAGE are
shown in Table 2.1. The resolving and stacking gels for Tris-glycine SDS-PAGE were
prepared using the recipes outlined in Sambrook et al, 1989.

Reagents

Composition

2x Sample buffer

0.005% (w/v) bromophenol blue, 2 0 % (v/v) glycerol, 5 % (w/v) SDS,
0.5 M Tris HC1, pH 8.8.

lx Running buffer

0.1% (w/v) SDS, 0.25 M glycine, 0.025 M Tris buffer, pH 8.3.

Coomassie blue stain

0.25% (w/v) coomassie brilliant blue (R250), 100 m L glacial acetic acid,
450 m L Methanol, 450 m L R O water.

Destain solution

100 m L glacial acetic acid, 450 m L Methanol, 450 m L R O water.

Table 2.1: Compositions of the buffers and stains used during SDS-PAGE.
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2.2.2 SDS-PAGE

Methods

2.2.2.1 Loading Protein Samples and Performing Electrophoresis - Samples containing
a minimum of 10 \ig of protein were usually prepared in PBS to which an equal amount
(v/v) of lx sample buffer (Table 2.1) was added. For reduced samples, a 1% final
concentration of 2-mercaptoethanol was also added. Samples were boiled for 5 minutes

before being loaded into the wells. Running buffer (Table 2.1) was subsequently poured

into the designated buffer chambers before the gel was electrophoresed at a constant 1
V until the dye front had reached the bottom of the gel. SDS-PAGE was performed
using a Novex® "XCELL E" SDS-PAGE unit connected to a Bio-Rad model 1000/500
power unit.

2.2.2.2 Staining and Destaining - Once the electrophoresis had been completed, the gel
was placed into a Coomassie Blue staining solution (Table 2.1) and left to stain for

approximately 1 to 1.5 hours. The gel was then destained with 'destain' solution (Tabl
2.1) until it had been sufficiently destained and the bands were clearly visible.

2.2.2.3 Gel Drying and Storage - The gel drying procedure was performed in accordance
with the manufacturer's specification (Novex, Sydney). Basically, this procedure
involved he destained gel being placed into a Gel-Dry™ drying solution for 20 minutes
before drying overnight at room temperature, sandwiched between two sheets of
cellophane, in a Novex gel-drying frame. Once dried, the cellophane-sandwiched gel

was lifted from the frame and taped on all sides to prevent the two sheets of cellopha
from separating. The gel was then stored flat within a book.
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2.3 AGAROSE GEL ELECTROPHORESIS
Agarose gel electrophoresis was used for the electrophoretic separation of native

proteins as well as for DNA samples. The techniques used for electrophoretic separatio

of these two types of samples were basically identical, with the exception of the buff
components used.

2.3.1 Buffers for Native and DNA Agarose Gels
The compositions of the various buffers and stains used during native and DNA
agarose gel electrophoresis are shown in Tables 2.2 and 2.3, respectively.

Reagents

Composition

lx Running buffer

40 m M Tris, 1.142 m L glacial acetic acid, 1 m M E D T A , p H 7.4.

Sample Buffer

1 % (w/v) Bromophenol blue, 1 0 % (v/v) glycerol

Staining solution

Colloidal coomassie G-250 (Noveline, Australia)

Destain solution

100 m L Glacial acetic acid, 450 m L methanol, 450 m L R O water.

Table 2.2: Compositions of the various reagents used during native agarose gel electrophoresis.

Reagents

Composition

lx Running buffer

40 m M Tris, 1.142 m L glacial acetic acid, 1 m M E D T A , p H 7.4.

6x Sample Buffer

1 % (w/v) Bromophenol blue, 1 0 % (v/v) glycerol

Table 2.2: Compositions of the various reagents used during D N A agarose gel electrophoresis.
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2.3.2 Agarose Gel Electrophoresis Set-up
The agarose gel electrophoresis unit used was the "Mini-Sub™ DNA Cell"
system (Bio-Rad Laboratories, Sydney). A Bio-Rad model 1000/500 power pack was
connected to this electrophoresis unit.

2.3.3 Agarose Gel Electrophoresis Methods:
2.3.3.1 Casting and running agarose gels - 1% agarose gels were prepared by heating
and dissolving 1 g of analytical grade agarose (Promega, Sydney) in 100 mL of lx

running buffer (or at an equivalent final concentration) in a microwave oven. For DNA

gels, ethidium bromide (EtBr) was added to the dissolved agarose solution (after it h
been allowed to cool to approximately 40 - 50 °C) to a final concentration of (0.5

pg/ml). Once dissolved, the gel was poured into an appropriately-sized gel casting tra
before a comb was inserted to form the wells, and the gel was allowed to set at room
temperature. Once the gel had set, the comb was removed before samples, containing a

minimum of 10 pg protein or DNA in the appropriate sample buffer, were loaded into th
wells. Thereafter, running buffer was applied to the buffer chambers located at both

of the gel and electrophoresed at a constant 60 V for approximately 2-2.5 hours or un
the dye front had reached the end of the gel.

2.3.3.2 Visualisation of DNA or Protein Bands - DNA, stained with EtBr and separated

on the basis of size by agarose gel electrophoresis, was detected as bright orange ba
when viewed under ultraviolet light. Gel images were captured by a digital video
camera, which was mounted above the viewing platform on which the gel was placed to
be viewed. Native proteins were visualised only after they had been transferred onto
membrane (PVDF or nitrocellulose), where they were stained with Colloidal coomassie
G-250 stain (see below).
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2.4 WESTERN (PROTEIN) TRANSFER
Western transfer is a procedure by which proteins are transferred onto a
membrane (e.g. Polyvinylidene difluoride (PVDF; Brasatec, South Australia) or

nitrocellulose membranes). Once transferred, these proteins can either be stained or
more commonly, probed with, for example, enzyme-labelled antibodies; refer to
section 2.5). Proteins can be transferred electrophoretically from SDS-PAGE gels or

by capillary action from native agarose gels. The general set-ups for these two west

transfer procedures are shown in Figure 2.1 and 2.2. In this project, membrane-bound

proteins (such as clusterin) were stained with Colloidal Coomassie G-250 (Table 2.2
for approximately 5 minutes, followed by a longer period of destaining with destain
solution (Table 2.2). Thereafter, the membrane was immuno-labelled and developed
with enhanced chemiluminescence detection (ECL).

2.5 IMMUNO-LABELLING OF MEMBRANE-BOUND PROTEINS
The first step in the labelling of membrane bound proteins involved the blocking
of potential binding sites on the membrane to minimize non-specific binding of
immunological reagents. This was achieved by incubating the membrane in heat-

denatured casein (HDC; section 2.1) for 1 hour at room temperature, after which, the
HDC was removed with several washes using lx PBS. This was followed by the

addition of the primary antibody (at 10 pg/ml in HDC; raised in mice and is only spe

for the protein of interest) and left at room temperature for another hour. After ri
the membrane in lx PBS to remove excess, unbound antibodies, a solution containing
the secondary antibody (sheep anti-mouse Ig-HRP (horseradish peroxidase) conjugated
antibody (Silenus, Melbourne, Australia) at 1:1000 dilution in HDC) was added and
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left at room temperature for one hour after which, the membrane was washed
and developed with ECL.

Clamp

Sequence for applying transfer materials
(applied to the white side)

ooooo
ooooo
ooooo

White
side

o

Black
side

o

1. Blotting sponge #1
2. One sheet of blotting paper
3. Single membrane
( P V D F or Nitrocellulose)
4. Gel
5. O n e sheet of blotting paper
6. Blotting sponge #2

Figure 2.1a : Schematic representation
of the 'mini gel holder cassette' for the
Bio-Rad western transfer unit. S h o w n
on the right of it is the sequence in
which transfer materials were applied
onto the cassette.
(Source: This diagram was drawn from
observation)

Electrical leads
to power pack

Mini Gel Holder Cassette

Figure 2.1b : A schematic
representation of the general
setup
for the Bio-Rad
western transfer unit for
transferring proteins from
S D S - P A G E gels onto a

(Black side)

(Black side)

membrane.
(Source: This diagram was
drawn from observation)

Stirling rod

Weight

1 Stack of
absorbent paper

4 Sheets of
blotting paper
Direction of buffer
uptake by
capillary action

Nitrocellulose
membrane

Agarose gel

2 Sheets of
blotting paper
with ends folded
to facilitate buffer
uptake
1x Native Gel
Electrophoresis
Running
Buffer

Glass Plate

Figure 2.2: Protein (Western) transfer by capillary action. The passive transfer of proteins from a
'native' agarose gel onto a nitrocellulose membrane was achieved by capillary transfer of buffer from a
central reservoir (tray), through the gel, membrane, blotting paper, and into a stack of absorbant paper
situated at the top of the set-up. This procedure usually required 1 2 - 1 6 hours to complete. The stack
of highly absorbant paper was simply toilet paper that had been cut to size.

(Source: This diagram was drawn from observation)
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2.6 ENHANCED CHEMILUMINESCENCE DETECTION(ECL)
ECL is a procedure (performed in the dark room) in which membrane-bound and
immuno-labelled proteins are detected on photographic film. This procedure has been
summarised as follow:

A detection solution comprising of equal volumes of the 'stable peroxide' and
'luminol/ enhancer' solutions (collectively known as the enhanced chemiluminescence

SuperSignal® substrate working solution; for detection of HRP labels; Pierce, Sydney
Australia) was spread over a membrane and left to develop for 1-2 min. For the
detection of picogram (10"12 g) or greater amounts of HRP-lebelled proteins,
SuperSignal® WestPico was used. For the detection of femtogram (10"15 g) amounts of
HRP-lebelled proteins, SuperSignal® WestFemto (Pierce, Sydney) was used. The

membrane was then drained of the detection solution, wrapped up in plastic food wrap

and placed, with a small sheet of autoradiography film (Du Pont) placed on top, into

light-proof cassette containing a Kodak 'X-Omatic Intensifying Screen' and allowed t
develop for a short period of time (ranging from a few seconds to a few minutes
depending on the level of chemiluminescence displayed by the membrane-bound

proteins). Once developed, the film was taken out of the light-proof cassette and pl
into a solution of 'developer' until the bands became visible. The film was then
transferred into a 'fixing' solution and left for a few minutes before being placed
water, after which the film was air-dried.

2.7IMMUNO - 'DOT BLOTS'
Another method for the detection of specific proteins in a given mixture involved
the application of small volumes (usually 1-10 pi) of proteins mixtures onto a
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nitrocellulose membrane.

These protein samples were applied in such small volumes

that they appeared as dots on the membrane (hence, the resulting membrane is known

a 'dot-blot'). Once the samples had dried, the protein of interest was detected usi
immuno-detection (section 2.5) and ECL techniques (section 2.6).

2.8 Bicinchoninic Acid (BCA) MICRO-PROTEINASSA Y
The BCA micro-protein assay (Smith et al, 1985) was used to determine the

concentration of total "unknown" proteins in solution. This technique was performe
96-well microtitre plates (Sarstedt, SA). The compositions of buffers used in this
procedure are shown in Table 2.4.

Reagents

Composition

Reagent A

8 % (w/v) Na 2 C0 3 .H 2 0, 1.6% (w/v) Na 2 tartrate, in millie-Q water
pH 11.25.

Reagent B

4 % (w/v) BCA.Na 2 in milli-Q water

Reagent C

4 % (w/v) CuS04.5H20 in milli-Q water

Working reagent ( W R )

4 Volumes of reagent C, 100 volumes of reagent B, 104 volumes of
reagent A.

Table 2.4: Compositions of B C A reagents used for the determination of protein concentrations.

2.8.1 Methods - T o a clean 96-well microtitre plate, 100 pi of B S A protein standards

were added to the wells in the first three columns (setting up a triplicate series)

of decreasing concentration (i.e. from 80-0 pg/ml) down the plate. To the next thre

columns, a series of binary or trinary dilutions of the "unknown" protein sample wa
performed down the plate (giving a final volume of 100 pi. To each well, 100 pi of

(Table 2.4) was added. With a lid in place, the plate was sealed with cellotape and
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incubated at 60 °C for 30 min; during this time, a purple colour developed in wells
containing protein. The plate was then removed and allowed to cool to room

temperature, after which the tape and the lid were removed. The plate was subsequen

read at 595 nm. A plot of absorbance of the BSA standards was generated and used to
interpolate the concentration of "unknown" proteins.

2.9 IMMUNOAFFINITY PURIFICATION OF CLUSTERIN
2.9.1 Preparation of Human Serum - Human serum (Red Cross Blood Bank, Sydney

Australia; stored at -80°C) was thawed in a 37°C water bath before protease inhibit

0.2 mM phenylmethylsulfonylfluoride (PMSF; active against chymotrypsin and trypsin,
added from a stock solution in DMSO) and 1 mM Ethylenediaminetetraacetic acid
(EDTA; active against metalloproteases), were added. The serum was then suction
filtered through a 70 mm glass microfibre filter paper (Whatman).

2.9.2 G7-Sepharose Purification of Clusterin - Before being used, the G7 anti-clust
monoclonal antibody-coupled Sepharose 4B immunoaffinity column was equilibrated
with PBS/azide until the absorbance, as measured by a Bio-Rad Econo UV monitor
(model EM-1) and recorded on a Bio-Rad model 1325 Econo recorder (Figure 2.5), had

reached a stable base line. The peristaltic pump was set to a flow rate of 0.5 ml/m

UV monitor was set to 0.2 absorbance units, whilst the chart recorder was set at 10

with a scroll rate of 0.2 cm/min. The protease-inhibited serum was then passed thro

the column, followed by PBS/azide until the base line had been restored. Clusterin,

this stage, was immobilised on the column. 0.5% (v/v) Triton X-100 in PBS/azide was
then passed through the column to remove any apolipoprotein A-I bound to the
immobilised clusterin, followed by more PBS/azide. Once the base line had been
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reached, clusterin was desorbed and eluted from the column using 2 M

guanidine

hydrochloride (pH 8.0) in PBS. Lastly, PBS/azide was pumped through the column to
wash out excess guanidine hydrochloride and to recondition the column. Clusterin,
having been eluted with guanidine hydrochloride (a protein-denaturating agent), was
thence dialysed against 5-6 L of PBS/azide at 4°C (overnight).

2.9.3 Protein G Purification of Clusterin - Clusterin is known to bind immunoglobulin
(Wilson and Easterbrook-Smith, 1992). Therefore, when the serum fraction is
passed through the G7-sepharose immunoaffinity column, some immunoglobulins
may be co-purified with clusterin. Clusterin-Ig fractions (eluted from the G7) were

passed through a protein G column (which binds IgG but not clusterin). Since clusteri
does not bind the protein G, it was collected as the first peak. PBS/azide was
subsequently pumped through the column to restore the absorbance (at 280 nm) to base
line. The bound Ig fraction was then eluted (producing the second peak) using 2 M
guanidine hydrochloride (pH 8.0), after which, more PBS/azide was used to wash the
column and restore A2so to base line. Concentrations of clusterin solutions were
determined by BCA micro-protein determination.
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Table 2.5: A tabulated list of chemicals and reagents (including their formulae and the n a m e of their
supplier) used throughout this thesis project.

NAME

FORMULAE

COMPANY/ SUPPLIER

41D Anti-clusterin Antibody

-

78E Anti-clusterin Antibody

-

oc-Crystallin (total) (From Bovine Eye Lens)

-

GiftfromYoke Berry

cc-Lactalbumin (From Bovine Milk)

-

Sigma

Acetic Acid (Glacial)
Acrylamide
adenosine 2',5'-Diphosphate (ADP)
Adenosine 5'- Triphosphate (ATP)
Agarose (Analytical Grade)

CH3COOH

Ajax Chemicals

C3H5NO

ICN Biomedicals

C10H15N5O10P2

Sigma

C,oH14N5OnP3Na2

Sigma

-

Promega

-

Sigma

Ammonium Persulfate

(NR^S.Og

Sigma

Bis-Acrylamide

C7H10N2O2

ICN Biomedicals

Alcohol Dehydrogenase (ADH) (From Equine Liver)

Bicinchoninic Acid (BCA)
Bovine Serum Albumin (BSA)
Bromophenol Blue
Casein (from Bovine Milk)
Catalase (from Bovine Liver)
Citric Acid
Colloidal Coomassie G-250 Staining Solution
Coomassie Blue (R250)
Copper Sulfate

C2oH10N204Na2

Sigma

-

Sigma

Ci9riioBr405S

Sigma

-

Sigma

-

Sigma

C 6 H 8 0 7 .H 2 0

C45H44N307S2Na
CuS02.5H20

Ajax Chemicals
NoveLine Pty Ltd
Sigma
Ajax Chemicals

Cyanogen Bromide- Activated Sepharose 4B

-

Sigma

Dextran

-

ICN Biomedicals

di-Sodium Hydrogen Orthophosphate

Na 2 HP0 4

Ajax Chemicals

Dimethyl Sulfoxide (DMSO)

(CD3)2S0

B D H Chemicals

Dithiothreitol (DTT)

C4Hio02S2

DMEM/HAMSF-12
Ethidium Bromide (EtBr)
Ethylenediaminetetraacetic Acid (EDTA)

-

Sigma
T R A C E Biosciences

C21H20N3Br

Sigma

Ci0H,2N2O8Na4

Sigma

Foetal Calf Serum (FCS)

-

T R A C E Biosciences

G7 Anti-clusterin Antibody

-

-

y-Crystallin (From Bovine Eye Lens)

-

Sigma

Glutathione s-Transferase (GST)

-

GiftfromSimon E.B-Smith

Glycerol
Glycine (Gly)
Guanidine Hydrochloride (GuHCl)

C,H 8 0 3

Sigma

C 2 H 5 N0 2

ICN Biomedicals

CH5N3.HC1

ICN Biomedicals
ICN Biomedicals

HEPES
Hydrochloric Acid

HC1

Ajax Chemicals

Hydrogen Peroxide

H202

Ajax Chemicals

Lysozyme
Magnesium Chloride

MgCl2.6H20

Sigma
United States Biochemicals

2-Mercaptoethanol (2-Hydroxyethylene Mercapan; betaMercaptoethanol)

C 2 H 6 0S

Sigma

Methanol

CH,OH

Ajax Chemicals

N-(2-Hydroxyethyl) piperazine-N'-(2-Ethanesulfonic acid) (HEPES)
Nicotinamide Adenine Dinucleotide (reduced form beta-NADH)

C 8 H lg N 2 0 4 S

Sigma

C2iH27N70,4P2

Sigma
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Ovotransferrin (alias; Conalbumin) from Chicken Egg White

-

Sigma

Phenylmethylsulfonylflouride (PMSF)

C 7 H 7 F0 2 S

Sigma

Phosphoenol Pyruvate (PEP)

C 3 H 2 06P

Sigma

Potassium Chloride
Potassium di-Hydrogen Orthophosphate
Propidium Iodide

KC1

Ajax Chemicals

KH2P04

Ajax Chemicals

C 27 H 34 N 4 I 2

Sigma

-

Sigma

-

Sigma

-

Silenus

Sodium Azide

NaN3

Sigma

Sodium Chloride

NaCl

Ajax Chemicals

Protein G
Pyruvate Kinase/ Lactate Dehydrogenase (from Rabbit Muscle)
(PK/LDH)
Sheep Anti-mouse Ig (Affinity Isolated; FTTC-Conjugated)
Sheep Anti-mouse Ig (Affinity Isolated; HRP-Conjugated)

Silenus

Sodium Dodecyl Sulfate (SDS)

C12H250S03

B D H Biochemical

Sodium Carbonate

Na 2 C0 3 .H 2 0

Ajax Chemicals

NaHC03

Ajax Chemicals

Sodium Hydrogen Carbonate
Sodium Hydroxide
Superose-6 Gel Filtration Medium
Tartrate (di-sodium)
TEMED(N,N,N',N'-Tetramethylethylenediamine)
Tris- (Hydroxymethylaminomethane)
Triton X-100

NaOH

C 4 H40 6 Na 2 .2H 2 0
C6H16N2

Ajax Chemicals
Pharmacia/ Amersham
Biotech.
Ajax Chemicals
Sigma

C4H„N03

ICN Biomedicals

-

Ajax Chemicals

Chapter 3

Clusterin has Chaperone Activity Similar to
the Small Heat-Shock Proteins
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3.1 INTRODUCTION

Like clusterin, small heat shock proteins (sHsps) are abundant and highly
ubiquitous proteins. Under physiological conditions, sHsps account for approximately

0.1% of the total protein content in cells. Small Hsps have been detected in virtually
all major types of organisms, from bacteria to plants and animals (Jakob et al, 1993;
Jones et al, 1986; Leroux et al, 1997). Whereas only a few members of the sHsp
family are present in mammals, birds and yeast, numerous sHsps have been reported in
the cytosol and organelles of cells from Drosophila melanogaster and plants
Ehrnsperger et al, 1997; Klemenz et al, 1991). The major eye lens protein, cccrystallin, which exists in two highly homologous isoforms, ocA- and aB-crystallin,
have also been included in the sHsp family due to their structural and functional
similarities. However, unlike other Hsp families, members of the sHsp family share
very little sequence homology with one another. Despite this, sHsps are grouped
together on the basis of (i) a highly conserved C-terminal region, termed the "a-

crystallin domain" (ii) their low monomeric molecular mass, (iii) increased expression
as a result of heat shock, and (iv) their ability to act as ATP-independent molecular
chaperones (Gething, 1997; Lee etal, 1995; Welch, 1985).

Structurally, CD spectroscopy has revealed that sHsps are predominantly (3structured whilst electron microscopy studies have shown that they exist as globular
complexes with a diameter of about 12-18 nm. Clusterin, on the other hand, has been
predicted to be predominantly oc-helical (41%), with the remainder of the sequence
consisting of p-sheets (19%) and turns (32%). At present, no detailed electron
microscopy images are available for clusterin. Whereas one subunit of clusterin has a
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molecular mass of approximately 40 kDa, the subunit molecular mass of sHsps ranges
from 12 to 42 kDa (Jakob et al, 1993). In the cell, sHsps do not exist as monomers,
but rather aggregate to form large ring-shaped complexes called heat shock granules
that share structural similarities with prosomes and proteosomes (Klemenz et al,
1991). These heat shock granules vary significantly in size and number of subunits
between proteins. For instance, the structure of Mycobacterium tuberculosis Hspl6.3

is comprised of a 150-kDa trimer of trimers (i.e. a total of 9 subunits) and is one of
smallest characterised sHsp quaternary structure, whereas the structure of
Methanococcus jannaschii Hspl6.5 has been reported to be comprised of twenty-four
monomers that interact with each other to form a hollow spherical complex with an
outer diameter of 120A and an inner diameter of 65A (Kim et al, 1998). Furthermore,
Pisum sativum Hspl8.1 and bovine oc-crystallin have 12 and 32 subunits, respectively.
In general, plant sHsp complexes are typically 200-300 kDa in mass, whilst yeast and
mammalian sHsps exist as oligomeric complexes of 32-40 subunits with an average
total molecular mass of 300-800 kDa (Jakob et al, 1993).
Small Hsps share no sequence homology with clusterin. Human clusterin and
bovine ocA-crystallin share only three small regions of sequence similarity. These
regions correspond to human clusterin residues 203-210, 227-233, and 243-249.
Residues 243-249 also correspond to a region of the "oc-crystallin domain" (residues

70-76 of ocA-crystallin) (Leroux et al, 1997). Whether this has some structural and/or
functional significance remains unknown. However, based solely on the fact that the

primary function of the oc-crystallin domain of sHsps is to mediate interactions betw

sHsps and hydrophobic regions of partially unfolded substrates, it is possible that t

corresponding region in clusterin may also be responsible for its ligand binding abil
This remains to be established.
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The expression of sHsps, like clusterin, is elevated primarily in response to heat
shock. The level of sHsps produced as a result of heat shock can increase by as much
as 20-fold, to amount to approximately 1% of the total intracellular protein content

(Waters et al, 1996). In plants and nematodes, this increase may even reach as high a
200-fold (;Jones et al, 1986; Waters et al, 1996). Oxidative stress (Courgeon et al,
1988), glucose deprivation, exposure to chemical agents (Stringham and Candido,

1994), infection by pathogens and cellular injuries (Mehlen et al, 1995) may also lea
to an increased production of sHsps. As molecular chaperones, sHsps function in an
ATP-independent manner to protect organisms from stress and confer thermotolerance

to cells. Recently, clusterin has been shown to act in vitro as a chaperone inhibitin
stress-induced precipitation of a wide range of substrate proteins in the absence of
(Humphreys et al, 1999). In vivo, sHsps have been shown to bind cytoskeletal
components - actin and the intermediate filaments, desmin, vimentin, and glial

fibrillary acidic proteins. The survival of cells subjected to heat shock and additio

oxidative stresses is enhanced due to the sHsps conferring increased stability to the
actin filaments (Jakob et al, 1993).
The ability of sHsps to prevent the aggregation of numerous non-related
stressed substrates in vitro is well documented (Horwitz, 1992; Jakob et al, 1993;
Leroux et al, 1997; Chang et al, 1996; Kim et al, 1998); oc-crystallin, human Hsp27
and murine Hsp25 were amongst the first sHsps to be identified with chaperone
activities (Horwitz, 1992; Jakob et al, 1993). The types of substrates favoured by

sHsps are usually identified as being in an intermediately folded (molten globule) st
and are highly prone to irreversible aggregation (Treweek et al, 2000; Carver et al,
1995). At present, the underlying mechanism of chaperone actions of sHsps (and

clusterin) has not been solved although it is thought that stabilisation of target pr
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by sHsps most likely occurs through hydrophobic interactions. This belief is based
mostly on data showing increased binding of oc-crystallin to hydrophobic dyes, 8anilino-1-naphtalene sulfonate (ANS) and bis-ANS, upon elevated temperature; a

stress condition which causes oc-crystallin to undergo structural changes, resulting i
increased exposed hydrophobicity and increased chaperone action Carver et al, 1995).

In addition, the oc-cystallin domain, which is conserved amongst the sHsps, is believed

to be directly involved in mediating the chaperone function of sHsps; this is supported
by studies in which mutations, introduced into the oc-crystallin domain of ocB-

crystallin, caused partial or complete loss of the ability of ocB-crystallin to inhibi
aggregation of stressed target proteins and to confer thermotolerance in E. coli
(Muchowski et al, 1999; Plater et al, 1999).

An important feature of some sHsps is their ability to stabilise unfolded
proteins in such a way that they can be subsequently refolded. This is a crucial
mechanism to ensure that non-native proteins, stabilised by molecular chaperones, can

be refolded back into their functionally active state and, hence, salvaged for further
While some sHsps are capable of partially refolding their own substrates, as
demonstrated by Hsp25 and Hsp27 acting on chemically denatured citrate synthase and

oc-glucosidase (Jakob et al, 1993), peptides that are stabilised by other sHsps (e.g. H
18.1, a pea sHsp) are refolded by more specialised classes of chaperones, many of
which are ATP-dependent (Lee et al, 1997). For example, the E. coli sHsp, IbpB, has
been shown to stabilise heat-denatured malate dehydrogenase (MDH) and ureadenatured lactate dehydrogenase (LDH) in folding-competent states for subsequent
refolding by DnaK, the major Hsp70 of E. coli, in a process that is accelerated by

Hsp60. It is not known whether clusterin can refold its substrates or indeed, whether i
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can stabilise unfolded proteins in a state competent for subsequent refolding by other
known chaperones with refolding capability.
Two well-documented classes of molecular chaperones involved in in vivo
protein folding include Hsp70 and Hsp60. The active form of Hsp70 (Hsp70-ADP)
binds to nascent polypeptides as they emerge from the ribosome, thereby preventing
inappropriate interactions between exposed hydrophobic areas on 'self and
neighbouring protein structures (Garret, R., and Grisham, CM., 1995). The partially
folded protein (in the molten-globule state) is then released from Hsp70 in an ATPdependent step in which ATP is hydrolysed to ADP, before being encapsulated by the
Hsp60/GroEL complex. Here, the polypeptide undergoes a succession of events
including protein binding, ATP-dependent release, and progressive folding prior to
being released in its biologically active and fully folded state.
Interestingly, the ability of Hsp70 to directly facilitate protein refolding has also
been documented. In 1993, Schroder et al. showed that DnaK was capable of refolding

denatured luciferase in vitro; whilst, in 1995, Simons et al, 1995, reported that BiP
major Hsp70 of the endoplasmic reticulum (ER), was able to refold carboxypeptidase

Y (a vacuolar protein) in vivo after translocation through the ER membrane. Similar to
Hsp60-mediated protein folding, ATP-hydrolysis is believed to be crucial for peptide
binding, release and refolding by Hsp70.

This chapter examines the role of clusterin as a molecular chaperone during in

vitro protein unfolding and refolding. The current study demonstrates that clusterin's
extremely broad substrate specificity extends beyond those recently reported by
Humphreys et al, 1999, and includes proteins in undiluted human serum. In addition,
results from native gel electrophoresis and size-exclusion chromatography will be
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presented to show that, like the sHsps, clusterin also forms high molecular weight
(HMW) complexes with its substrates. Furthermore, results will be presented to
illustrate the inability of clusterin to protect two proteins from heat-induced loss of

activity as well as the apparent failure of clusterin to catalyse the recovery of enzyme
activity following the removal of stress. Although clusterin is predicted to contain,
within its sequence, a nucleotide-binding motif (Choi et al, 1989), it is not known
whether clusterin possesses ATPase activity or whether ATP has any effect on
clusterin's chaperone activity. These issues were also investigated. In an attempt to

address the fate of clusterin-bound substrates, this chapter concludes by presenting da
to show that, like some sHsps, clusterin stabilises heat-stressed enzymes in a manner
which allows for subsequent refolding by Hsc70 (the constitutively expressed form of
Hsp70), resulting in the partial recovery of enzyme activity.
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3.2 METHODS
3.2.1 Inhibition of Protein Precipitation - The ability of human serum-derived
clusterin

(/JSCIUS)

to protect substrate proteins from stress-induced precipitation w

examined by measuring the turbidity associated with protein precipitation as

absorbance at 360 nm. A variety of assays were performed, (i) Individual solutions o

ovotransferrin (1 mg/ml) or total y-crystallin (1 mg/ml) in 50 mM Na2HPC>4 buffer, p

7.0, or mixtures of one of these proteins (at the same concentration) with /zsClus (
400 pg/ml) were heated for 40 min at 60°C. The light scattering associated with
protein precipitation for all solutions was measured at 2 min intervals using an
automated seven-chambered diode-array spectrophotometer (Hewlett-Packard GMBH,
Germany), (ii) Solutions of ovotransferrin (1 mg/ml) or lysozyme (250 pg/ml) in 50
mM Na2HPC»4 buffer, pH 7.0, or mixtures of one of these proteins (at the same
concentration) with /zsClus (100-1000 pg/ml) were incubated in 96 well microtitre

plates (Disposable products, Adelaide, Australia) for 6 h with or without the additi
20 mM DTT. During this time, light scattering of each solution was measured every 8
min with a Spectramax 250 microplate reader (Molecular Devices, Sunnyvale, CA).

(iii) The effects of ATP on the inhibition of stress-induced protein precipitation b

clusterin were investigated by monitoring the turbidity associated with target prote

precipitation as absorbance at 360 nm. In all cases, the buffer used contained 50 mM
Na2HP04, 50 mM KC1, and 5 mM MgCl2; in the presence or absence of 2 mM ATP.

(A) Solutions of catalase (1 mg/ml) were heated at 60 °C, in the presence or absence
clusterin (100 pg/ml). (B) Ovotransferrin (1 mg/ml) was heated at 70 °C in the
presence or absence of 75 pg/ml clusterin. (C) Lysozyme (0.25 mg/ml) was reduced
with 20 mM DTT at 42 °C with or without clusterin (400 pg/ml). The extent of
catalase and ovotransferrin precipitation was measured using a diode-array
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spectrophotometer

(Hewlett-Packard

GMBH,

Germany)

whereas

lysozyme

precipitation was conducted in 96 well microtitre plates and measured using a
Spectramax 250 plate reader (Molecular Devices, Sunnyvale, CA). (iv) A solution of
human serum was equally divided into two aliquots. One aliquot was left untreated
and was subsequently named 'normal human serum' (NHS). The other, named

'clusterin-depleted serum' or CDS, was depleted of clusterin by passing over an anti
clusterin monoclonal antibody immunoaffinity column (as described in chapter 2).
Clusterin depletion was confirmed by dot-blot analysis. In the first series of
experiments, both NHS and CDS were diluted 1 in 20 in PBS and supplemented with
100 pg/ml of purified clusterin or control proteins. A time course measuring the
amount of serum protein precipitation in these assays was conducted at 60°C using a
diode-array spectrophotometer (Hewlett-Packard model 8453 spectrophotometer;
integration time, 0.5 s; cycle time, 30 s), over a period of about 16 minutes. The

of protein precipitation was measured as an increase in absorbance at 360 nm. In the
second series of experiments, undiluted NHS or CDS were incubated at 37°C with or
without 20 mM DTT, and in some cases, with 100 pg/ml of clusterin or control

proteins added. These experiments were performed in 96 well microtitre plates and t
turbidity at A360 was measured using a Spectramax 250 plate reader.

3.2.2 ELISA - Native ovotransferrin, at 20 pg/ml in 50 mM Na2HP04 buffer, pH 7.0,
was adsorbed onto 96 well microtitre plates for 1 h at 37 °C. In some cases,

ovotransferrin was stressed during coating of the wells by either (i) heating the p
60 °C for 1 h or (ii) adding 20 mM DTT to the coating buffer and incubating for 5 h
37 °C. Native lysozyme, at 20 pg/ml in PBS, was adsorbed onto 96 well microtitre
plates for 5 h at 37 °C in the presence or absence of 20 mM DTT. In all cases, the
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plates were subsequently blocked with 1 % (w/v) heat-denatured casein ( H D C ) for 1 h

at 37 °C prior to incubation with 5 mM R(+)-[6,7-dichloro-2-cyclopentyl-2,3-dihydro

2-methyl-l-oxo-lH-inden-5-yl)oxy] acetic acid (IAA) for 1 h at 37 °C, to exclude the
possibility of subsequent disulfide bond formation between clusterin and coated

proteins. Purified clusterin, initially at 10 pg/ml, was then serially diluted in b
steps down the plates, using 1% HDC as diluent, and incubated at 37 °C for 1 h. To
minimise non-specific binding of clusterin to the ELISA plates, three washes were
performed with 0.1% (v/v) Triton X-100 in PBS. A cocktail of G7, 78E and 41D anticlusterin monoclonal antibodies was used to detect bound clusterin; DNP-9 was used
as an isotype control. All antibodies were used in the form of unpurified hybridoma
culture supernatant. Bound primary antibodies were detected with sheep-anti-mouseIg-HRP (Silenus, Sydney, Australia) using o-phenylenediamine dihydrochloride (OPD;
2.5 mg/ml in 0.05 M citric acid, 0.1 M Na2HP04, pH 5.0, containing 0.03% (v/v)
H202) as substrate.

3.2.3 Sephacryl S300 Size Exclusion Chromatography - Individual solutions of
clusterin (1 mg/ml) or ovotransferrin (5 mg/ml) and mixtures of clusterin (1 mg/ml)

with ovotransferrin (at 5 mg/ml) were left untreated or treated with heat (60°C for
all solutions in 50 mM Na2HP04, pH 7.0) or DTT (20 mM DTT at 37°C for 5 h; all
solutions in 50 mM Na2HP04, 0.1 M NaCl, pH 7.0). Similarly, solutions of clusterin
(1 mg/ml) or lysozyme (5 mg/ml) and mixtures of clusterin and lysozyme (at the same
final concentrations; in 50 mM Na2HP04, pH 7.0) were left unstressed or stressed by
heating at 60 °C for 1 h in the presence of 20 mM DTT. All samples were then
centrifuged (1 min at 10,000 rpm in a benchtop microfuge) to remove precipitated
proteins. 50 pi of each solution was loaded onto a 25 x 1 cm Sephacryl S300 column
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(Pharmacia Biotech, Melbourne, Australia), which was previously equilibrated with
PBS/Az. Separations were performed at a flow rate of 0.25 ml/min using a lowpressure liquid chromatography system equipped with a 280 nm flow cell
(Econosystem; Bio-Rad, Sydney, Australia).

3.2.4 SDS-PAGE Analysis of Clusterin-Substrate Complexes - The HMW complexes
formed between (i) clusterin and ovotransferrin undergoing heat- or DTT-mediated
stress, or (ii) lysozyme undergoing DTT-mediated stress, eluted in exclusion volume
peaks during size exclusion chromatography were analysed by SDS polyacrylamide gel

electrophoresis. In each case, 10 pg of purified clusterin, ovotransferrin, or lysozym

or mixtures of clusterin with one of the other proteins, and proteins collected in the
exclusion volume peaks from size exclusion chromatography were subjected to either
native agarose gel electrophoresis or SDS-PAGE (see sections 2.2 and 2.3). Proteins

that were separated by agarose gel electrophoresis were subsequently transferred onto
nitrocellulose membrane by western transfer procedure (section 2.4), stained and
immuno-labelled. Proteins separated by SDS-PAGE were electrophoretically
transferred onto PVDF membrane (section 2.4) and immuno-labelled. Ovotransferrin
was biotinylated using standard procedures. Immunolabelling was performed using (i)
anti-clusterin Mabs followed by sheep-anti-mouse Ig-HRP conjugate (Silenus,
Melbourne, Australia) or (ii) streptavidin-HRP (Amersham, Sydney, Australia),
followed by ECL (section 2.5).
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3.2.5 Assays of Heat-Induced Loss of Enzyme Activity - Loss of A D H enzyme activity

was assayed by removing aliquots from samples of enzyme being heated at 55 °C for
10 min. Prior to assay, aliquots of ADH were held undiluted on ice. Precipitated
protein was removed by centrifugation (30 s at 10,000 g in a benchtop microfuge)

aliquots of the supernatant added to a reaction buffer (2.5 mM NAD+, 100 mM ethano
in 50 mM trisCl, 100 mM NaCl, 5 mM MgCl2, pH 7.4). The formation of NADH was
measured by monitoring the increase in absorbance of the solutions at 340 nm for

In control experiments (not shown), it was established that plots of absorbance vs

were linear for at least 60 s in these assays and that there was a linear relatio
between the rate of change of absorbance and the amount of ADH added. Loss of

catalase enzyme activity was assayed by removal of aliquots from samples undergoi

heat-induced precipitation at 55 °C and immediately adding them to 0.12% (v/v) H20
in 50 mM phosphate, pH 7.0. Catalase activity was measured as a decrease in

absorbance at 210 nm. In some experiments, the enzymes were heated in the presenc
of 100 pg/ml clusterin and/or 2 mM ATP.

3.2.6 ATPase Assays - Production of ADP from ATP was measured using an enzyme-

coupled assay in which ADP production is linked to oxidation of NADH. The reactio
mixture contained 2 mM Hepes, pH 8.0, 10 mM MgCl2, 100 mM KC1, 10 uM EDTA,
170 pM ATP, 840 pM phosphoenol pyruvate, 300 pM NADH, 33.4 units/ml of lactate

dehydrogenase and 21.1 units/ml of pyruvate kinase (Lilley and Portis, 1997). The
reaction mixture (0.7 ml) was held in a quartz cuvette, maintained at 37 °C, and

oxidation monitored as a decrease in absorbance at 340 nm as a function of time a

addition of clusterin. The validity of this assay was confirmed by showing that (
addition of exogenous ADP (21 nmol) and (ii) generation of ADP from ATP through
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phosphorylation

of

3-phosphoglycerate

(1.1

pmol

added) catalysed

by

3-

phosphoglycerate kinase (0.76 units added) both led to NADH oxidation. In order to

test the possibility that clusterin might exhibit ATPase activity only when bound to
stressed proteins, a 180 pi aliquot of a mixture of clusterin (75 pg/ml) and
ovotransferrin (1 mg/ml) that had been heated at 60 °C for 5 min was added to the
ATPase reaction mixture and the assay performed as described.

3.2.7 Thermal Denaturation and Renaturation Experiments - To determine whether

clusterin is able to facilitate the renaturation of its substrates, thermal denatura
renaturation of two enzymes, catalase and ADH, was conducted, (i) Solutions of
catalase (0.2 mg/ml) in 100 mM Na2HP04, 50 mM KC1, 5 mM MgCl2, pH 7.0, with or
without clusterin (100 pg/ml) or lysozyme, a-lactalbumin, or myoglobin (control

proteins, each at 100 pg/ml), were heated at 55 °C for 30 min. The solutions were th

cooled on ice and centrifuged for 30 s at 10,000 g to remove precipitated protein. A

total of 20 pi of supernatant was added to 180 pi of refolding buffer (5 mM MgCl2, 50
mM KC1, 1 mg/ml BSA, 50 mM Tris, pH 7.5), with or without the addition of 35
pg/ml Hsc70 (the constitutively expressed form of Hsp70) and/or 2 mM ATP, and

incubated at room temperature. At various times, aliquots were taken and assayed for
catalase activity as above, (ii) Solutions of ADH (1 mg/ml) in 50 mM Na2HP04, pH
7.5 with or without clusterin (100 pg/ml) or lysozyme (control protein; also at 100
pg/ml) were heated at 55 °C for 10 min. The solutions were subsequently cooled on

ice and then cleared of precipitated protein by centrifugation at 10,000 g for 30 s.
of supernatant was added to 180 pi of refolding buffer and incubated at room

temperature. At various times, aliquots were taken and assayed for ADH activity. Thi
was achieved by placing the aliquots into a reaction mixture containing 50 mM Tris,
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pH 7.5, 100 m M NaCl, 2.5 m M N A D + , 100 m M ethanol, 5 m M MgCl 2 and 50 m M

KC1; in the presence or absence of 2 mM ATP. The rate of NAD+ reductio

monitored as an increase in absorbance at 340 nm as a function of time
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3.3

RESULTS

3.3.1 Clusterin Maintains the Solubility of Stressed Ovotransferrin, y-Crystallin and
Lysozyme.
One of the hallmarks of molecular chaperones is their ability to suppress the
aggregation of thermally or chemically denatured substrate polypeptides. A key
question to address when considering the role of clusterin as a molecular chaperone is
whether it can protect a wide range of unrelated proteins against stress-induced
precipitation. A previous report has shown that clusterin inhibits heat-induced
precipitation of GST and catalase and DTT-induced precipitation of BSA and alactalbumin (Humphreys et al., 1999). In this study, the ability of clusterin to inhibit

stress-induced precipitation of three other previously untested proteins, ovotransferrin
y-crystallin and lysozyme, was investigated. These proteins were chosen as model

proteins because they were readily available and bear no structural similarities to each

other. In the absence of clusterin, the heating of ovotransferrin and y-crystallin at 60
°C produced extensive precipitation within 10 and 40 min, respectively, as measured
by light scattering at A360 (Figure 3.3.1, panels A & C). Upon incubation at 42 °C in
the presence of 20 mM DTT, extensive precipitation of ovotransferrin and lysozyme
occurred within 2 - 3 h (Figure 3.3.1, panels B & D). For DTT-treated ovotransferrin
and lysozyme, a small decrease in light scattering was measured commencing at
approximately 160 and 180 min, respectively, corresponding to the appearance of large
visibly discrete protein aggregates in solution. When exposed to the same stress
conditions as test proteins, clusterin precipitation was not observed (data not shown),
indicating that clusterin remained soluble under these conditions. When co-incubated
with any of the proteins subjected to heat or DTT-mediated reduction, clusterin
potently inhibited protein precipitation (Figure 3.3.1).
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Since clusterin (and the small heat shock proteins) exist in solution as aggregates
of varying numbers of subunits, a convention that has been adopted when dealing with
the interactions between chaperones and their substrates is to define stoichiometry in

relation to the individual subunits of the chaperone and the substrate protein with whic
it interacts. To determine the stoichiometry of clusterin's chaperone action, it was

assumed that the molecular mass for intact clusterin was 80 kDa and the subunit mass, 40
kDa. Of the substrates tested, clusterin was most efficient as a chaperone for heat-
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stressed ovotransferrin; the subunit molar ratio ( S M R ) of clusterin:ovotransferrin for
complete inhibition of ovotransferrin precipitation was 1.0:10.6 (Figure 3.3.1 A; when
ovotransferrin was taken to have a subunit molecular mass of 75.8 kDa). The
corresponding SMRs for the complete prevention of precipitation of reduced
ovotransferrin (Figure 3.3.IB), y-crystallin (Figure 3.3.1C), and reduced lysozyme

(Figure 3.3.ID), were 1.0:0.96, 1.0:5.0 and 1.0:0.84, respectively. In contrast, control

proteins such as ovalbumin had negligible effects on the stress-induced precipitation of

the substrate proteins tested (data not shown). These results clearly illustrate the abi

of purified clusterin to suppress the in vitro stress-induced aggregation and precipita
of ovotransferrin, lysozyme and y-crystallin in a concentration-dependent manner.
Similar results have also been obtained with heat-stressed ADH (see Poon et al. 2000;
Appendix 1).

3.3.2 Clusterin Protects Serum Proteins from Stress-Induced Precipitation.
The ability of clusterin to protect purified proteins from stress-induced precipitation
could also be extended to include proteins found in human serum. When undiluted
human serum was heated at 60 °C, an extremely high level of protein precipitation
occurred. As a result, it was impossible to measure this event in real time by
spectrophotometry. To overcome this problem, both normal and clusterin-depleted
human serum was diluted 1 in 20 in PBS before use. When heated to 60 °C, proteins in
clusterin-depleted human serum (CDS; diluted 1 in 20 in PBS) precipitated; this was
detected and measured as light scattering at A360 (Figure 3.3.2, panel A). Relative to
CDS, the extent of protein precipitation was reduced in similarly treated normal human
serum (NHS; diluted 1 in 20 in PBS). This indicates that endogenous levels of
clusterin (present in undiluted NHS at 35-105 pg/ml) are sufficient to significantly
inhibit protein precipitation induced by heating at 60 °C. The addition of 100 pg/ml of
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purified clusterin to diluted C D S

reduced the extent of heat-induced protein

precipitation by about 75% (Figure 3.3.2, panel A). Similarly, the addition of 100
pg/ml of purified clusterin to diluted NHS also resulted in a 75% reduction in stressinduced protein precipitation (Figure 3.3.2, panel A). These results indicate that,
relative to the effects of endogenous clusterin and under the conditions tested, supraphysiological levels of clusterin caused greater inhibition of heat-induced protein
precipitation. The addition of 100 pg/ml of control proteins (e.g., BSA, ovalbumin)
had no significant effects on the extent of heat-induced protein precipitation (data not
shown).
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The extent of protein precipitation induced in undiluted h u m a n serum by D T T is m u c h

less than that induced by 60 °C heat. Thus, it is possible to follow this event in real
time by spectrophotometry. The addition of 20 mM DTT to undiluted CDS resulted in
extensive protein precipitation within 40 min after the commencement of the time-

course (Figure 3.3.2, panel B). Relative to CDS, the extent of protein precipitation wa
reduced in similarly treated NHS. The addition of 100 pg/ml of purified clusterin to

CDS reduced the extent of protein precipitation to slightly less than that measured for
NHS. A further decrease in protein precipitation was observed in samples of DTTtreated NHS supplemented with an additional 100 pg/ml purified clusterin (Figure
3.3.2, panel B).

3.3.3 Clusterin Binds Preferentially to Stressed Forms of Ovotransferrin and
Lysozyme.
Clusterin was previously shown to bind preferentially to the stress-denatured forms of
numerous proteins including GST, BSA, and a-lactalbumin (Humphreys et al., 1999).
Here, ELISA was used to demonstrate the preferential binding of clusterin (provided

either as a purified protein or in unfractionated human serum) to the stressed forms of
ovotransferrin and lysozyme (Figure 3.3.3). In all cases, no significant binding of
clusterin to unstressed ovotransferrin or lysozyme was observed (Figure 3.3.3 A-C). In
contrast, purified clusterin showed significantly increased binding to ovotransferrin,
which was stressed with either heat (60 °C; Figure 3.3.3 A) or DTT-mediated reduction
(Figure 3.3.3 B) and to DTT-treated lysozyme (Figure 3.3.3 C). Similar results were
obtained when unpurified clusterin, present in whole human serum, was tested (Figures
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3.3.3 D & E). These results clearly indicate the preferred binding of clusterin to
stressed versus non-stressed proteins.
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Figure 3.3.3: Results of ELISA measuring the binding of purified clusterin (A-C) or clusterin in crude
human serum (D and E) to native ( • ) or stressed (• ) adsorbed proteins; (A) Heat-stressed
ovotransferrin (ovo), (B & D ) DTT-reduced ovotransferrin (ovo + D T T ) , and (C & E) DTT-reduced
lysozyme (lys). D N P - 9 ( A ) was used as an isotype control antibody for the detection of clusterin
binding to stressed proteins. Other details are described in Methods (section 3.2.2). Each data point
represents the mean of three replicate measurements and the error bars shown are standard errors (SE) of
the mean in each case. In some cases, the S E are too small to be visible. The results shown are
representative of three independent experiments.
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3.3.4 Clusterin Interacts with Stressed Ovotransferrin, Lysozyme and a-Lactalbumin to
Form HMW Complexes.
The ability of clusterin to inhibit the stress-induced precipitation of numerous test

proteins, such as those reported in this thesis and in (Humphreys et al., 1999), strong

suggests that it forms stable complexes with these substrates in response to stress. Th
formation of HMW complexes between clusterin and each of the four stress-affected
substrates (GST, catalase, a-lactalbumin, and BSA) was detected by size exclusion
chromatography (Humphreys et al., 1999). Here, the complex formation between
clusterin and heat- or DTT-treated ovotransferrin, DTT-treated lysozyme, and DTTtreated a-lactalbumin was investigated by several techniques including size exclusion
chromatography, native gel electrophoresis and SDS-PAGE.
Size exclusion chromatography was conducted to investigate whether clusterin
forms HMW complexes with stressed ovotransferrin and lysozyme. Clusterin, at
physiological pH, exists in aqueous solution as an equilibrium mixture of monomers,
dimers and higher aggregation states (Easterbrook-Smith, S.B., unpublished results).

There was no significant difference between the elution profiles of untreated versus h

or DTT-treated clusterin (Figure 3.3.4 A & B), indicating that there was no change in t

aggregation state of clusterin in solution in response to heat or reduction by DTT. The

results suggest that the quaternary structure of clusterin is stable under these condi
Size exclusion chromatographic analyses of protein mixtures subjected to heat- or DTTmediated stress of ovotransferrin, or DTT-reduction of lysozyme, in the presence of
clusterin, revealed the disappearance of the lower order clusterin oligomers and
monomers and the concomitant appearance of the HMW species (Figure 3.3.4 A-C). The
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H M W species were not detected in analysis of clusterin alone or any of the individual
proteins, whether these proteins were stressed or not. The HMW species was also absent
in unstressed mixtures containing clusterin and ovotransferrin or lysozyme.
When the exclusion volume peak (containing the HMW species), obtained by size
exclusion chromatography, of mixtures of clusterin and DTT-treated lysozyme was
analysed by SDS-PAGE, both clusterin and lysozyme were detected (Figure 3.3.5). This
confirmed that the HMW species was comprised of a complex containing both clusterin
and stressed lysozyme (Figure 3.3.5 A). Similarly, when the exclusion volume peaks of
mixtures of clusterin and heat- or DTT-treated ovotransferrin were analysed by SDS-

PAGE, both clusterin and stressed target protein were detected, thus verifying that und
stress conditions, clusterin binds and forms HMW complexes with stressed proteins.

3.3.5 ATP Does Not Affect the Ability of Clusterin to Suppress Stress-Induced Protein
Aggregation.
The effects of ATP on the ability of clusterin to inhibit the stress-induced

precipitation of ovotransferrin, lysozyme, and catalase were investigated and the resul
presented in Figure 3.3.6. In each case, the addition of ATP to each of the substrates

undergoing stress resulted in a small reduction in protein precipitation, which occurre
regardless of whether clusterin was present or not. Thus, ATP had no effect on the

ability of clusterin to inhibit the stress-induced precipitation of the three proteins
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Figure 3.3.5: S D S - P A G E gel and immunoblots showing the presence of clusterin and stressed proteins in
the H M W complexes obtained in the exclusion peaks fromsize exclusion chromatographic analyses (see
Figure 3.4). The positions of molecular markers are indicated by arrows. Approximately 10 |4g of
protein was loaded into each lane. (A) Samples electrophoresed on a 12.5% S D S - P A G E gel under
reducing conditions: clusterin (lane 1), lysozyme (lane 2), exclusion peak fraction fromthe size exclusion
chromatographic separation of a mixture of clusterin and stressed lysozyme (lane 3). (B) (i) Samples
electrophoresed on a 1 0 % S D S - P A G E gel under reducing conditions: clusterin (lane 1), ovotransferrin
(lane 2), H M W fraction of mixture of clusterin and heat-treated ovotransferrin (lane 3), H M W fraction of
mixture of clusterin and DTT-treated ovotransferrin (lane 4). (ii) Immunoblots showing the
corresponding fractions as in B (i) probed with either anti-clusterin antibodies or with streptavidin-HRP
to detect biotinylated ovotransferrin.
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Figure 3.3.6: Effects of ATP on the ability of clusterin to inhibit stressed-induced protein precipitation. Target proteins were stressed alone (• ),
in the presence of 2 mM ATP ( H ), in the presence of clusterin ( # ), or in the presence of both 2 mM ATP and clusterin ( # ), and the turbidity
associated with protein precipitation was measured as A360 as described in 3.2.1. (A) Ovotransferrin (ovo)(l mg/ml) or mixtures of ovotransferrin
(1 mg/ml) and clusterin (75 fig/ml) were heat-stressed at 60 °C. (B) Lysozyme (lys) (0.25 mg/ml) or mixtures of lysozyme (0.25 mg/ml) and
clusterin (400 pg/ml) were reduced with 20 mM DTT at 42 °C. (C) Catalase (cat) (1 mg/ml) or mixtures of catalase (1 mg/ml) and clusterin (100
|ig/ml) were heated at 60 °C. The results shown are representative of three independent experiments.
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3.3.6 Clusterin Does Not Protect Enzymes from Stress-Induced Loss of Function.
Purified clusterin was previously shown to effectively suppress the heatinduced precipitation of two enzymes, ADH and catalase (Humphreys et al, 1999). In

this study, the ability of purified clusterin to protect these two proteins against hea
induced loss of enzyme activity was investigated. The results of this experiment are
presented in Figure 3.3.7. Regardless of the presence of ATP, in the absence of
clusterin, partial (about 30 - 40 %) inactivation of ADH and catalase was achieved by

heating at 55 °C for 10 and 30 min, respectively. Under these conditions, clusterin had
no effect on the extent of heat-induced enzyme inactivation. The results clearly

indicated that, irrespective of whether ATP was present or not, clusterin was unable to
protect these two enzymes against heat-induced loss of activity.
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Figure 3.3.7: Inability of clusterin to prevent heat-induced loss of enzyme activity. (A) A D H (1 mg/ml)
or mixtures of A D H (1 mg/ml) and clusterin (100 pg/ml), in the presence or absence of 2 m M A T P , were
heated at 55 °C and then assayed for A D H activity as described in 3.2.7. (B) Catalase (200 pg/ml) or
mixtures of catalase (200 pg/ml) and clusterin (100 pg/ml), in the presence or absence of 2 m M A T P ,
were heated at 55 °C and then assayed for catalase activity as described in 3.2.7. For both experiments,
the data (shown as the overall change in absorbance measured) represent means of triplicate
measurements; error bars represent standard deviations (SD) of the means. In all cases, the results are
representative of at least two independent experiments.
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3.3.7 Clusterin Has No Detectable ATPase Activity.
The presence or absence of ATPase activity was determined using a
spectrophotometric assay (at A34o) involving NADH oxidation via pyruvate kinase and
lactate dehydrogenase. Purified clusterin (2.44 pM), in the presence of 10 mM MgCl2
and 100 mM KC1, appeared to lack any ATPase activity as evident by the net zero
change in absorbance (measured at A340) over the observed time-course (Figure 3.3.8).

Clusterin also failed to exhibit any ATPase activity when associated with heat-stresse
ovotransferrin (Figure 3.3.8). To verify that clusterin's apparent lack of ATPase
activity was not due to an inefficient assay coupling system, ADP was either added
exogenously or generated from phosphoglycerate kinase-catalysed ATP-dependent
phosphorylation of 3-phosphoglycerate. In these cases, the initial rate of NADH
oxidation became one to two orders of magnitude higher than the control rate,
confirming the validity of the assay
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Figure 3.3.8: Spectrophotometric time course measurements showing that clusterin lacks measurable
ATPase activity. The absorbance of ATPase reaction buffer (see section 3.2.6) was measured as a
function of time after the addition of either 195 pg/ml clusterin ( • ) or a mixture of clusterin and
ovotransferrin (previously heated at 60 °C for 5 min) ( A ) to give afinalconcentration of 15.3 pg/ml
clusterin and 0.2 mg/ml ovotransferrin. In both experiments, 21 nmol of A D P was added 11 minutes
after the start of the assay (red arrow) to confirm that the assay was functional. In similar experiments,
purified ovotransferrin alone was added to the ATPase reaction buffer. N o ATPase activity was
measured associated with ovotransferrin (data not shown). Shown on the same plot, the absorbance of
ATPase reaction buffer (containing 84 p M N A D H ) was measured as a function of time after the addition
of 0.76 units of 3-phosphoglycerate kinase ( # ); at 4 min, 1.1 umol of 3-phosphoglycerate was added
(green arrow). The data shown are representative of three independent experiments.
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3.3.8 Clusterin is Unable to Independently Promote Reactivation of its Substrates but it
can Stabilise Stressed Proteins in a State Competent for Refolding by Hsc70.
The ability of clusterin to (i) independently facilitate the recovery of functional

activity of two enzymes, ADH and catalase, or (ii) stabilise these substrates in a state
competent for refolding by other known chaperones with refolding capability, was
investigated. The results of these studies are presented in Figure 3.3.9. Heatinactivation of ADH or catalase was achieved by heating at 55 °C for 10 and 30 min,
respectively, in the presence or absence of purified clusterin. After this treatment,
approximately 66% of the original catalase activity remained whereas for ADH, this
figure was closer to 82%. Reactivation of these two enzymes was measured as
described in section 3.2.7. When acting alone, clusterin was unable to promote the
recovery of ADH or catalase activity following the removal of stress (Figure 3.3.9).
An attempt was made to investigate whether clusterin could stabilise stressed proteins
in such a way that refolding could be achieved by other chaperones. Unfortunately, at
the time these experiments were performed, the absence of any known extracellular
mammalian chaperones with refolding capability meant that it was impossible to test

for their ability to refold stressed proteins stabilised by clusterin. Therefore, the on
alternative was to use an intracellular chaperone with known refolding capability; one
such protein was Hsc70 (a constitutively expressed mammalian heat shock protein). In
the presence of both Hsc70 and ATP, clusterin-stabilised ADH and catalase exhibited a
gradual recovery of the original enzyme activity when measured over a period of 5
hours. For ADH, a recovery of approximately 14% of the original activity was
observed (Figure 3.3.9 A); for catalase, the percentage of recovery was approximately
16% (Figure 3.3.9 B). When these enzymes were stressed in the presence of clusterin
and then assayed in the presence of Hsc70 but in the absence of ATP, the level of
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reactivation was less than 4 % (Figure 3.3.9). In similar experiments, when lysozyme
was substituted for clusterin, and the heat-stressed enzyme mixture subsequently
incubated with Hsc70 and A T P , the levels of reactivation for A D H and catalase were
approximately 1 and 3 % , respectively.
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Figure 3.3.9: Post-stress refolding of clusterin -stab 0 is ed A D H and catalase by Hsc70. Solutions of A D H
(A) or catalase (B) were heat-inactivated at 55 °C for 10 and 30 min, respectively, in the presence or
absence of clusterin (clus; 100 pg/ml) or lysozyme (lyso; 100 pg/ml). Aliquots, cleared of precipitated
protein by centrifugation, were then added to refolding buffer, with or without Hsc70 (35 pg/ml) or 2
m M A T P (see key). The recovery of enzyme activity was then measured spectrophotometrically (see
3.2.7). The recovery of enzyme activity is expressed as a percentage of the original enzyme activity
(prior to heat stress). The data are means ± standard deviations of triplicate measurements (in some cases
the error bars are too small to see) and are representative of three independent experiments. In similar
experiments, when a-lactalbumin or myoglobin were substituted for clusterin, results similar to those for
lysozyme were obtained (data not shown).
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Taken together, these results indicate that clusterin does not independently
refold heat-stressed ADH and catalase but binds to the stressed proteins to stabilise
them in a conformation that can be subsequently refolded by Hsc70. The level of
recovery of enzyme activity recovered in these assays is very similar to that reported
for recovery of citrate synthase activity following heating with the small heat shock
protein Hsp25 and subsequent incubation with Hsp70 (about 14% recovery)
(Ehrnsperger et al, 1997). The effect of clusterin appears to be specific for clusterin
because, in similar experiments, a-lactalbumin or myoglobin were unable to support
the high level of enzyme reactivation achieved by clusterin (data not shown).
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3.4 DISCUSSION

The experiments described above extend previous results that had highlighted
the ability of clusterin to prevent stress-induced precipitation of a number of unrelated
proteins, including glutathione-S-transferase (GST), catalase, a-lactalbumin and bovine
serum albumin (BSA). In this project, purified clusterin was shown to inhibit the
precipitation of heat-stressed ovotransferrin and y-crystallin, as well as DTT-reduced
ovotransferrin and lysozyme (Figure 3.3.1). In addition, for the first time, the ability
of clusterin (either purified or in unfractionated human serum) to inhibit stress-induced
precipitation of endogenous human serum proteins was demonstrated. Furthermore, by
ELISA, clusterin was shown to bind preferentially to stressed forms of either
ovotransferrin or lysozyme. As mentioned in section 1.2.4, the term molecular
chaperones was applied by John Ellis to describe a diverse group of functionally related
proteins that function in vivo to assist in protein assembly through their stabilising
interactions with partially unfolded protein conformers (Ellis, 1987; Ellis, 1992).
Therefore, based on the definition of what a molecular chaperone is, the ability of
clusterin to bind preferentially to stressed forms of a wide range of proteins to inhibit
their precipitation confirms that clusterin, like the Hsps, is a molecular chaperone.
Clusterin's ability to stabilise numerous stressed proteins (i) independently of ATP and
(ii) in a state competent for post-stress refolding and reactivation by Hsc70 further
illustrates functional similarities between clusterin and some sHsps.

One of the general features of molecular chaperones (including the sHsps) is
that they interact with the hydrophobic regions of partially folded, unfolded or
disassembled polypeptide chains to form solubilised high molecular weight (HMW)
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complexes. For molecular chaperones such as the mammalian sHsps, these complexes

(typically 300 - 800 kDa in size; Fersht et al, 1994), have been detected at times larger
than 1000 kDa (Jenne et al, 1991). Previously, clusterin was shown to form HMW
complexes with (i) heat-stressed GST or catalase, and (ii) reductively-stressed alactalbumin and BSA. Analysis by size exclusion chromatography of samples in which
clusterin was co-incubated with ovotransferrin or lysozyme undergoing stress-induced
denaturation revealed the presence of HMW species in the void volume that was eluted
from the column (Figure 3.3.4 A,B & D). Subsequent analysis by SDS-PAGE of these
HMW species, confirmed the presence of both clusterin and the stressed protein
(Figure 3.3.5). Since the HMW complexes were absent in samples of clusterin or
target proteins alone, whether these were stressed or not, or in mixtures of clusterin
with each of the individual substrate proteins in the absence of stress, the results
presented here confirm that clusterin interacts preferentially with stressed forms of
target proteins only.

To determine the stoichiometry of chaperone action as well as the efficiency of

clusterin as a molecular chaperone, potential substrate proteins, e.g. ovotransferrin, y
crystallin and lysozyme, were stressed in the presence of increasing amounts of
clusterin and the turbidity associated with substrate precipitation was measured as an
increase in absorbance at 360 nm (Figure 3.3.1 A-D). The stoichiometry of chaperone
action by clusterin was defined in terms of the subunit molar ratios (SMR) of clusterin
to substrate required to completely inhibit precipitation. Table 3.4.1 summarises the
physical characteristics, tested stress conditions and SMRs required for the complete
inhibition of stress-induced protein precipitation for all target proteins used to-date
assess clusterin's chaperone activity. The format of this table is such that the target
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proteins are listed in order of decreasing clusterin efficiency. F r o m this table, it can be

seen that of all substrates tested, clusterin was most efficient at stabilising DTT-treat
insulin; the clusteriminsulin SMR for this was 1.0:50. This was followed closely by
the stabilisation of DTT-reduced a-lactalbumin and heat-stressed ovotransferrin with
SMR values for clusterin:substrate of 1.0:11.0 and 1.0:10.6, respectively. The SMR of
clusterin:substrate for the other heat- or DTT-treated substrate proteins were much
lower, ranging from 1.0:5.0 (clusterin:heat-stressed y-crystallin) to 1.0:0.84
(clusterin:DTT-treated lysozyme) (Table 3.4.1). There does not appear to be any
correlation between the SMRs required for the complete inhibition of substrate
precipitation and the mass of these substrates, nor does there seem to be any
relationship between clusterin's efficiency as a molecular chaperone and the type of
stress used. Therefore, how well clusterin functions as a molecular chaperone seems to
depend not on the size of the substrate to which it binds or the stress conditions to
which its substrates are subjected, but on some unknown characteristic(s) of each of the
substrates tested. It is worth noting that clusterin is a more efficient molecular
chaperone than the sHsps; existing data suggest that at best, sHsps can only achieve an
SMR of one subunit of sHsp to one partially unfolded substrate protein (Pauling and
Corey, 1951; Anfinsen and Haber, 1961).
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U p to now, m a n y of the experiments investigating clusterin's chaperone action
have been performed in non-physiological buffers (such as 50 mM Na2HP04, pH 7.0).
It was desirable to determine whether the chaperone action of clusterin also operates
under physiologically relevant conditions, for example, in serum. As a normal
component of human serum, one would expect that if clusterin truly functions in vivo
as a molecular chaperone then it should be able to exert a chaperone effect on stressed
serum proteins. Results presented in this report demonstrate that clusterin protects
proteins in (i) diluted human serum from heat-induced precipitation and (ii) undiluted
human serum from DTT-mediated precipitation (Figure 3.3.2).
initial experiments investigating the chaperone action of clusterin on heatinduced serum protein precipitation were conducted in undiluted serum (data not
shown). However, upon performing this experiment in full sera, a problem was
encountered. Serum contains high levels of protein, about 75 mg/mL (Jenne and
Tschopp, 1992). Therefore, when full sera was heated, the rate and extent of protein
precipitation was so great that measurements in real time of chaperone effects of
clusterin were impossible. To solve this problem, a similar set of experiments was
performed using a 1 in 20 dilution of normal human serum (NHS), clusterin-depleted
serum (CDS), or either of these supplemented with 100 pg/ml purified clusterin. Heatand reduction-induced precipitation of serum proteins was (i) enhanced by
immunoaffinity depletion of clusterin from serum and (ii) specifically inhibited by the
addition of purified clusterin (Figure 3.3.2). No attempt was made to identify the
serum proteins that were stabilised by the chaperone action of clusterin. Nevertheless,

these findings raise the possibility that clusterin may play a clinically important role
protecting human plasma proteins from stress-induced precipitation. Furthermore,
certain diseases such as Alzheimer's and Creutzfeldt-Jacob diseases are associated with

85

abnormally high levels of protein precipitation. In cases such as these, the results

presented in this chapter suggest the possibility that the levels of clusterin in biolog
fluids such as plasma may affect the rate or extent of disease progression.
Clusterin has been predicted to contain, within its amino acid sequence, a
putative nucleotide-binding motif [89]. Nucleotide-binding motifs have been reported
in many chaperones, such as those belonging to the HsplOO, Hsp70 and Hsp60 heat
shock protein families. It is believed that the binding of nucleotides (ATP or ADP) to
these chaperones influences the kinetics of substrate binding and/or release (reviewed
in Gething, 1997). More importantly, it has been shown that, in most cases, the
processes of protein folding or refolding are ATP-dependent and that many of the
chaperones with refolding capability are also ATPases. In this study, a number of
experiments were conducted to determine (i) whether ATP affects clusterin's

chaperone action, (ii) if clusterin has any ATPase activity, and (iii) if clusterin could
alone or in co-operation with other chaperones, refold its substrates.
Results obtained in this chapter have provided evidence to show that, like the
sHsps, clusterin does not have the ability to hydrolyse ATP and hence, performs its
chaperone function in an ATP-independent manner (Figure 3.3.8). Previous
experiments showing the dose-dependent inhibition of stressed-induced precipitation of
numerous test proteins (listed in Table 3.1) by clusterin were all performed in the
absence of ATP (Figure 3.1; and in Humphreys et al, 1999). Here it was shown that
ATP has no effect on clusterin's in vitro chaperone action (Figure 3.3.6). However, to
exclude the possibility that clusterin may possess ATPase activity only when bound to

a substrate, clusterin was co-incubated with ovotransferrin undergoing heat-stress prior
to being assayed for ATPase activity (see 3.2.6). Once again, results showed that
clusterin, even when complexed with a bound substrate, did not exhibit any ATPase
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activity (Figure 3.3.8). Although the functional domains of clusterin are not known,
based on the results obtained here, it appears that clusterin does not contain a
functional ATPase domain. In addition, due to the inability of clusterin to hydrolyse
ATP, clusterin was not expected to have the ability to refold partly unfolded protein
structures since most chaperones that are able to refold stabilised substrates require
ATP to do so (Preville et al, 1999). This inference was supported by results showing

that clusterin was unable to independently facilitate the reactivation of heat-inactivate
ADH and catalase after the removal of stress. However, clusterin was able to stabilise
stressed ADH and catalase in a state competent for subsequent refolding by Hsc70 (in
the presence of ATP) (Figure 3.3.9).
Taken together, the findings presented in this chapter illustrate many functional
similarities between clusterin and the sHsps. Specifically, results show that clusterin
(i) functions in an ATP-independent manner to inhibit the stress-induced precipitation
of a variety of unrelated target proteins, including human serum proteins, by forming
soluble HMW complexes with them, (ii) does not possess any detectable ATPase
activity, (iii) does not protect enzymes from stress-induced loss of function nor
independently facilitate their refolding, and (iv) like some sHsps, stabilises target
proteins in a state competent for subsequent refolding by an ATP-dependent
chaperone.

A subset of the results presented in this chapter have been published in the following
journal paper:
Poon, S., Easterbrook-Smith, S.B.,Rybchyn, M.S., Carver, J.A., and Wilson, M.R.
(2000) "Clusterin is an ATP-independent chaperone with very broad substrate
specificity that stabilizes stressed proteins in a folding-competent state" Biochemistry:
39, 15953-15960. (Appendix)
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Chapter 4

Clusterin is a pH-Dependent Chaperone
Which Specifically Interacts With Disordered
Molten Globule States of Proteins
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4.1 INTRODUCTION

So far, the data presented in Humphreys et al, 1999, and in chapter 3
demonstrate the in vitro sHsp-like chaperone action of clusterin. Specifically, clusterin
was shown to prevent the stress-induced precipitation of numerous target proteins,
either in the form of purified proteins or in undiluted human serum. Like many sHsps,
clusterin does not have the ability to independently refold proteins but stabilises these
in a state competent for subsequent refolding by other ATP-dependent chaperones (e.g.
Hsc70; see section 3.3.8). However, similarities between clusterin and the sHsps are
not just confined to their functional role as molecular chaperones; both clusterin and
sHsps are highly ubiquitous and their expression is up-regulated in response to stress
(e.g. heat shock). In addition, increased expression of both types of chaperone has
been detected in many diseases (e.g. Scrapie, Alzheimer's and Creutzfeldt-Jakob
diseases) associated with abnormally high levels of misfolded and/or precipitated
proteins. Yet, in contrast to the sHsps, information regarding the mechanism of
clusterin's chaperone action is lacking. It is unknown what conformational state(s) of
substrate proteins clusterin specifically interacts with, or where along the unfolding
pathway this interaction occurs. In addition, it is not known what effect certain
environmental or pathophysiological factors (e.g. temperature) have on (i) the

oligomerisation state of clusterin, (ii) the ability of clusterin to interact with stresse
proteins, or (iii) clusterin's chaperone action. This chapter will address these issues.

A number of conditions (generally referred to as "stress"; section 1.2.3) can
lead to protein unfolding. As proteins traverse along the unfolding pathway towards

the unfolded state, most will undergo a structural transition from the fully folded native
state to an intermediate semi-compact molten globule state (section 7.2.2) which,
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depending on the degree of structure, can be classified as being "ordered" (e.g.
designated Ii) or "disordered" (I2) (Figure 4.1.1). Being partly structured, proteins in
the molten globule state expose significant hydrophobicity to solution. This
heightened level of hydrophobicity promotes protein - protein interaction, causing the

partially unfolded proteins to deviate from the unfolding pathway along the irreversible
off-folding pathway, which ultimately leads to their aggregation and precipitation
(Figure 4.1.1).
Information about the dynamics of the molten globule state has been acquired
from numerous studies of a model protein called a-lactalbumin (Horwitz et al, 1998;
Griko and Remeta, 1999; Lindner et al, 1997; Lindner et al, 1998). a-Lactalbumin is
a small (-14 kDa), monomeric calcium-binding milk protein, which forms a molten
globule at low pH or in the absence of calcium ion at neutral pH at temperatures above
25 °C (Griko and Remeta, 1999). Reduction of the four disulfide bonds of alactalbumin also results in the formation of a molten globule. The formation of the
molten globule is evidenced by a significant reduction in the NMR chemical shift

dispersion and a substantial loss of the near-ultraviolet circular dichroism (CD) signal
indicating that the side-chains are substantially disordered. Small Hsps, such as a-

crystallin, have been shown to interact specifically with the disordered (i.e. I2) molte
globule state of a number of proteins (including a-lactalbumin) to prevent these
proteins from deviating onto the off-folding pathway and to maintain their solubility
(Figure 4.1.1) (Lindner et al, 1997). However, the conformational state(s) of proteins
that interact with clusterin and the stage(s) along the unfolding pathway where this
interaction occurs have not yet been identified.
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Both sHsps and clusterin have been shown to inhibit the slow precipitation of
numerous target proteins (such as those listed in Table 3.1). However, sHsps such as

a-crystallin are incapable of preventing rapidly aggregating proteins from precipitating
(Lindner et al, 2001). This suggests that kinetic factors may be important in regulating
the chaperone action of sHsps. At present, the ability of clusterin to stabilise rapidly
precipitating proteins is not known.
For many sHsps, elevated temperature can have a significant effect on their
quaternary and tertiary structures. For example, when mammalian a-crystallin is
exposed to temperatures above 50 °C, the protein partially unfolds and undergoes a
transition to a molten globule-like state, resulting in higher solvent accessibility to
hydrophobic surfaces (determined by bis-ANS fluorescence) and an enhancement of
chaperone activity (Raman and Roa, 1997; Data and Roa, 1999). Similarly, at
physiological temperature, IbpB (an E. coli sHsp) exists in solution as a large multimer
of approximately 600 kDa. However, when exposed to elevated temperatures as high

as 55°C, IbpB undergoes (i) a partial loss of secondary structure, (ii) dissociation of t

multimeric structure into constituent oligomers, and (iii) an increase in protein surfac
hydrophobicity, resulting in enhanced chaperone action (Shearstone and Baneyx,
1999). Similar effects have also been shown for yeast Hsp26 (Haslbeck et al, 1999).
Like many sHsps, clusterin also exists in solution as a mixture of multimers (see
below). However, the effect of elevated temperature on the oligomerisation state of
clusterin is not known. In addition, it is not known whether increased temperature has

any effect on the ability of clusterin to bind to its substrates or to its chaperone act
These issues were investigated.
As mentioned in chapter 1 (section 1.3.2), clusterin is capable of aggregating
with itself under conditions of neutral pH and low salt concentrations to form
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dimers and tetramers (Griswold et al, 1986). A recent report has demonstrated
that this process is pH-dependent with dissociation of the oligomers occurring at
low pH (pH 6.0) (Hochgrebe et al, 2000). Dissociation of clusterin oligomers at
mildly acidic pH in vitro resulted in a concomitant increase in the ability of
clusterin to bind its native ligands, heparin (Pankhurst et al, 1998), IgG,
complement protein C9, apoA-I, and GST (Hochgrebe et al, 2000). Hydrophobic
regions exposed as a result of pH-dependent dissociation of clusterin homooligomers were thought to be responsible for the increased binding. These results
suggest that at low pH, the binding of clusterin to stressed proteins and its
chaperone action might also be enhanced. This possibility was investigated.
The effects of temperature and pH on both the interaction of clusterin with
target proteins and its chaperone action were examined by ELISA and precipitation
assays. In addition, the ability of clusterin to inhibit the rapid precipitation of the
proteins, y-crystallin and lysozyme, was tested. Furthermore, the interaction of
clusterin with intermediately folded forms of a-lactalbumin was examined by real-time
'H NMR spectroscopy. The results demonstrate that (i) mildly acidic pH significantly
enhances the ability of clusterin to bind to target proteins and enhances its chaperone
activity, (ii) temperature does not induce significant changes in the oligomerisation
state of clusterin, (iii) clusterin is incapable of inhibiting very rapid protein

precipitation, and (iv) clusterin does not significantly alter the rate of a-lactalbumin
reduction but does stabilise the less ordered form (i.e. the I2 state) of the protein.
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4.2 METHODS

4.2.1 Size Exclusion Chromatography - To determine the effect of elevated temperatur

on the oligomerization state of clusterin, 100 pi samples of 1 mg/ml clusterin in 50
Na2HP04, pH 7.0, were incubated at 37 or 50 °C for 1 h and immediately applied to a
1.5 x 30 cm (diameter x height) Superose-6 (Pharmacia) column equilibrated with lx
PBS. Chromatography was performed at the indicated temperatures and at a flow rate
of 0.5 ml/min. Standards used for calibrating the column included the following:
aldolase (158 kDa), catalase (232 kDa), ferritin (440 kDa), thyroglobulin (669 kDa)
and Blue Dextran (2000 kDa). Kaleidagraph Version 3.51 (Synergy Software,
Reading, PA) was used for quantitative data analysis and plotting.

4.2.2 ELISA - (i) ELISA experiments were used to investigate whether temperature has
any effect on the ability of clusterin to bind stressed substrate proteins. GST, at
pg/ml in 50 mM Na2HP04, pH 7.0 was adsorbed (whilst being stressed) onto a

microtitre plate (Diposable Products, Adelaide, Australia) by incubating at 60 °C fo
h. BSA and lysozyme (both at concentrations of 20 pg/ml) and ovotransferrin (10
pg/ml) were incubated at 42 °C for 5 hours in the presence or absence of 20 mM DTT.
The plates were then blocked with 1% (w/v) heat-denatured casein (HDC) prepared in
PBS (137 mM NaCl, 2.7 mM KC1, 1.5 mM KH2P04, 8 mM Na2HP04, pH 7.4).
Thereafter, the plate was washed thrice with lx PBS. Plate-bound, DTT-treated
proteins were incubated with 5 mM R(+)-[6,7-dichloro-2-cyclopentyl-2,3-dihydro-2-

methyl-l-oxo-lH-inden-5-yl)oxy] acetic acid (IAA) for 1 h at 37 °C in order to exclu

the possibility of subsequent formation of disulfide bonds between clusterin and the
target proteins. Clusterin, initially at 10 pg/ml in 50 mM Na2HP04, pH 7.0, was then
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serially diluted in binary steps d o w n each E L I S A plate, which was then incubated at
37, 42, 45 or 50 °C for 1 h. A mixture of G7, 4ID and 78E anti-clusterin monoclonal
antibodies was used to detect bound clusterin. All antibodies were used in the form
unpurified hybridoma culture supernatant. Bound primary antibodies were detected
with sheep anti-mouse Ig-HRP (SaMIgG-HRP; Silenus, Sydney, Australia) using ophenylenediamine dihydrochloride (OPD; 2.5 mg/ml in 0.05 M citric acid, 0.1 M
Na2HP04, pH 5.0, containing 0.03% (v/v) H202) as substrate.

(ii) To investigate the effects of pH on the binding of clusterin to stressed protei
ELISA experiments were conducted as follows. GST and ovotransferrin, at 20 pg/ml in
50 mM Na2HP04, pH 7.0 were adsorbed onto a microtitre plate (Disposable Products,
Adelaide, Australia) by incubating at 60 °C for 1 h. a-lactalbumin and BSA (both at
20 pg/ml) and ovotransferrin (10 pg/ml) in 50 mM Na2HP04, pH 7.0, were incubated
for 5 hours in the presence or absence of 20 mM DTT. The plates were then blocked
with 1% (w/v) heat-denatured casein (HDC) prepared in PBS (137 mM NaCl, 2.7 mM
KC1, 1.5 mM KH2P04, 8 mM Na2HP04, pH 7.4). The plate was washed thrice with lx
PBS. Plate-bound proteins were incubated with 5 mM IAA for 1 h at 37 °C. Clusterin,

initially at 10 pg/ml in 50 mM Na2HP04, pH 6.0, 6.5, or 7.0, was then serially dilute
in binary steps down each ELISA plate, which was then incubated at 37 °C for 1 h.
Bound clusterin was detected with G7, 41D and 78E anti-clusterin monoclonal
antibodies, and bound primary antibodies were detected with SaMIgG-HRP and OPD
substrate as described above.

4.2.3 Protein Precipitation Assays - (i) The effects of different temperature on the
extent of DTT-induced protein precipitation in the presence or absence of clusterin
were tested. The turbidity associated with protein precipitation was measured as
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absorbance at 360 n m . In experiments dealing with the substrate proteins B S A , alactalbumin and lysozyme, the extent of protein precipitation was compared at 37 °C

and 50 °C. In a separate experiment, insulin precipitation was conducted at 37, 45 an
50 °C. Individual solutions of BSA (750 pg/ml), a-lactalbumin (750 pg/ml), lysozyme
(250 pg/ml) or insulin (2 mg/ml) or mixtures of these proteins with clusterin (at
specific concentrations, as indicated in Figure legends), were prepared in 50 mM
Na2HP04, pH 7.0, and reduced with 20 mM DTT at one of the above-mentioned
temperatures. Readings were taken every 10 min for a total of 150 or 300 min with a
Spectramax 250 microplate reader (Molecular Devices, Sunnyvale, CA, USA).

(ii) The effects of pH on the inhibition of stress-induced protein precipitation by c
was measured as absorbance at 360 nm. In all experiments the extent of precipitation

pH 6.5 was compared to that at pH 7.5. Experiments involving ovotransferrin were also

performed at pH 6.0. Individual solutions of ovotransferrin (2 mg/ml) or catalase (30
pg/ml), GST (300 pg/ml) or mixtures of these proteins with clusterin (at specific
concentrations, as indicated in Figure legends), were prepared in 50 mM Na2HP04, pH

6.0, 6.5 or 7.5, where appropriate, and heated at 60 °C. Readings were taken every mi

for a total of 30 min using an automated diode-array spectrophotometer (Hewlett-Packa
GMBH, Germany). In a similar experiment, normal human serum (NHS) or clusterindepleted human serum (CDS; prepared by immunoaffinity chromatography), were diluted
1 in 10 in 50 mM Na2HP04 (pH 6.0-7.5), heated at 60 °C, and measurements of turbidity
taken as previously described. Lastly, the extent of protein precipitation at pH 7.5
compared to that at lower pH values, in the presence and absence of clusterin or the

a-crystallin (purified from bovine eye lenses; a gift from Ms Yoke Berry). Ovotransfe
(1 mg/ml) or mixtures of ovotransferrin (1 mg/ml) and a-crystallin (650 pg/ml) were
prepared in 50 mM Na2HP04, pH 6.0, 6.5, 7.0, or 7.5, and heated at 60 °C.
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(iii) The effects of clusterin on slowly precipitating y-crystallin or lysozyme was
determined by heating y-crystallin (1 mg/ml in 50 mM Na2HP04, pH 7.0) at 60 °C in

the presence or absence of 50 pg/ml clusterin. Similar experiments were conducted in
which lysozyme (250 pg/ml in 50 mM Na2HP04, pH 7.0) was incubated at 42 °C with
20 mM DTT in the presence or absence of 400 pg/ml clusterin. The extent of protein
precipitation in each case was measured as turbidity at 360 nm using a model 8453
diode-array spectrophotometer (Hewlett-Packard GMBH, Germany). To determine
what effect clusterin had on rapidly precipitating y-crystallin or lysozyme, the

following two assays were performed. (1) 300 pg of y-crystallin was denatured for 20
min in 20 pi of denaturing buffer (50 mM phosphate buffer containing 6 M guanidine
hydrochloride (GuHCl)). This solution was added to 10 pi of PBS containing 15 pg of

clusterin or one of two control proteins (BSA or ovotransferrin). Rapid y-crystallin
precipitation was achieved over 1 min via repeated additions of 10 - 20 pi aliquots
50 mM Na2HP04, pH 7.0, to give a final volume of 300 pi. (2) 3 mg of lysozyme was

denatured in 30 pi of denaturing buffer for 20 min. A 1 pL aliquot (containing 100 p

of lysozyme) was withdrawn and added to 19 pi of PBS containing 160 pg of clusterin,
BSA or ovotransferrin. These mixtures were then diluted 5-fold over approximately 1
min with subsequent additions of 10 pi aliquots of 50 mM Na2HP04, pH 7.0, to give a
final volume of 100 pi. Both assays were performed in separate wells of microtitre
plates and the final amount of protein precipitation in each case was measured as
turbidity at 360 nm with a Spectramax 250 microplate reader (Molecular Devices,
Sunnyvale, CA, USA).

97

4.2.4 NMR

Spectroscopic Analysis of Interactions Between Clusterin and Reduced a-

Lactalbumin - Real-time one-dimensional ]H NMR spectra of samples of a-lactalbumin

(at 3.0 mg/ml) with or without added clusterin (0.7 mg/ml) were acquired at 500 MHz o
a Varian Inova-500 NMR spectrometer. All samples were prepared in 570 pi of buffer
containing 50 mM Na2HP04, 0.1 M NaCl, 10% D20, pH 7.2. A series of spectra were
acquired over time after the addition of 30 pi of a 0.4 M solution of deuterated DTT

each of the samples to give a final concentration of 20 mM. In each case, the acquis

of spectra was continued until no further changes in the one-dimensional spectrum we
observed. In total, a sweep width of 5500 Hz was used over 9000 data points with an

acquisition time of 0.82 s per scan and a delay between scans of 1.0 s. Sixteen scans

were acquired per spectrum which, along with two blank control scans, gave a total t

between successive spectra of approximately 33 s. An exponential line broadening of 3
Hz was applied to all NMR spectra prior to Fourier transformation.
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4.3

RESULTS

4.3.1 Temperature Has Negligible Effect on the Oligomerisation State of Clusterin.
To examine the effect of increased temperature on the oligomerisation state of
clusterin, samples of clusterin were applied to a calibrated Pharmacia Superose-6 size
exclusion chromatography column immediately after a 1 hour incubation at either 37
°C or 50 °C and elution from the column was monitored as described in section 4.2.1.
Figure 4.3.1 shows that, under the conditions used, there was no significant difference

in the elution profiles for clusterin samples that had been heated at either 37 °C or 5

°C. This indicates that the oligomerisation state of clusterin remains relatively stabl
over the temperature range of 37 - 50 °C.
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Figure 4.3.1: Effects of temperature on the oligomerisation state of clusterin. Samples of clus
analysed by size-exclusion chromatography at 50 °C (Panel A ) and 37 °C (Panel B ) as described in
Methods (see 4.2.1). The absorbance at 280 n m (thick solid lines) were normalised and deconvoluted
into peaks eluting at -71 min (thickdashed line), -63 min (thin solid line), -56 min (dotted line) and -40
min (dashed line) as described in Methods. The arrows show the elution positions of molecular weight
markers which were (from left to right): Blue Dextran (2 M D a ) , catalase (232 kDa), aldolase (158 kDa),
albumin (67 kDa) and ovalbumin (43 kDa). The results shown are representative of three independent
experiments.
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4.3.2 Elevated Temperature Slightly Enhances Substrate Binding by Clusterin.
In ELISA, the level of binding of purified clusterin to plate-bound stressed
BSA, GST or lysozyme was only slightly enhanced at elevated temperature (Figure
4.3.2). In experiments in which BSA or GST were used as the target proteins, the
amount of substrate binding by clusterin was dependent on the temperature used
(Figure 4.3.2 A & B). Of the temperatures tested, clusterin binding was greatest at 50
°C, with progressively less binding occurring at 45, 42, and 37 °C. The binding of
clusterin to plate-bound stressed lysozyme was similarly affected by elevated
temperature. However, unlike the results for BSA and GST, clusterin bound most
strongly with stressed lysozyme at 45 °C, with slightly less binding at 50, 42 and 37 °C
(Figure 4.3.2 C). The cause of this observed difference is not known. Nevertheless,
the ELISA results demonstrate that elevated temperature only slightly enhances the
binding of clusterin to stressed proteins.

4.3.3 The Chaperone Action of Clusterin is only Slightly Enhanced at Elevated
Temperature.
The effect of elevated temperature on clusterin's ability to inhibit stress-induced
precipitation of insulin, BSA, a-lactalbumin and lysozyme was investigated and the
results presented in Figure 4.3.3 A-D, respectively. Reduction of the test proteins in
the absence of clusterin produced extensive precipitation. In each case, the rate of
precipitation was more rapid when the target protein was reduced at temperatures
greater than 37 °C, but the final amount of protein precipitation was similar regardless
of the temperature used. In the presence of exogenous clusterin and at 37 °C, the final
level of target protein precipitation at the end of each time course was significantly
reduced due to the chaperone action of clusterin. When the target proteins were

100

stressed at 45 or 5 0 ° C in the presence of clusterin, the final level of protein

precipitation was slightly less than that achieved at 37 °C, indicating that the chaperone
action of clusterin was only slightly enhanced at elevated temperatures.
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Figure 4.3.2: Results of E L I S A measuring the temperature-dependent binding of clusterin to stressed
proteins; (A) DTT-reduced bovine serum albumin (BSA), (B) Heat-stressed glutathione-S-transferase
(GST), and (C) DTT-reduced Lysozyme (lys). Individual data points are the mean of triplicate
measurements. In each case, the error bars shown represent standard deviations of the mean and in
many cases are too small to be visible. T h e results shown are representative of two independent
experiments.
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Figure 4.3.3: Effects of elevated temperature on clusterin's chaperone activity. (A) Insulin (2 mg/ml)
was reduced with 2 m M D T T at 37 °C, 45 °C, or 50 °C in the presence or absence of clusterin (400
Mg/ml); see key. (B) B S A (750 Mg/ml) was reduced with 20 m M D T T at 37 °C or 50 °C in the presence
or absence of clusterin (300 Mg/ml). (C) a-lactalbumin (750 Mg/ml) was reduced with 20 m M D T T at 37
T o r 50 °C in the presence or absence of clusterin (300 Mg/ml). (D) Lysozyme (250 Mg/ml) was reduced
with 20 m M D T T at 37 °C or 50 °C in the presence or absence of clusterin (700 Mg/ml). Each
experiment was performed a minimum of three times and the individual traces shown are representative.
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4.3.4 Low pH Enhances Binding of Clusterin to Stressed Proteins.
In chapter 3, clusterin was shown by ELISA to bind preferentially to stressed
forms of ovotransferrin and lysozyme at near-physiological pH (i.e. pH 7.0). Here, the
effects of mildly acidic pH on the binding of purified clusterin to stressed forms of
ovotransferrin, GST, a-lactalbumin or BSA were investigated by ELISA (Figure
4.3.4). In all cases, regardless of whether the substrate protein was heat stressed or
chemically reduced, the level of binding of purified clusterin to these substrates was
clearly enhanced under mildly acidic conditions. Purified clusterin exhibited greatest
binding to stressed proteins at pH 6.0, with progressively less binding occurring at pH
6.5 and 7.5. Similar results were obtained in ELISA experiments in which (i) GST,
ovotransferrin or lysozyme were used as target proteins, and (ii) clusterin, in the form
of pH-adjusted unfractionated human serum, was substituted for purified clusterin
(Figure 4.3.5). However, the level of increased binding of clusterin to stressed proteins
at low pH was considerably greater for purified clusterin than for clusterin in
unfractionated serum (compare Figure 4.3.4 to Figure 4.3.5). The most likely
explanation for this observation is that serum proteins, undergoing partial unfolding at
pH 6.0, were competing with plate-bound stressed protein for clusterin binding. At pH
5.0 and 4.0, the level of binding of purified clusterin to stressed target proteins was
similar to that obtained at pH 6.0 (data not shown). Control experiments verified that
pH had no effect on the amount of stressed proteins immobilised on the ELISA wells
(data not shown).
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Figure 4.3.4: Effects of mildly acidic p H on the binding of clusterin to heat-stressed (A) ovotransferrin
(ovo), (B) glutathione-5-transferase (GST), and reduced (C) ovotransferrin (ovo + D T T ) , (D) alactalbumin (a-lact) and (E) bovine serum albumin ( B S A + D T T ) . All experiments were conducted in
50 m M N a 2 H P 0 4 buffer at p H 6.0 ( • ), p H 6.5 ( • ), or p H 7.5 ( • ) - see key. Data points shown
represent triplicate measurements. In each case, the error bars shown represent standard deviations of
the mean and in many cases are too small to be visible. Results shown are representative of three
independent experiments.
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4.3.5 Low pH Enhances Cluster in-Mediated Inhibition of Protein Precipitation.
Results shown in Figures 4.3.4 and 4.3.5 clearly indicated that the binding of
clusterin to stressed proteins in ELISA is enhanced at mildly acidic pH (see section
4.3.4). However, the effect of mildly acidic pH on the chaperone action of clusterin
was unknown. To address this issue, a number of target proteins, either purified
proteins or proteins present in unfractionated human serum, were stressed (i) in the
presence or absence of clusterin and (ii) at pH ranging from 6.0 - 7.5. The results of
these experiments are shown in Figure 4.3.6. For all target proteins tested in the

absence of clusterin, the rate and extent of protein precipitation were similar regardles
of the pH used. In the presence of exogenous clusterin, the extent of protein
precipitation was reduced in a pH-dependent manner. For example, at pH 6.0, clusterin
was able to suppress approximately 97% of ovotransferrin precipitation compared to
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7 1 % at p H 6.5 and 3 3 % at p H 7.5 (Figure 4.3.6 A ) . A similar trend was observed for
GST and catalase (Figure 4.3.6 B & C). The corresponding levels of clusterin-

mediated inhibition of protein precipitation in unfractionated human serum were 83%
at pH 6.0 and 53% at pH 7.5 (Figure 4.3.6 D).

Figure 4.3.6: Effects of mildly acidic p H on clusterin's chaperone action. (A) ovotransferrin (Ovo), (B)
GST, (C) catalase (Cat) or (D) proteins in unfractionated human serum (diluted 1 in 10), were stressed as
described in Methods (section 4.2). Protein precipitation at p H 7.5, 6.5 or 6.0 and in the presence or
absence of exogenous clusterin (see key) was measured as absorbance at 360 n m a s a function of time.
Clusterin-depleted serum ( C D S ) was prepared from normal human serum ( N H S ) by immunoaffinity
chromatography, as described in Chapter 2; General Materials and Methods. Each experiment was
performed a m i n i m u m of three times and the individual traces shown are representative.
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Further decreasing the p H to 5.0 and 4.0 only marginally increased the ability
of clusterin to inhibit heat-induced precipitation of proteins (data not shown). Taken
together, the results presented here clearly show that mildly acidic pH enhances the

ability of clusterin to inhibit the precipitation of stressed proteins. In contrast, mil
acidic pH had an opposite effect on the chaperone action of the cytosolic sHsp, a-

crystallin. Figure 4.3.7 demonstrates that, at pH 6.0, a-crystallin was unable to inhibi
the heat-induced precipitation of ovotransferrin whereas, at pH 6.5, 7.0 and 7.5, the
final levels of protein precipitation were reduced by approximately 10, 76, and 88%,
respectively. Similar results were obtained when catalase was used as a stressed
protein target (data not shown).

Key
A -a-crys, pH7.5
A

+ a-crys, p H 7 . 5

•

+ a-crys, p H 7 . 0

•

+ a-crys, p H 6 . 5

•

+ a-crys, p H 6 . 0

Figure 4.3.7: Plot showing the effects of low p H on the chaperone activity of a-crystallin.
Ovotransferrin (1 mg/ml) was heat-stressed in the presence (solid symbols) or absence (empty symbols)
of a-crystallin at p H 7.5 (triangles), p H 7.0 (circles), p H 6.5 (squares) or p H 6.0 (diamonds) - see Key.
For clarity, results in the absence of a-crystallin at p H 6.0, 6.5 and 7.0 are not shown. Each experiment
was performed a m i n i m u m of three times and the individual traces shown are representative.
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4.3.6 Clusterin Does Not Inhibit the Rapid Precipitation of Lysozyme or y-Crystallin.
Figure 4.3.8 shows that clusterin, at a subunit molar ratio of 1.0:20 clusterimy-

crystallin or 1.6:1.0 clusterimlysozyme, is able to suppress the slow precipitation of y
crystallin undergoing heat stress at 60 °C and lysozyme undergoing DTT-mediated
reduction at 42 °C by approximately 60% and 50%, respectively (Figure 4.3.8 A & B).
When either of these proteins is unfolded in 6M GuHCl and then diluted into
phosphate buffer (as described in 4.2.3), they rapidly precipitate from solution. Using
the same subunit molar ratio of clusterin: target as in the experiments measuring slow
precipitation, clusterin was unable to suppress the rapid precipitation of either ycrystallin or lysozyme (Figure 4.3.8 C & D). Even when the clusterin:target ratios

were doubled, clusterin failed to inhibit the rapid precipitation of either protein (data
not shown). Control proteins, BSA and ovotransferrin, were also unable to inhibit the
rapid precipitation of lysozyme and y-crystallin (Figure 4.3.8 A & B).
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Figure 4.3.8: Effect of clusterin on the slow and rapid precipitation of y-crystallin and lysozyme. Slow
precipitation: (A) y-crystallin and (B) lysozyme was stressed by heat and reduction, respectively, as
described in Methods (4.2) and protein precipitation was measured as absorbance at 360 n m as a
function of time. These experiments were performed either in the absence of clusterin (empty symbols)
or in the presence of clusterin (solid symbols) (see key). The data points shown represent the mean of
triplicate measurements. Rapid precipitation: (C) y-crystallin and (D) lysozyme were denatured in 6 M
GuHCl and rapidly precipitated following 10- and 5-fold dilution with 50 m M N a 2 H P 0 4 buffer, p H 7.0,
respectively. These experiment were performed in the absence of clusterin (empty bar) or in the
presence of clusterin (solid bar), B S A (shaded bar), or ovotransferrin (striped bar). The results shown in
C and D are end point measurements and the error bars shown are standard errors of the mean of
triplicate measurements. N o n e of the proteins added had a significant effect on the extent of rapid
precipitation of either y-crystallin or lysozyme (/5>0.05, r-test). The results shown are representative of
three independent experiments.
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4.3.7 Real-time ]HNMR

Analysis of the Interaction Between Clusterin and Reduced a-

Lactalbumin.
The ability of clusterin to interact with and confer stability to chemically
reduced a-lactalbumin has previously been established (Humphreys et al, 1999). To

investigate this interaction at the molecular level and to determine the conformation of
reduced a-lactalbumin with which clusterin specifically interacts, the time-dependent
reduction of a-lactalbumin, in the presence or absence of clusterin, was monitored in
real-time using a 500 MHz NMR spectrometer, as described in section 4.2.4. Figure
4.3.9A & B shows the aromatic region of selected one-dimensional !H NMR spectra of
solutions of a-lactalbumin, either non-reduced or reduced with DTT, in the absence
(Figure 4.3.9A) or in the presence (Figure 4.3.9B) of clusterin. The !H NMR spectra
for non-reduced a-lactalbumin, alone or with clusterin, are characterised by welldispersed and highly defined resonance peaks (at 0 s; Figure 4.3.9A & B). Similarities
between these spectra indicate that the dominant resonances arose from a-lactalbumin
(as expected since clusterin was present at a much lower level in the mixture).
Therefore, changes in resonance intensity or dispersion in subsequent spectra were
solely attributable to conformational changes undergone by a-lactalbumin.
As can be seen from Figure 4.3.9A, in the absence of clusterin, incubation of alactalbumin with DTT resulted in a rapid alteration in the NMR spectra. This involved
transition from (i) the resolved NMR spectrum of the native species (at 0 s) to (ii) a
broad spectrum with some dispersion, reflecting the presence of partially unfolded
intermediates containing mostly secondary and some tertiary structure (Ii, e.g. at 384
s), to (iii) an even broader spectrum lacking any dispersion, produced by an

intermediate with some secondary structure but no tertiary structure (I2, e.g. at 639 s)
With time (e.g. 2170 s), the I2 state of a-lactalbumin was completely lost as the
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reduced protein aggregated and precipitated from solution. Upon removal of the

sample from the spectrometer after the experiment, a substantial amount of protei
precipitate was present in the NMR tube.
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figure 4.3.9: Real-time 'H N M R spectra and kinetics of a-lactalbumin reduction in the presence or
absence of clusterin. Aromatic region of the *H N M R spectra of (A) a-lactalbumin alone, and (B)
4.3:1.0 (w:w) a-lactalbumin:clusterin, at the times indicated after the addition of D T T . Representative
results are shown. (C) Plot showing the resonance intensity of the a-lactalbumin tyrosine (3,5) aromatic
nng protons (at 6.8 p p m ) as a function of time during reduction; a-lactalbumin alone ( O ); 4.3:1.0
(w:w) a-lactalbuminxlusterin (• ).
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Similar spectra were recorded for a-lactalbumin undergoing DTT-mediated
reduction in the presence of clusterin (Figure 4.3.9B). However, in this case, the
progression from the native species (at 0 s) to the I2 state of a-lactalbumin was slower
(compare Figure 4.3.9A & B). In addition, whereas the I2 state of a-lactalbumin was
abolished by 2170 s when the protein was reduced in the absence of clusterin, in the

presence of clusterin the I2 state of reduced a-lactalbumin was still present 5400 s aft
the addition of DTT (Figure 4.3.9C). Thus, clusterin had a stabilising effect on the I2
state of a-lactalbumin. When the sample was removed from the NMR spectrometer
after the experiment, the protein solution had remained clear, indicating that clusterin
had successfully formed complexes with partly unfolded a-lactalbumin, inhibiting its
precipitation from solution.

Figure 4.3.9C shows a plot of the intensity of resonance (at 6.8 ppm) versus
time after the addition of DTT for a-lactalbumin in the presence or absence of
clusterin. The resonance at 6.8 ppm arises from the (3,5) aromatic ring protons of
tyrosine residues of reduced a-lactalbumin and is relatively isolated from the broad
envelope of other aromatic resonance. Since native a-lactalbumin does not have a

significant resonance at this chemical shift, monitoring its intensity with time after t
addition of DTT provided a means of following the build-up and decay of the I2 state
without complications from resonances arising from the native state of a-lactalbumin.
From Figure 4.3.9C, it can be seen that for a-lactalbumin reduced either in the
presence or absence of clusterin, the intensity of resonance at 6.8 ppm increased
rapidly to a maximum at approximately 380 s, indicating that clusterin had no
significant effect on the build-up of signal from the I2 state. In addition, since the
maximum NMR resonance intensity from the I2 state of a-lactalbumin occurs when all
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four of its disulfide bonds are reduced (Carver et al, 2002), the data presented in
Figure 4.3.9C indicate that clusterin does not significantly affect the rate of disulfide
bond reduction in a-lactalbumin.
After maximum resonance intensity was reached, the signal progressively
decayed as reduced a-lactalbumin (in the I2 state) either (i) aggregated in the absence
of clusterin, or (ii) complexed with clusterin (Figure 4.3.9C). As a means to compare
the rates of decay of the 6.8 ppm resonance for a-lactalbumin, the equation for the
first-order process was fitted to the data shown in these figures. As a result, the
calculated first-order rate constants for the time-dependent resonance intensity decay
were (1.81 ± 0.09) x 10"3 s"1, in the absence of clusterin, and (5.07 ± 0.13) x 10"4 s"1, in
the presence of clusterin. Therefore, under the conditions described, clusterin
approximately tripled the lifetime of the I2 state of a-lactalbumin.
Recently, a similar pattern of binding by clusterin to insulin has also been
recorded using *H NMR spectroscopy (data known shown). Together with the results
showing the binding of clusterin to a-lactalbumin, this result suggests that clusterin
may specifically interact with the disordered intermediately folded molten globule
states of stressed proteins.
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4.4 DISCUSSION

A large number of publications are devoted to the analysis and characterisation
of the structure and chaperone action of sHsps under both physiological and stress
conditions (e.g. exposure to elevated temperature). These studies indicate that
interactions between sHsps and stressed proteins are achieved through hydrophobic
interactions. This may also be true for clusterin. Cross-linking of the hydrophobic
probe bis(l-anilinonaphthalene-8-sulfonate) (bis-ANS) to clusterin reduces the latter's

ability to inhibit the precipitation of its substrates by competing with stressed protein
for hydrophobic regions on clusterin (Poon et al, 2002; see Appendix). Many studies
indicate that under physiological conditions sHsps exist in solution as large multimeric
complexes. Upon exposure to heat stress, many sHsps undergo substantial structural
changes that may result in (i) loss of native-like motifs, leading to the formation of
molten globule-like structures, (ii) dissociation of the multimer to form oligomers and
other lower-order forms, and (iii) increased protein surface hydrophobicity, which can
lead to an enhancement of chaperone activity (section 4.1). Taken together, these
observations suggest that, for these sHsps, the non-aggregated, lower-order forms of
the proteins are responsible for their chaperone action.
Similarly, clusterin has also been shown to exist in solution as multimeric
structures. However, unlike the sHsps, results shown in Figure 4.3.1 demonstrate that

elevated temperature does not significantly affect the oligomerisation state of clusterin.
In addition, exposure of clusterin to temperatures between 37 °C and 50 °C did not

substantially alter its ability to interact with heat-stressed or chemically reduced targ
proteins (Figure 4.3.2), or its ability to inhibit precipitation of proteins undergoing
DTT-mediated reduction (Figure 4.3.3). Furthermore, as reported in Poon et al, 2002,
a decrease in the amount of exposed hydrophobicity on clusterin was detected with
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increasing temperature. Taken together, these results demonstrate that, at elevated
temperatures, clusterin remains oligomerised, has decreased exposed hydrophobicity,
but is still capable of functioning as a chaperone. This suggests that the hydrophobic
regions of clusterin that become less exposed to solution at elevated temperatures are
probably discrete from those regions that associate during clusterin oligomerisation and
that may form parts of the chaperone-binding site(s).
The effects of mildly acidic pH on the oligomerisation state of clusterin have
previously been documented (Hochgrebe et al, 2000). Gel filtration studies indicated
that, at physiological pH (i.e. pH 7.5), clusterin exists as aggregates of varying
numbers of associated afS heterodimers, which dissociates into monomers at mildly
acidic pH (pH 5.5 - 6.0). In contrast to results obtained at elevated temperatures,
dissociation of the clusterin oligomers occurs at low pH and is accompanied by
increased exposure of hydrophobic regions on clusterin and increased binding of
clusterin to native protein and polysaccharide ligands (Hochgrebe et al, 2000;
Pankhurst et al, 1998). However, mildly acidic pH induces very little change in the
overall secondary structure of clusterin as detected by CD analysis. Therefore, it was
reasoned that under these conditions, the enhanced binding of clusterin to the various
native target ligands could not be attributed to any hydrophobic regions that would
have only been exposed to solvent as a result of substantial structural alterations.
Hydrophobic regions normally buried in the clusterin-clusterin interfaces but which
become exposed to solvent following pH-dependent dissociation of clusterin oligomers
may be responsible for the enhanced ligand binding.
Results presented in this chapter indicate that at mildly acidic pH, the
chaperone activity of clusterin is significantly enhanced (Figure 4.3.4 - 4.3.6). It is
possible that hydrophobic regions responsible for the enhanced binding of clusterin to
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native ligands at low p H m a y also contribute to the enhanced interaction between
clusterin and stressed proteins under these conditions. In a recent report, it was
suggested that clusterin contains three regions of natively disordered or molten

globule-like structures that are sensitive to protease digestion (Bailey et al, 2001). The
binding of the hydrophobic probe, ANS, to clusterin protected at least one of these
disordered regions from trypsin-mediated proteolysis, indicating that it is hydrophobic
and may therefore contribute to the binding site(s) on clusterin for stressed protein
ligands.

The effect of low pH on the structure of clusterin is strikingly similar to that of
increased temperature on the sHsps. There are no previously published studies of the
effect of low pH on the chaperone action of sHsps, although results shown in Figure
4.3.7 indicate that the in vitro chaperone action of the sHsp, a-crystallin, is
dramatically reduced when exposed to mildly acidic conditions. The enhanced ligandbinding and chaperone action of clusterin at low pH may have important physiological
relevance. A phenomenon known as acidosis occurs at sites of tissue damage or
inflammation where the local pH can drop below 6. Acidosis has been reported to
occur at sites of inflammation, cardiac ischaemia, infracted brain, and in the brains of
Alzheimer's sufferers (McGeer and McGeer, 1997). Under these conditions, clusterin
oligomers may dissociate and the enhanced binding/chaperone actions of the
heterodimeric species could help to inhibit the aggregation and deposition of
inflammatory and/or toxic proteins which would otherwise exacerbate pathology.
Under stress conditions, the unfolding of a target protein occurs via a series of
partly structured intermediates or molten globule states (see Figure 4.1.1). Depending
on the amount of native-like structure, molten globules can be classified as being
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ordered (Ii) or disordered (I2).

O f these, the I2 intermediates are the least stable

because they are less structured; they contain some secondary structure but very little,
if any, tertiary structure, and hence expose significantly greater amounts of
hydrophobicity to solution than the Ij intermediates. This increased exposure of
hydrophobicity causes the I2 molten globules to slowly aggregate and precipitate via
the irreversible off-folding pathway.
Small Hsps such as a-crystallin have been shown to interact specifically with
the less stable I2 form of molten globules. Small Hsps have no affinity for target
proteins that are either in the native state or in the stable Ii molten globule state
(Lindner et al, 1997). Similar results have been presented in Poon et al, 2002; the
report showed that clusterin does not bind to (i) native a-lactalbumin, (ii) its stable,
monomeric, partly structured intermediates, or (iii) the fully unfolded form of alactalbumin. Clusterin binds only to the reduced form of a-lactalbumin, which is I2like (on the basis of CD spectroscopic analysis; Okazaki et al, 1994) and is known to
slowly aggregate and precipitate (Humphreys et al, 1999; Lindner et al, 1997). The
ability of clusterin to specifically interact with the I2 form of a-lactalbumin suggests
that kinetic factors might be important in regulating the chaperone action of clusterin.
To examine this hypothesis, precipitation experiments were conducted to test the
ability of clusterin to inhibit (i) the slow precipitation of y-crystallin and lysozyme
(induced by heat and reduction, respectively), versus (ii) the rapid precipitation of the
same proteins induced by dilution from denaturant. Results presented in Figure 4.3.8
demonstrate that clusterin was effective in suppressing the slow precipitation of ycrystallin and lysozyme, but was unable to prevent these same target proteins from
rapid precipitation. Taken together, these results indicate that, like sHsps, clusterin
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binds specifically to slowly aggregating proteins on the off-folding pathway and that
kinetic factors are important in its chaperone action.
Real-time !H NMR spectroscopic analysis of the interaction between clusterin
and a-lactalbumin suggests that this process occurs in two phases. A similar two-step
binding pattern has also been described for the interaction of the sHsp, a-crystallin,
upon interaction with reduced a-lactalbumin (Lindner et al, 1997; Lindner et al,
2001). Clusterin's ability to extend the lifetime of the I2 state of a-lactalbumin about
3-fold (Figure 4.3.9C) indicates that, during the first phase, the non-aggregated
(probably monomeric) form of the intermediate was stabilised through an interaction
with clusterin. The progressive loss of the NMR spectrum of the I2 state of alactalbumin during reduction in the presence of clusterin indicates that, during the
second phase, larger clusterin-a-lactalbumin complexes form, producing species of
large molecular mass that would tumble slowly and give rise to very broad NMR
spectra. When chemically reduced with DTT, a-lactalbumin is known to form HMW
complexes with clusterin (Humphreys et al, 1999).

In conclusion, the data presented in this chapter indicate that the chaperone
action of clusterin is dependent on both conformational and kinetic factors. Exposure
to mildly acidic conditions induces dissociation of clusterin oligomers, resulting in an
increased exposure of hydrophobic regions to solution, and an enhancement of
clusterin's chaperone action. Like sHsps, clusterin cannot inhibit very rapidly

precipitating proteins. Instead, clusterin preferentially binds to partly unfolded, slowly
aggregating protein intermediates. Taken together, these results suggest that clusterin
is a pH-dependent chaperone that functions by specifically interacting with disordered
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molten globule states of slowly aggregating proteins on the irreversible off-folding
pathway.

A subset of the results presented in this chapter have been published in the following
journal papers:
Poon, S., Treweek, T.M., Wilson, M.R., Easterbrook-Smith, S.B., and Carver, J.A.
(2002) "Clusterin is an extracellular chaperone that specifically interacts with slowly
aggregating proteins on their off-folding pathway" FEBS Letters: 513, 259-266. (see
Appendix)
Poon, S., Rybchyn, M.S., Easterbrook-Smith, S.B., Carver, J.A., Pankhurst, G.J., and
Wilson, M.R. (2002) "Mildly Acidic p H Activates the Extracellular Molecular
Chaperone Clusterin" J. Biol. Chem: 277, 39532-39540. (see Appendix)
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Chapter 5

Production and Expression of Vectors
Encoding Wild Type and Mutant
Clusterin Molecules
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5.1 INTRODUCTION
Clusterin is a highly conserved protein that is constitutively expressed and
secreted by a wide range of cell types (section 7 J.2) (Rosenberg and Silkensen, 1995;
Jenne and Tschopp, 1992). Under normal conditions, clusterin is primarily expressed
in epithelial cells and at fluid-tissue interfaces where it has been suggested to protect
cell membranes from the harmful effects of prolonged exposure to "biologically active

fluids" such as bile, gastric juice, pancreatic juice and urine (Jordan-Starck et al, 1994;
Aronow et al, 1993). Expression of clusterin is up-regulated by cellular stress (e.g.
heat shock, oxidative stress) (Clark and Griswold, 1997) as well as a variety of signals
related to the growth state and oncogenic status of the cell. Clusterin gene expression
has also been detected in a number of diseases such as Alzheimer's disease (May et al,
1989; 1990), scrapie (Duguid et al, 1989), epilepsy, various human gliomas (Danik et
al, 1991), and in the retinas of patients with retinitis pigmentosa (Jones et al, 1992).
The role played by clusterin in these and other diseases is not known. However, in
vitro results presented in (Humphreys et. al, 1999) and in this thesis indicate that

clusterin is a chaperone; it preferentially interacts with and stabilises proteins that ar
partially unfolded, as was shown when clusterin suppressed the precipitation of
chemically-reduced proteins in unfractionated human serum (section 3.3.2). Therefore,
it is reasonable to suggest that clusterin might also function in vivo to stabilise non-

native protein structures and to confer cellular protection against a wide range of stress
conditions.

The region(s) of clusterin structure responsible for the chaperone action of the
protein have not been identified. However, sequence analysis of the primary structure
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of clusterin has revealed several regions that could be of functional importance. These
include five regions of predicted amphipathic a-helices (Bailey et al, 2001), a motif
analogous to the cytolytic components of the complement membrane-attack complex
(Jenne and Tschopp, 1989; 1992), a putative nucleotide-binding site (Tsuruta et al,
1990) and two predicted myosin-like coiled-coil domains (Jordan-Strack et al, 1992)
(Figure 5.1.1). According to Bailey et al, 2001, the five regions of predicted
amphipathic a-helices correspond to residues 19-39, 149-169, 217-234, 309-327, and
407-422 of the mature clusterin molecule. Using the coils algorithm, the two coiledcoil a-helical regions were predicted to correspond to residues 18-77 and 296-328 of
mature clusterin (Wilson and Easterbrook-Smith, 2000). The a-helices are of
particular interest for elucidating the regions of clusterin that are important for its
chaperone action. Since amphipathic a-helices are thought to be important in
mediating interactions with hydrophobic molecules, they may be responsible for the
propensity of clusterin to interact stably with lipids and hydrophobic domains present
in other proteins. In addition, they may also explain why clusterin could (i) mediate

cell-cell interactions, (ii) bind with high affinity to a wide range of biological ligand
including amyloid (3 (1-40), complement components, and lipids such as those found in

high-density lipoproteins, and (iii) function in vitro as a chaperone protein, binding to
denatured proteins to prevent aggregation and precipitation.
Several studies by others working on clusterin have been conducted to identify
structural regions responsible for the promiscuous binding ability of this protein. In
one particular study, 34 peptides, each consisting of 15 amino acids, were synthesised
from hydrophilic regions of human clusterin and their ability to promote cell adhesion
in vitro was assessed (Silkensen et al, 1999). Of these, two peptides, designated Clu29 (corresponding to residues 337-351) and Clu-32 (residues 381-395), completely
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inhibited clusterin-mediated cell adhesion, whereas the peptide, Clu-10 (residues 96110), promoted cell adhesion These results suggest that the region of human clusterin
corresponding to peptide Clu-10 may be important for cell adhesion. In another study,
sequence analysis predicted three regions of natively disordered, molten globule-like
structures containing putative amphipathic a-helices (Bailey et al, 2001). Limited
digestion with trypsin revealed 11 trypsin cleavage sites that were located within or
immediately proximal to the predicted molten globule-like domains, indicating that
these regions are highly flexible. ANS binding to these domains resulted in the
protection of one trypsin cleavage site, suggesting that at least one of the predicted
molten globule-like regions is hydrophobic and is likely to be involved in the binding
of protein or lipid substrates by clusterin. A more recent study tested whether the
binding of clusterin to ligands could be inhibited by competitive binding with other
clusterin ligands or by anti-clusterin monoclonal antibodies (Lakins et al, 2002;

Appendix). The results of this study suggested that clusterin has three separate bindin

sites for: stressed proteins, unstressed ligands, and the cell surface receptor low-de
lipoprotein receptor-related protein-2 (LRP-2). In the same report, the ability of
purified human serum clusterin (/isClus) to suppress stress-induced protein
precipitation was compared to that of purified recombinant Pichia pastoris - derived

clusterin (rpClus), which has variable proteolytic truncations of the C-terminal region
of the a-chain and the N-terminal region of the f3-chain. Results showed that, even
with the truncations, r/?Clus had similar in vitro chaperone activity to hsClxxs.

Therefore, collectively, these studies strongly suggest that the site(s) responsible f
chaperone action of clusterin is(are) likely to be located more towards the N-terminal
region of the a-chain and the C-terminal region of the P-chain. However, the exact
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location of the binding sites for stressed proteins, unstressed ligands, and L R P - 2
remains to be identified.
As an initial step towards identifying the structural region(s) responsible for the
promiscuous binding ability and chaperone action of human clusterin, expression
plasmids encoding wild type or a range of mutant human clusterin molecules were
developed. Mutations (in the form of proline-substitutions or truncations) were
introduced into specific regions of the clusterin sequence (Figure 5.1.1) that were
thought likely to be of functional importance (e.g. predicted amphipathic or coiled-coil
a-helices, and regions towards the N-terminus of the a-chain and C-terminus of the (3chain). By inducing significant conformational changes or truncations to these regions
and testing for their effects on the binding and chaperone abilities of clusterin, the
functional regions of the protein may be determined.
Table 5.1.1 lists characteristics of the various clusterin mutants developed in
this study. Proline-substitution mutants clusA27P, clusQ155P, clusM228P, clusL322P,
and clusA413P were developed by substituting helix-disrupting proline for various
amino acids in the clusterin sequence. For these mutants, the sites of prolinesubstitution were determined from GOR IV secondary structure analyses of the
predicted regions of a-helix in human clusterin (section 5.2.7). These sites were
specifically chosen because, at these residue positions, proline was predicted to be
most disruptive to the helical structures (which are possible functional domains of
clusterin; see above). Truncation mutants clusT17 and clusT78 were developed by
removing portions of the a-chain N-terminus whilst mutants clus294T, clus356T and
clus413T had portions of the p-chain C-terminal tail removed. Expression of wild type
and mutant clusterin genes was attempted in Spodoptera frugiperda IPLB-Sf9 (Sf9)
insect cells (Invitrogen, CA, USA), a clonal isolate derived from the parental
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Spodoptera frugiperda cell line IPLB-Sf-21-AE ( S C I ) of the ovaries of fall
armyworms. Sf9 insect cells were chosen (above other expression systems; e.g.,
mammalian, yeast, bacteria) as the host for the production of recombinant wild type
and mutant clusterin due largely to their reported ability to express recombinant
proteins at very high levels (up to 25-50% of the total cell protein; Luckow and
Summers, 1988). In addition, Sf9 have also been reported to carry out posttranslational
modifications (e.g. fatty acid acylation, glycosylation, and phosphorylation) in a
manner similar to that of mammalian cells (Vialard et al, 1995). This chapter
describes (i) processes involved in the construction of expression clones for the
production of recombinant wild type and mutant human clusterin, and (ii) results of
expression of wild type and mutant clusterin molecules in Sf9 insect cells.
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5.2

METHODS

5.2.1 Determining the Sites for Proline Substitution or Truncation in Human Clusteri

- The sites for proline-substitution in human clusterin was determined using the GOR
IV secondary structure prediction program (located at http://npsa-pbil.ibcp.fr/cgibin/npsa_au tomat.pl?page=npsa_gor4.html). Briefly, the program utilises predictive
algorithms developed by Gamier, Gibrat, and Robson (Gamier et al, 1996) to predict

whether an amino acid in a given protein (in this case, clusterin) is part of an a-he

(3-strand, turn, or coil. The GOR TV algorithm is based on the theoretical propensity
amino acid residues to form particular secondary structures based on each residue's

side-chain structure and its interaction with the structure of neighbouring residues.
According to this algorithm, if an amino acid is flanked by residues that prefer to

part of an a-helix, it is likely that the same amino acid also forms part of the heli
even though its individual helix preference may be low. When a polypeptide sequence

is entered into the program, two outputs are generated; the first output assigns eac
amino acid residue within the sequence to one conformational state of a-helix (H),

extended or beta strand (E), or coil (C); the second gives the probability values fo
secondary structure at each amino acid position.
To determine the optimal site for proline-substitution in human clusterin,

sequences corresponding to each of the predicted regions of amphipathic or coiled-co
a-helices of clusterin were entered into the GOR TV program. These regions were
chosen for site-directed mutagenesis because they are likely to be involved in
clusterin's ligand-binding ability or chaperone action (section 5.1). Systematic

substitution of amino acids within these sequences for proline was performed and the

total number of non-helix-forming residues was determined. For each case, the residue

position at which proline caused the greatest disruption of helix structure (determi
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by the number of predicted non-helix-forming residues) was chosen as the optimal site
for proline-substitution.

As the a-chain N-terminus and (3-chain C-terminus of clusterin have been
predicted to contain functional domains, possibly involving the amphipathic or coiledcoil a-helices (section 5.1), all of the truncation sites were placed at various residue
positions within these regions of the protein. A total of five truncation sites were
chosen; these include residue positions 17 and 78 of the a-chain, and positions 294,
356, and 403 of the [3-chain (section 5.3.1).

5.2.2 Quickchange™ Site-Directed Mutagenesis (Overview) - A total of five prolinesubstitution mutants were developed in this study (Figure 5.1.1). The substitution of
helix-disrupting proline for various amino acids in the clusterin sequence was achieved
using the Quickchange™ site-directed mutagenesis kit (Stratagene, CA, USA). An
overview of the procedures involved is summarised in Figure 5.2.1. Basically, it
utilises a supercoiled double-stranded DNA (dsDNA) vector (in this case, pTZ-HT7;
Figure 5.2.2A) with the full-length clusterin gene and two synthetic oligonucleotide
primers that (i) contain the desired mutation (i.e. a codon which encodes for the amino
acid, proline) and (ii) are complementary to opposite strands of the vector. The
oligonucleotide primers are extended during temperature cycling by Pfu Turbo DNA
polymerase, during which a mutated circular plasmid containing staggered nicks is
generated. Staggered nicks occur due to the inability of the two ends of each DNA
strand of the mutated plasmid to anneal together following temperature cycling (Figure
5.2.1). Dpn I (a restriction endonuclease which is specific for the 5'-GmATC-3'
sequence of methylated and hemimethylated DNA) is then added to digest unreacted
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parental D N A templates and to select for mutation-containing synthesised D N A . Since
the template DNA is isolated from DNA adenine methylase positive (dam+) E. coli and
is therefore dam methylated, it is susceptible to Dpn I digestion. The nicked mutated
plasmid is then transformed into XL 1-Blue supercompetent E.coli cells where they are
repaired.

(Q)
V—V
V_^*

1. G e n e in plasmid with
target site ( • ) for
mutation.

1
fr^
IL
A)
\^>lr
1

2. Denature plasmid and anneal
primers ( $ ) containing
desired mutations ( • ).

*-— — v

1

(' ( J? V
** — — —

1

fry)
VrV

3. Extend and incorporate
mutagenic primers resulting
in nicked circular strands.
Trie locations where these
nicks occur are indicated

by(X).
4. Digest the methylated, non-mutated
parent D N A template with Dpnl.

\—-^

^

1
^

5. Transform into XL1-Blue
Supercompetent cells.

Figure 5.2.1: Overview of the Quickchange™ site-directed mutagenesis method as outlined
instruction manual which accompanied the kit (Stratagene).
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In this study, the full-length clusterin gene in the plasmid, pTZ-HT7 (Figure
5.2.2A) was mutated using PCR to produce gene constructs encoding the various
proline-substitution mutants. The mutagenic oligonucleotide primers used were
clusA27P (GTCAATAAGGAAATTCAAAATCCCGTCAACGGGGTGAAACAGA),
clusQ155P (CACATGCTGGATGTCATGCCCGACCACTTCAGCCGCGCG), clusM
228P (TTCCAGCCCTTCCTTGAGCCCATACACGAGGCTCAGCAG), clusL322P
(TTGACCAGGAAATACAACGAGCCCCTAAAGTCCTACCAGTGG), and A413P
(CCTAAATTTATGGAGACCGTGCCCGAGAAAGAGCTGCAGGAA). The mutated

codons that were introduced using these primers are underlined. For each prime
the complementary primer was also used. All primers were synthesised by

Invitrogen/Life Technologies, NY, USA. The compositions of the PCR mixtures ar

indicated in Table 5.2.1. PCR was performed in a MJ Research Model PTC-200 DNA

Engine thermocycler (MJ Research Inc., NY, USA) using the conditions indicated
Table 5.2.2.

After PCR amplification, the mutant construct plasmids were subsequently

treated with 10 units of Dpn I restriction enzyme (Invitrogen/Life Technologie

USA). Thereafter, all Quickchange™ - mutated plasmids were transformed into XL

Blue supercompetent cells as specified below (section 5.2.2) and allowed to p
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fl (IG)

A. pTZ-HT7
(~ 4250 kb)

bla (Apr)

Clus (-1.3 kb)

rep (pMBl)

T1-T2

B.pDONR™201

attP1

(4470 kb)
ccdB

attP2

C. pXJNsect-Dest38
(12419 kb)

Actin
Promote

attR1 c m r

HR3
Actin polyA

Figure 5.2.2: M a p of various plasmid vectors that were used to create the Gateway™ expression clones,
as described in 5.2.4. A. pTZ-HT7; a plasmid derived frompTZ19R vector (MBI Fenrentas)containing
the clusterin gene. B. p D O N R ™ 2 0 1 (Invitrogen); upon insertion of the gene of interest during the B P
recombination reaction, this plasmid becomes the entry clone. C. pXINsect-Dest38 (Invitrogen); during
the L R reaction, recombination of this plasmid with the entry clone results in the formation of the
expression clones.
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Control

Sample

Reaction

Reactions

Amount Used

Amount Used

10X Reaction Buffer

5 pi

5 pi

pWhitescript 4.5-kb Control Plasmid (5 ng/pl)

10 ng

-

-

50 ng

Olionucleotide Control Primer #1

125 ng

-

Olionucleotide Control Primer #2

125 ng

-

Mutagenic Oligonucleotide Primer #1

-

125 ng

Mutagenic Oligonucleotide Primer #2

-

125 ng

dNTPMix(lOmM)

lpl

lpl

PfuTurbo D N A Polymerase (2.5 U/pl)

lpl

lpl

To 50 pi

To 50 pi

Composition

Double-Stranded Template D N A (pTZ-HT7)

Double-Distilled Water

Table 5.2.1: List and amounts of various components used for Quickchange
clusterin gene in the plasmid, p T Z - H T 7 .

mutagenesis of the

Cycles

Temperature

Time

1

Denaturation
95 °C

30 seconds

12

Denaturation
95 °C

30 seconds

Annealing
55 °C

1 minute

Elongation
68 °C

2 minutes/kb of plasmid length

Table 5.2.2: Cycling parameters for the PCR-based incorporation of proline residues into clusterin
c D N A via Quickchange™ mutagenesis.
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5.2.3 Transforming into XLl-Blue Supercompetent Cells - X L 1-Blue supercompetent
cells were thawed on ice for 1-2 minutes. For each reaction mixture, 50 pi of XLl-

Blue cells were dispensed into a pre-chilled Falcon 2059 polypropylene tube. To these
1 pi of Dpn I-treated DNA from each reaction was added, gently mixed and incubated

on ice for 30 minutes. All transformation reactions were heat pulsed for 45 seconds a
42 °C and then placed immediately back on ice for 2 minutes. Thereafter, 0.5 ml of
NZY+ broth (1% (w/v) NZ amine (casein hydrolysate), 0.5% (w/v) yeast extract, 0.5%
(w/v) NaCl, 12.5 mM MgCl2, 12.5 mM MgS04, 20 mM glucose, pH 7.5) preheated to

42 °C was added to the mixtures and incubated whilst shaking at 240 rpm for 1 h at 37
°C. 250 pi of each transformation mixture was then spread onto LB agar plates
containing 50 pg/ml ampicillin, 80 pg/ml 5-bromo-4-chloro-3-indoyl-P-Dgalactopyranoside (X-gal) and 20 mM isopropyl-l-thio-(3-D-galactopyranoside (IPTG)

and the cells were allowed to propagate overnight (12-16 h) at 37 °C. Thereafter, cel
that had been successfully transformed with the mutated plasmid were selected by
blue-white colour screening with X-gal and IPTG. These cells were picked for small-

scale culture (25 ml) from which the mutated plasmid was extracted and purified using
the Wizard® Plus miniprep DNA Purification System (Promega, WI, USA)- refer to
section 5.2.5. All constructs were verified by DNA agarose gel electrophoresis.

5.2.4 Gateway™ Cloning Technology (Overview) - The Gateway™ cloning system
involves three separate procedures; (i) generation of a^B-flanked PCR products, (ii)

creation of entry clones via the BP reaction, and (iii) creation of expression clones
the LR reaction. An overview of these procedures is shown in Figure 5.2.3. The
benefit of using this system is that clusterin cDNA can be transferred into an entry

vector, from which it can then be transferred via a simple one-step reaction into one
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many different Gateway

-compatible expression vectors (Figure 5.2.4).

Vectors

developed for this system contains unique regions (referred to as att sites) that flan

gene of interest (i.e. clusterin) and allow for site-specific and directional recombin

cloning and subcloning of the gene without the need for restriction enzymes and ligase
In this study, the Gateway cloning system was used to clone and subclone wild type
and mutant clusterin sequences into the appropriate donor (pDONR™201; Figure
5.2.2B) and expression (pXTNsect-DEST38; Figure 5.2.2C) vectors. The expression of
both wild type and mutated recombinant clusterin was achieved using Sf9 insect cells.

5.2.4.1 Generation of attB-Flanked PCR Products - As mentioned above, the first step
in the Gateway™ cloning of the gene for wild type and mutant clusterin is the
generation of PCR products that are flanked by the attB sites. The PCR products for
developing wild type and proline-substitution mutants were created via two-stage PCR

amplification using two sets of overlapping clusterin wild-type primers. The first set
primers contained: (forward primer) - (i) a 12 bp segment of the attBl sequence
(AAAAAGCAGGCT), (ii) a Kozac sequence (GCCACC), (iv) a start codon (ATG),
and (v) a 15 bp template specific sequence; (reverse primer, complementary to the
coding sequence) - (i) a 12 bp segment of the attBl sequence (AGAAAGCTGGGT),
(ii) a stop codon (TCA), and (iii) a template-specific sequence. The second set of
primers (adapter-primers attBl and attBl) were used to install the complete attBl

(GGGGACAAGTTTGTACAAAAAAGCAGGCT) and attBl (GGGGACCACTTTG
TACAAGAAAGCTGGGT) sequences (Figure 5.2.5).
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Vector containing
gene of interest
(e.g. clusterin)

PCR
tion
Amplificati

^

clus
O K r r t

r

clus
att P2
att B1
PCR

att B2
Product

BP
Reaction

ccdB

I

Donor Vector
(pDONR-201)

ccdB

attU^^'attll
attm

clus

att ^2

By-product

Entry Clone

V

•

/

O"
LR
_
Reaction

clus
Entry Clone

O"

I

att Br^i_gJf
att B2
clus
Expression Clone

attmXs^. y?'attR2
ccdB

I

Destination Vector
(pXINsect-Dest38)

affPITv

^7attP2

ccdB
By-product

Transformation into target cells
(e.g. Sf-9 Insect Cells)

Figure 5.2.3: General overview of the G a t e w a y ™ cloning system. This system which was used to
clone and subclone wild-type and mutated clusterin genes, involves three main steps. In the first,
recombination (attB) sites are introduced to the flanks of the genes of interest via P C R amplification. In
the second step, these genes are transferred by recombination into a donor plasmid ( p D O N R ™ 2 0 1 ) to
create the entry clones. During the last step, the genes are transferred via recombination into a
destination vector (e.g. pXINsect-Dest38) to produce the expression clones. The resulting expression
clones are subsequently transformed into target cells (e.g. Sf9) which then express the proteins of
interest.
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The PCR products for developing wild type and proline-substitution mutants

were amplified from pTZ-HT7 and Quickchange™-mutated plasmids, respect
The primers used during the first round of PCR were clusWT12bForward
(AAAAAGCAGGCTCGGCCACCATGATGAAGACTCTGCTG) and clusWT12b
Reverse (AGAAAGCTGGGTCTCACTCCTCCCGGTGCTT). PCR products for the
truncation mutants were created using truncation-specific primers via

amplification similar to that used to amplify the full-length clusteri

HT7. The truncation-specific primers used in the first stage of PCR we
clusT1712bForward (AAAAAGCAGGCTCGGCCACCATGAGTAAGTACG TCA
AT), clusT7812bForward (AAAAAGCAGGCTCGGCCACCATGGGAGTGTGCA
TTGAG), clus294T12bReverse (AGAAAGCTGGGTCTCAGTTGGTGGAACAG
TCCAC), clus356T12bReverse (AGAAAGCTGGGTCTCAGCCTTGCGTGAGGTT
TGC), and clus403T12bReverse (AGAAAGCTGGGTCTCACCTGGAGACTTCTA

CAGG). In cases where a forward truncation-specific primer was used, th

clusWT12bReverse primer was also used. The clusWT12bForward primer was

when the reverse truncation-specific primers were used. All PCR amplif

performed in an MJ Research Model PTC-200 DNA Engine thermocycler usin

conditions indicated in Table 5.2.3. All PCR products were verified by

electrophoresis (section 2.3) prior to their transfer into the donor v
to create the Entry clones.
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Stages

Cycles

Temperature

1

95 °C

30 seconds

Denaturation
95 °C

30 seconds

Annealing
45 °C

30 seconds

Elongation
68 °C

2 minutes/kb of plasmid length

Denaturation
95 °C

30 seconds

Annealing
55 °C

30 seconds

Elongation
68 °C

2 minutes/kb of plasmid length

1
10

2

20

Time

Table 5.2.3: Cycling parameters for P C R amplification of the clusterin gene flanked by attB sites.

5.2.4.2 Creating Entry Clones Via the BP Reaction - The transfer of the PCR pro

into pDONR-201 was conducted via the BP reaction; so-called due to the conversio

the attB sequence to attL, producing a by-product with an attP sequence (see Fig

5.2.3). The reaction mixtures consisted of the components listed in Table 5.2.4.
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Negative
Control

Positive
Control

Tubel

Tube 2

P C R Product (100 fmol)

—

—

pEXP7-tet Positive Control (50 ng/|il)

—

2ul

Sample
TubeX
1-10 |il

p D O N R 2 0 1 Vector, 150 ng/|il

2 |il

2 |il

2 |il

B P Reaction Buffer (5X)

4ul

4 |il

4ol

T E Buffer

10 uT

8ul

To 16 |il

Table 5.2.4: Amounts of various components used to create entry clones via the B P recombination
reaction. pExp7-tet is a 1.4 kb linear D N A which encodes the tetracycline resistance gene (Tcr) and its
promoter for expression. W h e n reacted with the donor vector, it can be used to estimate kanamycin
resistant (Km') transformants that contain the transferred Tc r gene.

To each of the sample reactions, 4 JLXI of BP CLONASE Enzyme mix (Invitrogen)

was added, vortexed briefly (2 s) twice, and incubated at 25 °C for 60 min. The

2 \i\ of Proteinase K solution (2 mg/ml) was added and further incubation condu
37 °C for 10 min. 1 u\l of each sample reaction was transformed into 50 JLLI

EFFICIENCY DH5a competent cells prior to incubation on ice for 30 min. All samp

were heat-shocked at 42 °C for 30 s, placed on ice for a further 1-2 min, and d

by the addition of 450 |il S.O.C. medium (2% (w/v) tryptone, 0.5% (w/v) yeast e
0.05% (w/v) NaCl, 20 mM glucose; dissolved in de-ionised water, pH 7.0). 100 ul

transformed cells were subsequently plated onto Luria-Bertani (LB) agar (1% (w/

tryptone, 0.5% (w/v) yeast extract, 2% agar, 1% NaCl; dissolved in de-ionised wa
pH 7.0) plates containing 50 ug/ml kanamycin and incubated overnight at 37 °C.

construct plasmids were isolated and purified using the Wizard® Plus Miniprep D
Purification kit (section 5.2.6).
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5.2.4.3 Creating Expression Clones Via the LR Reaction - The creation of the

expression clones was achieved via the LR reaction; so-called due to the proc

involving the reaction of an Entry clone (attL) with a Destination clone (attR
a new Expression clone (attB) (see Figure 5.1.4). The destination vector used
pXINsect-Dest38. The required reaction mixtures consisted of the following:

Negative
Control

Positive
Control

Sample

Tubel

Tube 2

TubeX

Entry clone (require 300 ng)

—

—

pENTR-gus Positive control (50 ng/|Ltl)

—

2 (xl

1-11 pi

1-11 jil

1-11 |il

L R Reaction Buffer (5X)

4 |il

4 |il

4 |il

T E Buffer

lOul

8 |il

To 16 |il

Destination vector (require 300 ng)

1-11 Ml
—

Table 5.2.5: Components and their amounts used to create expression clones for wild type and mutant
clusterin. p E N T R - g u s is a 1.8 kb plasmid encoding the gus gene. W h e n reacted with a destination
vector, the resulting expression clone contains both E. coli and eukaryotic translational signals upstream
of the gus gene, allowing for native expression in E. coli, yeast, insect, and mammalian cells depending
on the destination vector used.

To each of the sample reactions (shown above), 4 |itl of LR CLONASE Enzyme mix
(Invitrogen) was added, vortexed briefly (2 s) twice, and incubated at 25 °C for 60 min.
Thereafter, 2 |xl of Proteinase K solution (2 mg/ml) was added and further incubation
conducted at 37 °C for 10 min. 1 \il of each sample reaction was transformed into 50
|il of LIBRARY EFFICIENCY DH5a competent cells as above. 100 ul of transformed
cells were plated onto LB plates containing 100 Ug/ml ampicillin and allowed to
propagate overnight at 37 °C. All constructed plasmids were isolated using the
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Wizard" Plus Miniprep D N A Purification kit (section 5.2.5) and verified by automated,
bi-directional DNA sequencing for their correct sequence prior to transfection into
insect (Sf9) cells. DNA sequencing was performed by Tim Gleeson (Canadian
Molecular Research Services, ON, Canada).

5.2.5 Transfection of Sf9 Insect Cells - Into separate wells of a 24-well plate, each
containing 1.5 ml Sf-900 II serum-free medium (SFM), 9 x 105 Sf9 cells were added
and allowed to attach by incubating overnight at 27 °C. 1 ug of sterile, purified
expression plasmid DNA was diluted to a final volume of 200 |il in Sf-900 II SFM
before being added to 200 ul SF-900 E SFM containing 12 ul

CELLFECTIN®

reagent

and 0.1 ug pBmAmeo, a pUC-based plasmid which confers neomycin resistance to

transfected cells. The resulting mixture was then incubated at room temperature for 4
min. During this incubation, the Sf9 cells were washed once with 2 ml Sf-900 II SFM
after which, 800 ul of SFM was added to the wells. To these, 200 ul of the DNA/
CELLFECTIN complexes was added after the 45 minutes incubation. Thereafter, the
plates were incubated for a further 5 h at 27 °C, washed once with 2 ml of Sf-900 II

SFM, replaced with 1 ml of SFM, and then returned to the 27 °C incubator. After 48 h,
the transfected Sf9 cells were resuspended in SFM supplemented with 5% (v/v) foetal
calf serum (FCS) and selected with 500 ug/ml GENETICIN®. Transfected insect cells
were maintained in the presence of GENETICIN® for 2 weeks before tissue-culture
supernatants of these cells were screened for the presence of clusterin.

5.2.6 Wizard® Plus Miniprep DNA Purification System - The small-scale isolation and
(R)

purification of plasmid D N A from bacterial cultures was achieved using the Wizard
Plus miniprep DNA purification kit (Promega, WI, USA). Following the specified
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protocol, 10 ml of bacterial culture was centrifuged at 1,400 g for 10 min, resuspended
in 400 |ll of cell resuspension solution, and transferred to a 1.5 ml microcentrifuge

tube. To this, 400 ul of cell lysis solution was added and the tube inverted four times

to ensure adequate lysis of the cells. 400 ul of neutralisation solution was immediate
added and mixing was achieved by inverting the tube several times. The lysate was

then cleared by centrifugation at 10,000 x g for 5 min. The supernatant, containing th
DNA, was subsequently passed through a minicolumn, which was connected to a 3 ml
disposable syringe containing 1 ml of Wizard® Minipreps DNA Purification resin. To
each syringe, 2 ml of column wash buffer was added and gently pushed through with a
syringe plunger. The minicolumn was then detached from the syringe, transferred to a
1.5 ml microcentrifuge tube and centrifuged at 10,000 x g for 2 min. Finally, the
minicolumn, to which 50 ul of nuclease-free water was added, was transferred to a new
microcentrifuge tube and centrifuged at 10,000 x g for 20 s to elute the plasmid DNA.
Purified DNA was stored at -20 °C.
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5.3

RESULTS

5.3.1 Chosen Sites for Proline-Substitution and Truncation in Human Clusterin
The sites for proline-substitution in the helical regions of clusterin were
determined using the GOR IV secondary structure prediction program as described in
section 2.2.1. The results are summarised as follow:

Amphipathic helix 1 (19-39) - Six single proline substitution mutants were tested,
including E23P, I24P, A27P, V28P, V31P, and K32P (data not shown). Of these,
A27P was predicted to be the most disruptive to helical structure, causing a contiguous
run of thirteen non-helix-forming residues at 19-31 (i.e., 65% disruption). The native
sequence is predicted to have only one non-helix-forming residue at 30.

Coiled-coil 1 (40-77) - This predicted coiled-coil region has a high propensity to form
a helix. Even with three proline substitutions clustered close together (at residue

positions 49, 53, and 58), only partial disruption of the long helical region is predic

(a stretch of thirteen non-helical residues predicted; i.e., 35% disruption). Therefore,

was decided that site-directed mutation is not the way to study this particular structu
feature.

Amphipathic helix 2 (149-168) - Six single proline substitutions were tested within this
region, including V153P, M154P, Q155P, D156P, H157P, and F158P (data not
shown). M154P, Q155P and H157P were found to be equally the most disruptive, each
causing a run of eight contiguous non-helix-forming residues at 154-161 (i.e., 42%
disruption). Within 149-168, the native sequence has only 1/20 residues that are
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predicted to be non-helix forming. Q 1 5 5 P was chosen (above M 1 7 4 P ) because the
former is likely to also reduce the amphipathicity of the predicted helix [138].

Amphipathic helix 3 (217-234) - Of the eleven single proline substitutions tested,
including H219P, A220P, M221P, F222P, Q223P, F225P, L226P, E227P, M228P,
I229P, and H230P (data not shown), M228P was predicted to be the most disruptive to

helical structure, causing a contiguous run of eleven non-helix-forming residues from
217-227 (i.e., 50% disruption).

Amphipathic helix 4 (309-327) - Of the eleven single proline substitution mutations
analysed, which include V311P, E313P, L315P, T316P, R317P, K318P, Y319P,
E321P, L322P, L323P, and K324P (data not shown), L322P and K324P were

maximally disruptive, each associated with a prediction of a contiguous run of six no

helix-forming residues at 319-324 and 320-325, respectively (i.e., 33% disruption); the
native sequence has no non-helix-forming residues within 309-327). L322P was

chosen as the site for proline substitution simply because it is slightly closer to t
centre of the predicted helix.

Coiled-coil 2 (296-308) - Of six single-site proline substitution mutants analysed,
including K300P, L301P, R302P, E304P, L305P, and D306P (data not shown), the
most disruptive to coil structure were L301P and R302P, both of which were predicted
to produce a run of six contiguous non-helix-forming residues (in both cases at 296301). However, even the native sequence was predicted to have a run of three
contiguous non-helix-forming residues at 296-299. So, these mutants were not
predicted to be very "good" helix-breakers.
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Amphipathic helix 5 (407-423) - O f the ten single proline substitution mutants
analysed, which include E410P, T411P, V412P, A413P, E414P, K415P, A416P,
L417P, E419P, and Y420P (data not shown), A413P was predicted to be the most
disruptive to helix. A contiguous stretch of six non-helix-forming residues was
predicted at 407-412 (i.e., 37.5% disruption).

In summary, the optimal sites for proline substitution as determined from GOR IV

analysis of the helical regions of human clusterin are positions 27 (A27P), 155 (Q155P),
228 (M228P), 322 (L322P), and 413 (A413P).

Five truncation sites within clusterin were designed to selectively delete portions
of the a-chain N-terminus and (3-chain C-terminus - the region of clusterin proposed to

contain the functional motifs of the protein (section 5.1). These sites included residue

positions T17, T78, 295T, 356T, and 403T. In the case of T17, the truncation site (which

occur in the a-chain) was placed close to the start of the first predicted a-helix to ca
the deletion of the first 16 (non-helix-forming) amino acid residues of the mature

clusterin molecule. The truncation site for T78, also located in the a-chain, was chosen

to cause the deletion of the first 77 amino acids of the clusterin molecule, including t
first predicted amphipathic (residue 19-39) and coiled-coil (residue 40-77) a-helices.
The truncation site at residue 295 was selected to delete 132 amino acid residues from
the (3-chain C-terminus, a region of the protein which contains the fourth and fifth
predicted amphipathic a-helices (residues 309-327 and 407-423) as well as the second
coiled-coil a-helix (residue 296-308). Truncation sites at residues 356 and 403 were
designed to cause the deletion of 71 and 24 residues from the (3-chain C-terminus,
respectively. In both cases, the resulting truncated clusterin molecules should contain
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all amphipathic and coiled-coil a-helices, with the exception of the fifth amphipathic <xhelix, which is deleted.

5.3.2 Site-Directed Mutagenesis
The substitution of various amino acid residues for the helix-disrupting proline
in clusterin was achieved using the commercially available Quickchange™ sitedirected mutagenesis kit as outlined in section 5.2.2. A total of five mutant plasmid
constructs were developed using this kit (Table 5.1.1), all of which were subsequently
transformed into XLl-Blue E. coli cells. Successfully transformed cells containing the
mutated plasmids were selected by blue-white colour screening with X-gal and IPTG.
Visual scoring of these cells indicated very high (>95%) mutagenesis efficiencies.
Agarose gel electrophoresis confirmed the sizes of mutant recombinant clusterin
amplicons (data not shown).

5.3.3 PCR Amplification of Wild Type and Mutant Clusterin Genes and Creation of Entry
Clones.
cDNA encoding wild type and proline mutants were cloned using Gatewayspecific attB-flanked primers via two-step PCR amplification (section 5.2.3.1). While
wild type clusterin cDNA was cloned from the pTZ-HT7 plasmid, cDNA encoding the
proline mutants were cloned from the various Quickchange™ - mutated plasmids. PCR

products for the truncation mutants were developed using truncation-specific primers v
a similar two-step PCR amplification process (section 5.2.3.1). The resulting attBflanked PCR products were analysed on a 1% agarose gel (Figure 5.3.1) prior to their
insertion into separate donor (pDONR™) plasmids via BP recombination reactions

(section 5.2.3.2) to create the entry clones. A total of eleven entry clones were deve
(one containing wild-type clusterin cDNA, five containing Quickchange - mutated
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c D N A , and five containing truncated c D N A ) . All entry clones, in the form of uncut
plasmids, were analysed by agarose gel electrophoresis (Figure 5.3.2) prior to
transformation into LIBRARY EFFICIENCY DH5a cells, which were selected with
kanamycin and allowed to propagate.

Lanes
12

3 4 5 6 7

8 9 10 11 12 13 14

Figure 5.3.1: Image of an ethidium bromide-stained 1 % agarose gel showing attB-PCR products; Lane
1, D N A marker (1 kb D N A Step Ladder; Promega, W I , U S A ) ; Lane 2, attB-clusWT (wild type); Lane 3,
a«B-clusT17; Lane 4, affB-clusT78; Lane 5, a«B-clus294T; Lane 6, affB-clus356T; Lane 7, attBclus403T; Lane 8, D N A marker; Lane 9, aftB-clusWT; Lane 10, a«B-clusA27P; Lane 11, attBclusQ155P; Lane 12, a«B-clusM228P; Lane 13, affB-clusL322P; Lane 14, a?fB-clusA413P.

149

A
12

Lanes
3

4 5

B
6

7

12

Lanes
3

4 5

6

7

10

.
<ta
f

5
4
3

CU
N

2

^-m-s

GA

linear
nicked

• t • m •

supercoil

Figure 5.3.2: Image of an ethidium bromide-stained 1 % agarose gel showing entry clones for; A ) wild
type and truncation mutants; Lane 1, D N A marker (1 kb D N A Step Ladder; Promega, W I , U S A ) ; Lane
2, pENTR-clusWT (wild type); Lane 3, P ENTR-clusT17; Lane 4, P ENTR-clusT78; Lane 5, p E N T R clus294T; Lane 6, pENTR-cIus356T; Lane 7, pENTR-clus403T. B ) wild type and proline-substitution
mutants; Lane 1, D N A marker; Lane 2, pENTR-clusWT; Lane 3, pENTR-clusA27P; Lane 4, pENTRclusQ155P; Lane 5, pENTR-clusM228P; Lane 6, pENTR-clusL322P; Lane 7, pENTR-clusA413P. The
major bands shown represent entry clones in the supercoiled state. Minor bands represent nicked and
linearised plasmids

5.3.4 Creation and Analysis of Expression Clones.
The expression clones were developed via LR recombination reactions between
the entry clones and the destination vector, pXINsect-Dest38 (section 5.2.3.3). All
expression clones were subsequently analysed by agarose gel electrophoresis (Figure
5.3.3) and then transformed into LIBRARY EFFICIENCY DH5a cells. Successfully
transformed cells containing the expression clones were selected with ampicillin.
Automated bi-directional DNA sequencing (section 5.2.3.3) confirmed that each of the
expression clones contained the correct gene sequence (Appendix).
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A

Lanes
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B

Lanes
1 2 3 4 5 6 7

Figure 5.3.3: Image of an ethidium bromide-stained 1 % agarose gel showing expression vectors for;
A) wild type and truncation mutants; Lane 1, D N A marker (1 kb D N A Step Ladder; Promega, W I ,
USA); Lane 2, pXINsect-Dest38-clusWT (wild type); Lane 3, pXINsect-Dest38-clusT17; Lane 4,
pXINsect-Dest38-clusT78; Lane 5, pXINsect-Dest38-clus294T; Lane 6, pXINsect-Dest38-clus356T;
Lane 7, pXINsect-Dest38-clus403T; B ) wild type and proline-substitution mutants; Lane 1, D N A
marker; Lane 2, pXTNsect-Dest38-clusWT; Lane 3, pXINsect-Dest38-clusA27P; Lane 4, pXINsectDest38-clusQ155P; Lane 5, pXINsect-Dest38-clusM228P; Lane 6, pXINsect-Dest38-clusL322P; Lane
7, pXINsect-Dest38-clusA413P.

5.3.5 Expression of Wild-type and Mutant Clusterin in Sf-9 Cells.
Expression plasmids containing cDNA for wild type or mutant clusterin
molecules were transiently co-transfected with the pBmA:neo plasmid into Sf9 cells
with CELLFECTIN®. The selective agent GENETICIN® (500 ug/ml) was added to the
growth medium (Sf-900 E SFM; supplemented with 5% (v/v) FCS) 48 hours after
transfection. Successfully transfected cells grew very slowly. Two weeks after
transfection, tissue-culture supernatants from individual wells containing transfected
cells were collected and analysed by immuno-dot blot and western transfer procedures
(sections 2.4 & 2.7). Immuno-dot blot analysis of these tissue-culture supernatant
detected the presence of an expressed protein (which was absent in non-expressing

control cells) that was reactive with G7, 4ID, and 78E anti-clusterin antibodies (Figure
5.3.4) - indicating the presence of clusterin in each of the supernatants. Further
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analysis of the tissue-culture supernatant fractions by western blotting also revealed the

presence of clusterin (Figure 5.3.5). Taken together, these results indicated that (i) the
Sf9 cells were successfully transfected with the expression clones containing either
wild type or mutated clusterin cDNA, and (ii) the truncations or single amino acid
substitutions tested did not cause any aberrant conformational changes to the antibody
recognition/binding sites (at least, for the antibodies tested).

serum Clusterin
(positive control)
wild-type
clusA27P
clusQ155P
clusM228P
clusL322P
clusA413P

•o
•
•

•
•

•

•

•

•

•

•

non-trans feet S/9
supernatant
clusT17
clusT78
clus294T
clus356T
clus403T

Figure 5.3.4: Immuno-dot blot analysis of tissue culture supernatants obtained from transfected Sf9
cells two weeks after transfection. The presence of clusterin was detected using a cocktail of G 7 , 41D,
and 78E anti-clusterin monoclonal antibodies (as described in section 2.7). A sample of purified h u m a n
serum clusterin was also dotted onto the membrane to serve as a positive control. Non-transfected Sf9
cells did not appear to express detectable amount of clusterin (circle).

However, it appears that the transiently transfected Sf9 insect cells were unable
to produce large amounts of recombinant clusterin. SuperSignal® WestPico western
blot substrate, which can detect 10"12 grams of HRP-labelled proteins during enhanced
chemiluminescence detection (ECL; section 2.6) failed to detect the presence of
recombinant clusterin in any of the Sf9 supernatants, even when the supernatants were
concentrated 20-fold. Instead, the detection of western blotted Sf9-derived clusterin
from most Sf9 supernatants was successful only when SuperSignal® WestFemto, an
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E C L substrate that can detect 10" grams of HRP-labelled proteins, was used (Figure
5.3.5).

Lanes

Figure 5.3.5: Western blot of a 1 0 % S D S - P A G E gel of purified human serum and Sf9-derived
recombinant clusterin. Lane 1, purified human serum clusterin; Lane 2, Sf9-derived wild type clusterin;
Lane 3, clusA27P; Lane 4, clusQ155P; Lane 5, clusM228P; Lane 6, clusL322P, Lane 7, clusA413P;
Lane 8, clusT17; Lane 9: clusT78; Lane 10, clus294T; Lane 11, clus356T; Lane 12, clus403T.

Furthermore, examination of the immunoblot reveals that the Sf9-expressed
wild type and mutated clusterin had molecular masses that were approximately 15 kDa
smaller than expected (Figure 5.3.5). For instance, wild type serum clusterin has a
molecular mass of approximately 78-80 kDa (Figure 5.3.5, lane 1). However,
recombinant wild type Sf9 clusterin was detected as a 64 kDa protein (Figure 5.3.5,

lane 2), as was the proline- substitution mutant clusterin molecules (Figure 5.3.5; lan
3-7). The truncation of clusT78 results in the removal of 77 amino acid residues from
the N-terminus of the a-chain, which also includes the removal of a glycosylation site

(at residue N64) from the mature protein. As a result of this truncation, the estimated

size of the resulting clusterin molecule, if it was expressed in mammalian cells, is -6
kDa). Since ClusT78 was detected as a 53 kDa protein on the Western blot (Figure

153

5.3.5; lane 9), it w a s also smaller than expected. T h e smaller than expected masses of
the Sf9-expressed clusterin molecules may have resulted from one of three
possibilities; the expressed proteins were partially glycosylated, incompletely
translated or inappropriately cleaved by proteolytic enzymes. Incomplete translation
resulting in the expression or production of truncated clusterin molecules is unlikely
because DNA sequencing confirmed the correct complete sequence for the various
wild type and site-directed mutant clusterin cDNAs in the expression vectors. In
addition, since multiple bands (corresponding to truncated portions of clusterin) were
not detected in any of the supernatant fractions, it would be unlikely that inappropriate
proteolysis was responsible for producing the undersized clusterin molecules.
Therefore, accepting this reasoning, the most likely cause for the size discrepancy may
be incomplete glycosylation of the mature Sf9-derived clusterin molecules. However,
further experiments would be required to confirm this.
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5.4 DISCUSSION
To understand the fundamental relationship of a protein's structure to its
function, it is necessary to identify the amino acids and/or structural motifs that are
involved in the activity of the protein. A common approach towards such an
understanding involves comparing the amino acid sequences of proteins (isolated from
different species) that have the same biological function. By comparing the amino acid
sequences of such proteins, it may be possible to identify conserved regions of amino
acids that are essential for the protein's function. Indeed, many sHsps have been
studied in this way. Sequence analysis of sHsps have revealed that, despite being
structurally divergent, they share a common sequence of amino acids (the "a-crystallin
domain") which is essential for the chaperone action of these proteins (section 3.7).
Another approach in the study of a protein's structure-function relationship involves
the determination of the three-dimensional structure of the protein. The interactions
between many enzymes (such as lysozyme and DNA polymerases) and their substrates
have been studied by initially determining the three-dimensional structure of the
enzyme. Unfortunately, neither of these approaches is suitable for elucidating the
functional domains of clusterin due to (i) a lack of sequence homology with other
known proteins and (ii) the absence of a crystal structure.
The development in the last decade of genetic engineering techniques such as
site-directed mutagenesis offers an alternative to the above approaches. The basic
principle of site-directed mutagenesis involves the introduction of specific mutations
into the coding sequence of a protein such that when the gene encoding the protein is
expressed in a suitable host, specifically mutated proteins are produced. Screening of
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these mutants for function can identify the structures that are responsible for the
function(s) of the native protein.
This chapter describes the processes involved in the development of
recombinant clusterin mutants - potential tools for the identification of structural
elements involved in the chaperone action of human clusterin. Mutations in the form
of proline-substitutions or truncations were introduced into the coding sequence of
human clusterin (situated in the vector pTZ-HT7) using synthetic mutagenic
oligonucleotide primers (sections 5.2.1 & 5.2.4.1). Next, the wild type and mutant
cDNAs were incorporated into the donor vector (pDONR™201) via BP recombination
reactions to produce corresponding entry clones (section 5.2.4.2). From these vectors,
the cDNAs were subsequently transferred via LR recombination reactions into an
appropriate destination vector (pXINsect-Dest38) to produce the expression clones

(section 5.2.4.3). Finally, these expression clones were transiently transfected into Sf9
insect cells where they were incorporated into the host cell genome from which the
cDNAs were transcribed and translated to produce the various clusterin molecules
(section 5.2.5). Sf9 insect cells were chosen as the host cells for the production of
recombinant clusterin due to their reported ability to produce high levels of properly
post-translationally modified recombinant proteins.
Despite these reported abilities of Sf9 insect cells, results presented in this
chapter indicate that transiently transfected Sf9 cells were unable to produce high
levels of recombinant clusterin. Since the Sf9 transfectants were not cloned, the Sf9
cell cultures may have contained a large number of non-transformants/non-secretors
that may have outnumbered secreting transformants. Therefore, even though the Sf9
cultures appeared to be viable and highly confluent, the population of secreting
transformants may have been small; hence the low level of expressed recombinant.
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Analysis of the expressed proteins by immunoblotting also revealed that Sf9-expressed
wild type and proline-substituted mutant clusterin molecules were approximately 15
kDa smaller than purified serum clusterin (section 5.3.5; Figure 5.3.6). Since DNA
sequencing had verified the correct full-length sequence for genes encoding wild type
and mutant clusterin, it was highly unlikely that this size discrepancy resulted from
truncations of the coding sequence. In addition, it was unlikely that inappropriate
proteolysis was responsible for the size discrepancy since if it was the case, there
should have been other bands (corresponding to proteolytic fragments of clusterin)
detected. Therefore, the size discrepancy most likely resulted from reduced
glycosylation of the expressed proteins. Little is known about the glycosylation
mechanisms of Sf9 cells, although it is generally believed that Sf9 is capable of
carrying out post-translational modifications (such as glycosylation) in much the same
way as vertebrate cells (Vialard et al, 1995). Interestingly, a recent report has
indicated that Sf9 insect cells have difficulties in adding the more complex sugars, such
as galactose and sialic acid (Pfeifer, 1998). Since clusterin is known to contain sialyl
Lewis type oligosaccharides (Kapron et al, 1997), it is likely that Sf9 insect cells are
incapable of expressing fully glycosylated clusterin.
The inability of Sf9 insect cells to express large amounts of correctly processed
recombinant clusterin has prompted a reinvestigation into the possible use of other host
systems for the expression of high levels of recombinant wild-type and mutant
clusterin. At present, a number of other host systems are available for gene expression
and recombinant protein production, including bacteria, filamentous fungi, plants, yeast
and mammalian cells (reviewed in "The recombinant protein handbook: Protein
purification and simple purification", Amersham pharmacia biotech, 2000).
Traditionally, bacterial expression systems have been the preferred choice due to (i) the
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availability of a wide range of cloning vectors, (ii) an extensive literature, (iii) high
protein yield obtained from moderate scale cultures, and (iv) economy. However, the
key disadvantage of bacterial cells, which prevented their use in this study, is their

inability to perform any post-translational modifications that may be necessary for the
expression of properly structured and fully functional clusterin.
Expression of recombinant wild type clusterin has previously been attempted
using the Pichia pastoris yeast expression system. Like mammalian cells, yeast cells
are known to perform glycosylation and disulfide bond formation. In addition, the
advantage of using yeast expression systems is that yeast can be used to express large
amount of protein at low cost. However, the P. pastoris expression system is not
suitable for the expression of recombinant wild-type or mutant clusterin due to

inappropriate proteolysis of the C-terminus of the a-chain and the N-terminus of the (3
chain (Lakins et al, 2002).
Mammalian expression systems could be most appropriate for the expression
of recombinant clusterin. One limitation to many mammalian systems (which

prompted the use of Sf9 cells in this study) is the relatively low expression levels tha
can normally be achieved using these systems. However, the use of mammalian

expression system will ensure that correct post-translational modifications to wild-typ
clusterin and its mutants will be obtained. Successful clusterin expression has been
achieved in cultured porcine smooth muscle (Moulson and Millis, 1999; Millis et al,
2001), baby hamster kidney (BHK-21) fibroblast (Pilarsky et al, 1993), mink lung
epithelial (Reddy et al, 1996), Shionogi mammalian carcinoma (Renny et al, 1994),
and Madin-Darby canine kidney (MDCK) (Hartmann et al, 1991; Urban et al, 1987)
cell lines. Preliminary results have shown that cultured Chinese Hamster Ovary
(CHO)-expressed wild type clusterin co-migrates with human serum clusterin,
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indicating that, unlike Sf9-expressed clusterin, it w a s properly post-translationally
modified (Fay Dawes; unpublished results). In addition, the concentration of expressed
wild type clusterin in transfected CHO tissue culture supernatant was estimated to be
around 10 ug/ml, significantly greater than that obtained with transfected Sf9 cells. In
light of these results, future efforts will be directed towards the use of the CHOexpression system for the production of recombinant clusterin molecules. By utilising
the versatility of the Gateway™ cloning system (see Figure 5.2.4), transfer of the
mutated clusterin cDNAs will simply require a one step recombination reaction
between the entry clones developed in this study and an appropriate Gateway™specific mammalian expression vector.

In conclusion, clusterin cDNA was mutated by site-directed proline
substitutions and selected truncations. Using the Gateway™ cloning technology
developed by Invitrogen/Life Technologies, a series of expression clones containing
wild-type or mutated clusterin cDNA were successfully constructed and transfected
into Sf9 cells. However, the results obtained strongly suggest that Sf9 cells are
incapable of producing fully glycosylated clusterin. To produce properly processed
wild-type and mutated clusterin for future studies, a different expression system (e.g.
CHO) will certainly be required.
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Chapter 6

Conclusions
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A number of environmental conditions, collectively referred to as stress, can
lead to protein deposition, unfolding and aggregation. Some of these adverse
conditions include extremes of temperature or pH, oxidants, charged metal ions, and
molecular crowding. All living organisms respond to these stress conditions by
rapidly increasing the synthesis of a diverse group of proteins called molecular
chaperones. The primary function of molecular chaperones is to recognise and bind
unfolded or partially folded proteins. By doing so, they prevent illicit intermolecular
interactions and hence protein aggregation and precipitation. Of the molecular
chaperone superfamily, the best characterised chaperones belong to the stress-induced
proteins that are collectively known as the heat shock proteins (Hsps). All heat shock
proteins belong to one of five families: HsplOO, Hsp90, Hsp70, Hsp60 and the small
heat shock protein (sHsp) family. Some Hsps (e.g. Hsp60) have ATPase activity and
are involved in protein folding in vivo. Many others (e.g. sHsps) lack ATPase activity
and function by preventing the aggregation of cellular proteins accumulating as a result
of stress. In a recent study, clusterin was shown to specifically inhibit the stressinduced precipitation of a broad range of structurally divergent substrate proteins in
vitro, thus acting like a molecular chaperone. The chaperone action of clusterin has
been compared to that of the sHsp family (Humphreys et al, 1999).

Results presented throughout this thesis confirm the in vitro sHsp-like
chaperone action of clusterin. Like sHsps, clusterin is capable of binding a wide range
of structurally divergent substrate proteins. In addition to those investigated in
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(Humphreys et al, 1999), clusterin w a s shown to inhibit (i) the heat- or reductioninduced precipitation of ovotransferrin, (ii) the precipitation of lysozyme induced by
reduction, (iii) heat-induced precipitation of y-crystallin, and (iv) heat- and reductioninduced precipitation of proteins in diluted and undiluted human serum, respectively
(Figures 3.3.1 & 3.3.2). Using an approach similar to that described in (Humphreys et
al, 1999), clusterin was shown to bind preferentially to stressed forms of
ovotransferrin, lysozyme and a-lactalbumin to form solubilised high molecular weight
complexes (Figures 3.3.3-3.3.5). Complex formation between the various stressdenatured proteins and clusterin suggests that stable binding of substrates is
fundamental to clusterin's ability to inhibit stress-induced protein precipitation.
It is generally accepted that all chaperones (including sHsps) share the property
of binding to exposed regions of hydrophobicity on partially unfolded, stressed
conformations of proteins to prevent their irreversible aggregation. The interaction
between clusterin and stressed proteins appears to occur in much the same way. This
is supported by an experiment which showed that cross-linking of the hydrophobic
probe, bis(l-anilinonaphthalene-8-sulfonate) (bis-ANS), to clusterin reduces the

latter's ability to inhibit the precipitation of its substrates by competing with stressed
proteins for hydrophobic regions on clusterin (Poon et al, 2001).
Small heat shock proteins differ from many other chaperones because (i) they
carry out their chaperone action independently of ATP, and (ii) they have little or no

inherent ability to refold stressed proteins. Here, results show that inhibition of protein
precipitation by clusterin also occurs in an ATP-independent manner (Figure 3.3.1)
and that ATP has no effect on the in vitro chaperone action of clusterin (Figure 3.3.6).
In addition, regardless of the presence of ATP, clusterin is unable to protect ADH or
catalase from heat-induced loss of activity (Figure 3.3.7). Furthermore, clusterin,
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alone or w h e n complexed with a substrate protein, does not appear to have the ability
to hydrolyse ATP (Figure 3.3.8). Taken together, these results strongly suggest that
ATP is not directly involved in the chaperone action of clusterin. These in vitro
studies also suggests that clusterin is unlikely to possess the ability to refold partly
unfolded proteins since most chaperones that are able to refold stabilised substrates
require ATP to do so (lakob et al, 1993). This suggestion was supported by results
showing that clusterin was unable to independently facilitate the reactivation of heatinactivated ADH and catalase after the removal of stress (Figure 3.3.9). However, in
the presence of a chaperone with refolding capability, Hsc70, and ATP, clusterinstabilised ADH and catalase were partially refolded (Figure 3.3.9).
Results presented in 4.3.6 demonstrate that clusterin was effective in
suppressing the slow precipitation of y-crystallin and lysozyme, but was unable to
prevent these same target proteins from rapid precipitation (Figure 4.3.8). Real-time
H NMR spectroscopic analysis of the interaction between clusterin and a-lactalbumin
revealed that clusterin specifically interacts with the disordered molten globule (I2)
state of this protein on its off-folding pathway (Figure 4.3.9). In addition, results
presented in Poon et al, 2001, show that clusterin does not bind to (i) native a-

lactalbumin, (ii) its stable, monomeric, partly structured intermediates, or (iii) the full
unfolded form of a-lactalbumin but instead, binds only to the reduced form of alactalbumin which is 12-like. Taken together, these results indicate that the proteins
most likely to interact with clusterin are those in a disordered molten globule state and
slowly aggregating on the off-folding pathway.
A model for the involvement of clusterin during protein unfolding is shown in
Figure 6.1.1. Looking at this figure, it can be seen that this scheme is analogous to that
proposed for the sHsps. According to this model, stressed proteins undergo unfolding
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from the native conformation to the fully unfolded state via a series of intermediate
"molten globule" states which, depending on the degree of structure, can be classified
as being "ordered" (Ii) or "disordered" (I2). In the molten globule state, partially
unfolded proteins expose significant hydrophobicity which causes them to become
highly unstable and prone to aggregation and precipitation via the irreversible offfolding pathway. Like sHsps, clusterin prevents precipitation of these forms of
proteins by binding them to form stable high molecular weight complexes. The nonnative proteins are stabilised in a manner which allows for their subsequent refolding
and reactivation by other classes of chaperones with refolding capabilities.

Protein-Unfolding
±

I.

±

I2

<—

•

U

•
ADP + Pi - * — ^

Protein
Aggregation

Off-foldim
Pathway

ATP
Hsc70
Precipitation

Stable protein
complex
Clusterin / sHsps

F I G U R E 6.1.1: A schematic representation showing the proposed mechanism of chaperone
action of clusterin during protein unfolding. Stressed proteins initially undergo protein unfolding via the
classical protein-unfolding pathway (blue). Native (N) proteins begin by losing their structural
conformation and adopting intermediary (molten-globule; M G ) conformations. These unstable
intermediary states can be classified as being ordered (I,) or disordered (I2) depending on how much of
the overall structure has been disrupted or unfolded. Sometimes the stressed proteins may become
completely unfolded (U). Often however, before a protein has the chance to fully unfold, protein
aggregation with adjacent polypeptides occurs which usually leads to the eventual irreversible
precipitation of the proteins involved. T o prevent this, chaperones such as clusterin (and sHsps)
recognise and bind partly unfolded 'substrate' proteins to form stable protein complexes. Once bound,
these substrate proteins are held in a state competent for subsequent refolding by another chaperone
protein (e.g. Hsc70).

A number of reports characterising the interaction of sHsps with non-native
proteins have noted that exposure of sHsps to elevated temperature induces significant
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structural changes, resulting in (i) dissociation of sHsp oligomers, (ii) increased
surface hydrophobicity, and (iii) enhanced binding to substrate proteins (Shearstone
and Baneyx, 1999; Haslbeck et al, 1999). In contrast, elevated temperature does not
result in significant changes to either the oligomeric state or chaperone activity of
clusterin (Figures 4.3.2 & 4.3.3). However, mildly acidic conditions induce in
clusterin a structural transformation and enhanced chaperone action; these changes are
strikingly similar to those induced in sHsps by elevated temperature. At low pH,
dissociation of clusterin oligomers was accompanied by increased exposure of
hydrophobic regions (Poon et al, 2001), resulting in an enhanced ability of clusterin to

inhibit the stress-induced precipitation of the substrate proteins tested (Figures 4.3.4 4.3.6). In a physiological context, this effect may be of significant importance. At
sites of inflammation, cardiac ischaemia, infarcted brain, and in the brains of
Alzheimer's sufferers (McGeer and McGeer, 1997), a phenomenon known as acidosis
occurs, where the local pH can fall below 6. Under these mildly acidic conditions, the
enhancement of clusterin's chaperone action could help reduce the rate of progression
or severity of pathology by inhibiting the aggregation and deposition of inflammatory
and/or toxic insoluble protein deposits. If so, clusterin may have applications in
medicine and disease therapy.

There is extensive evidence of a correlation between clusterin expression and
different types of diseases (e.g. Alzheimer's disease), many of which arise as a result
of protein misfolding and/or aggregation (see section 1.2.3). Although it is not clear
what the exact function of clusterin or sHsps is in these pathological conditions, the
many physiologically relevant similarities between clusterin and the sHsps (e.g.

structural features, distribution, and relative abundance; refer to chapter 2) suggest tha
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its function in these diseases m a y be very similar to that of the sHsps.

The

demonstrated sHsp-like chaperone action of clusterin raises the possibility that
clusterin may function in vivo as a molecular chaperone. This suggestion is supported
by the ability of clusterin to inhibit the stress-induced precipitation of proteins in
serum (Figure 3.3.2).
Clusterin expression has been correlated with cell survival as exemplified by
the cyto-protective effects of the overexpression of clusterin by TNFa-treated cells
(Humphreys et al, 1997). In addition, it has been reported that purified clusterin
added to medium containing cultured cells protects the cells from TNFa (Sintich et al,
1999) and from oxidative stress (Schwochau et al, 1998). Furthermore, when
exogenous clusterin was added at 100 ug/ml (a physiologically relevant concentration)
to the medium of human cell lines undergoing heat-stress (42°C for 44 h), it
specifically increased cell survival by approximately 10% (S. Poon; unpublished
results). Together, these results provide evidence that clusterin is capable of exerting
cytoprotection by conferring thermotolerance to cells. In addition, these results
suggest that clusterin may be able to confer protection when acting either intra- or
extracellularly. However, as yet, the biological site(s) at which clusterin exerts its
chaperone action have not been identified. Nevertheless, if clusterin exerts an
intracellular chaperone action under stress conditions, it would most certainly be able
to act in concert with ATP-dependent chaperones such as Hsc70 to stabilise and
facilitate correct refolding of stressed proteins. This would provide a mechanism of
cytoprotection similar to that proposed for the sHsps (Lee et al, 1997). If clusterin
operates as an extracellular chaperone, a potential mechanism of action could involve
the stabilisation and prevention of aggregation of stressed proteins (such as receptors)
on the cell surface. This action could promote cell survival by minimising stress-
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induced aberrant signalling. T h e ability of clusterin to cooperate in vitro with Hsc70
to facilitate refolding of stressed proteins suggests that in vivo, clusterin-stabilised
stressed surface proteins might be refolded to regain normal function by the action of
as yet unidentified ATP-dependent chaperones. In this context, it is noteworthy that
oxidative and osmotic stresses are known to induce the release of ATP from cells to
the extracellular space. It is therefore possible that stresses might induce sufficient
release and accumulation of ATP in the extracellular space close to the stressed cell
membranes to facilitate ATP-dependent refolding of stressed proteins.

At present, the regions of clusterin responsible for its chaperone action have
not been identified. In addition, no X-ray crystallography data are available to provide
clues about the three-dimensional structure of the protein. However, sequence analysis
of clusterin has revealed several regions of structure that might be important in its
function (de Silva et al, 1990b). Of particular interest to the study of the structurefunction relationship of clusterin are five predicted regions of amphipathic a-helices
and two predicted regions of coiled-coil structures (Figure 5.1.1). Amphipathic ahelices are thought to be important in mediating interactions with hydrophobic
molecules. As clusterin has been shown to bind exposed regions of hydrophobicity on
partially unfolded proteins (Hochgrebe et al, 2000; Poon et al, 2002), it is likely that
the amphipathic a-helices are involved in the chaperone action of clusterin.
A recent study has presented results to suggest that regions important for the
chaperone action of clusterin may be located towards the N- and C-terminus of the aand p-chain of the protein, respectively (Lakins et al, 2002). Interestingly, these
regions were predicted to contain three of the five amphipathic a-helices found in
clusterin, as well as the two coiled-coil a-helices (Figure 5.1.1). Sequence studies
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have revealed that parts of these regions, involving the predicted a-helices, are
probably natively disordered and molten globule-like (Bailey et al, 2001). In addition,
the binding of the hydrophobic probe l-anilino-8-naphthalenesulfonate (ANS) to these
regions indicates their hydrophobic nature. Hydrophobic interactions are known to be
important in the binding of chaperones to partially unfolded, disordered molten globule
substrates. Therefore, based on the evidence provided above, it is reasonable to
suggest that the regions of clusterin responsible for its chaperone function lie towards
the N- and C-termini of the a and p chains (i.e. the predicted regions of disorder and
hydrophobicity), probably within the predicted a-helical regions.
To test the validity of this statement, a series of recombinant human clusterin
mutants were produced using site-directed mutagenesis and Gateway™ cloning
technology, and expressed in Spodoptera frugiperda 1PLB-Sf9 (Sf9) insect cells (refer
to Chapter 5). Specific mutations were introduced into the cDNA of clusterin to
encode mutants in which (i) an amino acid within each of the amphipathic a-helices is
changed to a proline, a procedure which should disrupt the secondary structure of the
a-helices, and (ii) parts of the N- and C-termini of the a and P chains are truncated.
As results in Figure 5.3.6 show, the expressed products, including wild type
recombinant clusterin, were approximately 15 kDa smaller than their expected sizes,
indicating that they were probably incompletely glycosylated (section 5.3.5). In

addition, contrary to numerous reports, results also indicate that transiently transfect
Sf9 insect cells were unable to produce high levels of recombinant clusterin.
However, in this laboratory, transfected CHO cells have recently been shown to
express properly processed clusterin at levels much higher than that obtained with
transiently transfected Sf9 cells. Thus, expression of wild-type and mutant clusterin

168

for use in future studies of clusterin's structure-function relationship will be conducted
using an appropriate mammalian expression system.

Clearly, much remains to be done to clarify the cellular site(s) at which the
chaperone action of clusterin is physiologically active and to better define the
molecular mechanism(s) by which clusterin protects proteins and cells from stress.
Future studies will also have to examine the role of clusterin in the numerous diseases
with which it is associated and from this, determine whether clusterin may have
therapeutic applications. Furthermore, it will be necessary to determine the 3dimensional structure (either by X-ray crystallography or NMR spectroscopy) of

clusterin to better understand what structural features of the protein allow it to functio
as a molecular chaperone. Hopefully, expression and further studies of the various
clusterin mutants will also provide valuable information to facilitate identification of
the region(s) of the protein responsible for the chaperone action.
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The following is a collection of D N A sequences that were obtained by bidirectional sequencing of wild type and mutated clusterin cDNA in the expression

vector, pXTNsect-Dest38. Start codon is highlighted in green; stop codon is highligh

in red; the signal peptide is shown as green text; cDNAs corresponding to the a- and

chains are shown as blue and red text, respectively; and (where appropriate) sites w
proline substitution has occurred is shown as underlined purple text. Letters other
A,C,G, or T, represent bases that could not be definitively identified by DNA
sequencing.

pXINsect-Dest38clus WT
AAGTTTKTACAAAAAAGCAGGCTCGGCCACC^BATGAAGACTCTGCTGCTGTTTGTGG
GGCTGCTGCTGACCTGGGAGAGTGGGCAGGTCCTGGGGGACCAAACGGTCTCAGACAAT
GAGCTCCAGGAAATGTCCAATCAGGGAAGTAAGTACGTCAATAAGGAAATTCAAAATGC
TGTCAACGGGGTGAAACAGATAAAGACTCTCATAGAAAANACAAACGAAGAGCGCAAGA
CACTGCTCAGCAACCTAGAAGAAGCCAAGAAGAAGAAAGAGGATGCCCTAAATGAGACC
AGGGAATCAGAGACAAAGCTGAAGGAGCTCCCAGGAGTGTGCAATGAGACCATGATGGC
CCTCTGGGAAGAGTGTAAGCCCTGCCTGAAACAGACCTGCATGAAGTTCTACGCACGCG
TCTGCAGAAGTGGCTCAGGCCTGGTTGGCCGCCAGCTTGAGGAGTTCCTGAACCAGAGC
TCGCCCTTCTACTTCTGGATGARTGGTGACCGCATCGACTCCCTGCTGGAGAACGACCG
GCAGCAGACGCACATGCTGGATGTCATGCAGGACCACTTCAGCCGCGCGTCCAGCATCA
TAGACGAGCTCTTCCAGGACAGGTTCTTCACCCGGGAGCCCCAGGATACCTACCACTAC
CTGCCCTTCAGCCTGCCCCACCGGAGGCCTCACTTCTWCTTTTMCCAAGTYCCGATCGT
CCGAGCTTGATGCCTTCTCTCCGTACGAGCCCCTGAACTTCCACGCATGTTCCAGCCCT
TCCTTRAACTGATACACGAGGCTCAGCAGGCCATGGACATCCACTTCCACAGCCCGGCC
TTCCAAGCACCCGCCAACAGAATTCATACGAGAAGGCGACGATGACCGGACTGTGTGCC
GGGAGGCTCAGGCCACTCACGGCTGCTGCCTGTTCCACCAACAACCCCTRCCAGGCTAA
GCTGCGGCGGGAGCTCGACGAATCCCTCCAGGTCGCTGAGAGGTTGACCAGGAAATACA
ACGAGCTGCTAAAGTCCTACCAGTGGAAGATGCTCAACACCTCCTCCTTGCTGGAGCAG
CTGAACGAGCAGTTTAACTGGGTGTCCCGGCTGGCAAACCTCACGCAAGGCGAAGACCA
GTACTATCTGCGGGTCACCACGGTGGCTTCCCACACTTCTGACTCGGACGTTCCTTCCG
GTGTCACTGAGGTGGTCGTGAAGCTCTTTGACTCTGATCCCATCACTGTGACGGTCCCT
GTAGAAGTCTCCAGGAAGAACCCTAAATTTATGGAGACCGTGGCGGAGAAAGCGCTGCA
GGAATACCGCAAAAAGCACCGGGAGGAG| (GACCCAGCTMTCTTGTACAAAGTTGG

pXINsect-Dest38clusTl 7

AACTTTGTACAAAAAAGCAGGCTCGGCCACCATCACTCASTMCGTCAATAAGGAAATTC
AAAATGCTGTCAACGGGGTGACAACATAAAGACTCTTATAGAAAAAACAAACGAAGAGC
SCAAGAYACTGCTCAGCAACMTAGAAGAAGCTAAGAAGAAGAAAGAGGATGTTTTAAAT
GAGACCAGGGAATCAGAGACAAAGCTGAAGGAGCTCCCAGGAGTTGCAATGAGACCATG
ATGGCCCTCTGGGAAGAGTGTAAGCCCTGCCTGAAACAGACCTGCATGAAGTTCTACGC
ACGCGTCTGCAGAAGTGGCTCAGGCCTCCTTGGCCGCCAGCTTGAGGAGTTCCTGAACA
GAGCTCGCCCTTGTACTTCTGGATGAATCGTSACCGCATCGACTCCCTCCTGGASAACG
ACCGGCAGCASACGCACTATGTTSGATGTCATGCAGGAHTWCTTHAGCWGCGCGTNCAG
CAYCATMGADGAKCTCTYCCAGGACASGYTCTTCACACGGGASCCCCAGGATACCTACC
ACTACCTGCHCTTTAGCWTCCCCWATCGGAGGCCTCACTTCTTCTYTTCAAGTCCCGCA
TCGTCCGCAGCTTGATGCCCTTCTCTCCGTACGAGCCCCTGAACTTCCACACCATGTTC
CAGCCCTTCCTTGATATGATACACGCCGCCAACAGAAWTCATACGAGAAGGCGACGATG
ACCGGACTGTGTGCCGGGAGATCCGCCACAACTCCACGGGCTGCTGCGGATGAAGGACC
AGTGTGACAAGTGCCGGGAGATCTTGTCTGTGGACTGTTCCACCAACAACCCCTCCCAG
GCTAACCTGCGGCGGGAGCTCGACGAATCCCTCCAGGTCGCTGAGAGGTTGACCAGAAA
ATACAACGAGCTGCWAAAGTCCTACCAGTGGAAGATGCTCAACACCTCCTCCTTGCTGG
AGCAGCTGAACGAACAGTTTAACTGGGTGTCCCAGCTAGCAAACCTCACGCAAAGCGAA
GACCAGTACTATCTGCGGGTCACCACGGTGGCTTCCCACACTTCTGACTCGGACCTTCC
TTCCGGTGTCACTGAGGTGTCGTGAAGCTCTTTGACTCTGATCCCATCACTGTGACGGT
CCCTGTAGAAGTCTCCAGGAAGAACCCTAAATTTATGGAGACCGTGGCGGAGAAAGCCC
TACAGGAATACCGCAAAAAGCACCGGGAGGAG| |GACCCAACTGTSTTGTAGAYYGTT
GG

pXINsect-Dest38clusT78

AACTTTGTACAAAAAAGCAGGCTCGGCCACC^HGGAGTGTGCAATGAGACCAGGATGG
CCCTCTGGGAAGAVTGTAAGCCCTGCCTGAAACAGACCTGCATGAAGTTCTACGCACGC
GTCTGCAGAAGTGGCTCAVGCCTGGTTGGCCGCCAGCTTGAGGAGTTCCTGAACCAGAG
CTCGCCCTTCTACTTCTGGATGAATGGTGACCGCATCGACTGGGTGCTGGAGAACGACC
GGCAGCAGACGCACATGCTGGATGTCATGCAGGACCACTTCAVCCGCGCGTCCAGCATC
ATAGACGAGCTCTTCCAGGACAGGTTCTTCACCCGGGAGCCCCAGGATACCTACCACTA
CCTGCCCTTCAGCCTGCCCCACCGGAGGCCTCACTTCTTCTTTCCCAAGTCCCGCATCG
TCCGCAGGYGGYGGCCCYGSTSGCCGGYCGGGCCCCMGYYSGYCCYCGCCATGTTCCAG
CCCTTCTTAAGATGATACACGAGGCTCAGCAGGCCATGGACATCCACTTCCACAGCCCG
GCCTTCCAGCACCCGCCAACAGAATTCATACGYGAAGGCGASGAMGACCGGACTGTGTG
CCGGGAGATCCGCTAVAACTCMACGGGCTGCTGCGGWTMAAGGACCAGTGTMARAAGTG
CCGGGWGMTTTTGTVTGTGGAMTGTMCCYCGMACAACGCSGGCCAGGRTAAGRTGCGGC
GGGAGCTCGWVGAATVCCTCCAGGTMGMTGAGAGGTTGACCYGMMAATACHACGAGCTG
CTAHAGTCCTACCAGTGGHAGATGCTCAACACCTCCTCCTTGCTGGAGCAGCTGMACGA
GVAGTTTAACTGGGTGTCCCGGCTGGCAAACMTVASGCAAGGCGAAGACCAGTACTATC
TGCGGGTCACSACGGTGGCTTCCCACACTTCTGAVTCGGACGTTCCTTCCGGTGTCACT
GAGGTGGTCGTGAAGCTCTTTGACTCTGATCCCATCACTGTGACGGTCCCTGTAGAAGT
CTCCAGGAAGAACCCWAAATTTATGGAGACCGTGGCGGAGAAAGCGCTGCAGGAATACC

GCAAAAAGCACCGGGAGGAGBJIGACCCAGCTTTCTTGTACAAAGTTGG

PXINsect-Dest38clus294T

AACTTTGTACAAAAAAGCAGGCTCGGCCACCATGATGAAGACTCTRCTGYTGTTTGTGG
GGCTGCTGCTGACCTGGGAGAGTGGGCAGGTCCTGGGGGACCAAACGGTCTCAGACAAT
GAGCTCCAGGAAATGTCCAATCAGGGAAGTAAGTACGTCAATRAGGAAATTCAAAATGC
TGTCAACGGGGTGAAACAGATAAAGACTGTGATAGAAAAAACAAACGAAGAGCGCAAGA
CACTGCTCAGCAACCTAGAAGAAGCCAAGAAGAAGAAAGAGGATGCCCTAAATGAGACC
AGGGAATCAGAGACAAAGCTGAAGGAGCTCCCAGGAGTGTGCAATGAGACCATGATGGC
CCTCTGGGAAGAGTGTGAGCSCTGCCTGAGACAGACCTACATGARATTCTACGCACGCG
TCTCCACAACTCCCTCACCCCTCMTTCCCCGCCACCTTCACAAATTCCTGAACCACAAC
TCRCMCTTCTACTTCTGGATGAATGGTGACCCCATCGACTCCCTGCTCAAAAACCACCC
CCACCAGACGCACATACTACATGTCATACAAAACCACTTCAACCGCACATCCAGCATCA
TAMCCYACCTCTTCCACGACACGTTCTTCACCCGGAAGCCCCACGCTCCCTACCACTAC
CTCCTCTTCAGCCTGCCCCACCAGAAGCCTCACTTCTTCTTTCCCAAGTCCCGCATCGT
CCGCAGCTTGATGCCCTTCTCTCCGTACGAGCCCCTGCACTCCCACGCCATGTTCCAGC
CCTTCCTTGAGATGATACACGAGGCTCAGCAGGCCATGSACATCCACTTCCACAGCCCG
GGCTTCCAGCACCCGCCAACAGKACTCATACGAGAAGGCGACGATGACCGGACTGTGTG
CCGGGAGATCCGCCACAACTCCACGGGCTGCTGCGGATGAAGGACCAGTGTGACAAGTG
CCGGGAGHTCTTGTCTGTGGACTGATCCACCAAC( |GACCCAGCTMTCTTGTARAAAG
TTGG

pXINsect-Dest38clus356T

AAGTTTGTACAAAAAAGCAGGCTCGGCCACC|HATGAAGACTCTGCTGCTGTTTGTGG
GGCTGCTGCTGACCTGGGAGAGTGGGCAGGTCCTGGGGGACCAAACGGTCTCAGACAAT
GAGCTCCAGGAAATGTCCAATCAGGGAAGTAAGTACGTCAATAAGGAAATTCAAAATGC
TGTCAACGGGGTGAAACAGATAAAGACTCTCATAGAAAAAACAAACGAAGAGCGCAAGA
CACTGCTCAGCAACCTAGAAGAAGCCAAGAAGAAGAAAGAGGATGCCCTAAATGAGACC
AGGGAATCAGAGACAAAGCTGAAGGAGCTCCCAGGAGTGTGCAATGAGACCATGATGGC
CCTCTGGGAAGAGTGTAAGCCCTGCCTGAMACAGACCTGCATGAAGTTCTACGCACGCG
GTCTGCAGAAGTGGGTCAGGCCTGGTTGGCCGCCAGCTTGAGGAGTTCCTGAACCAGAG
CTCGCCCTTCTACTTCTGGATGAATGGTGACCGCATCGACTCCCTGCTGGAGAACGACC
GGCAGCAGACGCACATGCTGGATGTCATGCAGGACCACTTCAGCCGCGCGTCCAGCATC
ATAGACGAGCTCTTCCAGGACAGGTTCTTCACCCGGGAGCCCCAGGATACCTACCACTA
CCTGCCCTTCAGCCTGCCCCACCGGAGGCCTCACTTCTTCTTTCCCAAGTCCCGCATCG
TCCGCAGCTTGATGCCCTTCTCTCCGTACGAGCCCCTGAACTTCCACGCCATGTTCCAG
CCCTTCCTTGAGATGATACACGAGGCTCAGCAGGCCATGGACATCCACTTCCACAGCCC
GGCCTTCCAGCACCCGCCAACAGAATTCATACGAGAAGGCGACGATGACCGGACTGTGT
GCCGGGAGATCCGCCACAACTCCACGGGCTGCCTGCGGATGAAGGACCAGTGTGACAAG
TGCCGGGAGATCTTGTCTGTGGACTGTTCCACCAACAACCCCTCCCAGGCTAAGCTGCG
GCGGGAGCTCGACGAATCCCTCCAGGTCGCTGAGAGGTTGACCAGGAAATACAACGAGC
TGCTAAAGTCCTACCAGTGGAAGATGCTCAACACCTCCTCCTTGCTGGAGCAGCTGAAC

GAGCAGTTTAACTGGGTGTCCCGGCTGGCAAACCTACACGCAAGGCHIGACCCAGCTT
TCTTGTACAAAGTTGG

PXINsect-Dest38clus403T

AAGTTTGTACAAAAAAGCAGGCTCGGCCACCATdATGAAGACTCTGCTGCRGAWRTGTK
GGGCTGCTGCTGACCTGGKAGATTGGGCAGGTCCTGGGGGACCAAACGGTCTCATCCAW
TGAGCTCCAGGAAATKTCCAATCAGGGAAGTWAGTACGTCAATAAGGAAATTCAAAATG
CTGTCAACGGGGTGAAACATATAAAGACTCTCATAGAAAAAACAAACGAAGAGCGCAAG
ACACTGCTCAGCAACCTAGAAGAAGCCAAGAAGAAGATAGAKGATGCCCTATWTTATAC
CAGGGAATCATAKACAAAGCTGAAGGAGCTCCCAGGAGTGTGCAATGAKACCATGATGG
CCCTCTGGKAAGAKTGTWAGCCCHGCCTGATMYATACCTGCATGAWGTTCTACGCACGC
TCCMGCAGAAGAGGCACAGGCCAGGVAGGCCGCCAGCMAGAGGAGAACCAGAACCAGAG
CACGCCCAACAACAACAGGAAGAAMGGAGACCGCAACGACACCCAGCAGGAGAACGACC
CGGCAGCAGACGCACAAGCAGGAAGACAAGCAGGACCACRACAGCCGCGCGGCCAGCAA
CAAAGACGAGCMCCACCAGGAACAGGAACAACACCCGGGAGCCCCAGGAAACCAACCAC
AACCMGCCCCACAGCCCGCCCCACCGGAGGCCACACAACAACAAAMCCAGTTCCCGCAT
CGTCCGCAGCTTGATGCCCTTCTCTCCGTACGAGCCCCTGAACTTCCACGCCATGTTCC
AGCCCTTCKTTGAGTTGATACACGAGGCTCAGCAGGCCATGGACATCCACTTCCACAGC
CCGGCCTTCCAGCACCCGCCTTKAGAAATAATACGAGAAGGCGACGATGACCGGACTGT
GTGCCGGGAGAWCCGCKACAACTCAACGGGCTGCTGCGGATGAAGGACCWGTGTYACAA
GTGCCGGGAGATCTTGTCTGTGGAKTGTTCCACKAACAACKCKTACCAGGCTAAGCTGC
GGCGGGYGCTCGAKGAATLCCTCCAGGTAGKTGAGAGGTTGACCAGAAAATACAACGAG
CTGCWAAAGTCCTACCAGTGGAAGATGKTCAACACCTCCTCCTAGCTGGAGCAGCTYAA
CGAGKAGAAAAACTGGGTGTKCCYGCTAGKAAACATAAAGCAAGGKGAAGACCAGAACT
ATCTGCGGGTCACAACGGTGGCTTCCCAKACWTATYAATCGGACGTWCCTTCCGGTGTK
AKTGAGGTGGTCGTGAAGCTCTTTGACTKTGATCCCATCACTGTGACGGTCCCTGTAGR
AAGTKTCAGG| |GACCCAGCTHTCTTGTACAAAGTTGG

pXINsect-Dest33clusA2 7P

AAGTTTGTACAAAAAAGCAGGCTCGGCCACCATGATGAAGACTCTGCTGCTGTTTGTRG
GGCTGCTGCTGACCTGGGAGARTGGGCAGGTCCTGGGGGACCAAACGGTCTCAVACAAT
NAVCTCCAGGAAATGTCCAATCAGGGAAGTAAGTACGTCAATAAGGAAATTMAAAATCC
CGTCAACGGGGTGAAACAGATAAAGACTCTCATAGAAAWNACAAACGAAGAGCGCAAGA
MACTGCTCAGCAACCTAGAAGAAGCCAAGAAGAAGAAAGAGGRTGCCCTAAATRARACC
AGGGAATCARAGACAAAGCTGAAGGAGCTCCCAGGAGTGTGCAATGAGACCATGATGGC
CCTCTGGRAAGARTGTAAGCMCTGCCTGAVMCMGACCTGCATGARGTTCTACGCWCGCG
TCTGCAGAAGTGGCTCAGGCCTGGTTGGCCGCCAGCTTGAGGAGTTCCTGAACCAGAGC
TCGCCCTTCTACTTCTGGRTGARTGGTGAVCGCATCGACCTCCCTGCTGGACAACGACC
GGCAGCAGACGCACATGCTGGATGTMATGCAGGACCACTTCARCCGCGCGTCCAGCATC
AHAVAGMGMRVCTCTTCCAGGACAGGTTCTYCMCCCGGGVAGCCCCAGGATACCTACCA
CTACCTGCCCTTCAGCCTGCCCCACCGGAGGCCTCACTTCTTGTTTCCCAAGTCCCGCA
TCGTCCGCAGCTTGATGCCTTCTCTCCGTACGAGCCCCTGAACTTCCACGCATGTTCCA
GCCCTTCCTTRAACTGATACACGAGGCTCAGCAGGCCATGGACATCCACTTCCACAGCC
CGGCCTTCCAAGCACCCGCCAACAGAATTCATACGAGAAGGCGACGATGACCGGACTGT
GTGCCGGGAGGCTCAGGCCACTCACGGCTGCTGCCTGTTCCACCAACAACCCCTRCCAG
GCTAAGCTGCGGCGGGAGCTCGACGAATCCCTCCAGGTCGCTGAGAGGTTGACCAGGAA
ATACAACGAGCTGCTAAAGTCCTACCAGTGGAAGATGCTCAACACCTCCTCCTTGCTGG
AGCAGCTGAACGAGCAGTTTAACTGGGTGTCCCGGCTGGCAAACCTCACGCAAGGCGAA
GACCAGTACTATCTGCGGGTCACCACGGTGGCTTCCCACACTTCTGACTCGGACGTTCC
TTCCGGTGTCACTGAGGTGGTCGTGAAGCTCTTTGACTCTGATCCCATCACTGTGACGG

TCCCTGTAGAAGTCTCCAGGAAGAACCCTAAATTTATGGAGACCGTGGCGGAGAAAGCG
CTGCAGGAATACCGCAAAAAGCACCGGGAGGAG| (GACCCAGCTTTCTTGTACAAAGT
TGG

pXINsect-Dest38clusQ155P

AACTTTGTACAAAAAAGCAGGCTCGGCCACCATGATGAAGACTCTGCTGCTGTTTGTGG
GGCTGCTGCTGACCTGGGAGAGTGGGCAGGTCCTGGGGGACCAAACGGTCTCAVACAAT
NAVCTCCAGGAAATGTCCAATCAGGGAAGTAAGTACGTCAATAAGGAAATTMAAAATGC
GTCAACGGGGTGAAACAGATAAAGACTCTCATAGAAAWNACAAACGAAGAGCGCAAGAIYI
ACTGCTCAGCAACCTAGAAGAAGCCAAGAAGAAGAAAGAGGRTGCCCTAAATRARACCA
GGGAATCARAGACAAAGCTGAAGGAGCTCCCAGGAGTGTGCAATGAGACCATGATGGCC
CTCTGGGAAGAGTGTAAGCSCTGCCTGAGACAGACCTGCATGARGTTCTACGCACGCGT
CTGCAGAAGTGGCTCAGGCCTGGTTGGCCGCCAGCTTGAGGAGTTCCTGAACCAGAGCT
CGCCCTTCTACTTCTGGRTGARTGGTGACCGCATCGACTCCCTGCTGGAGAACGACCGG
CAGCAGACGCACATGCTTGRKGTGRTGCCCGACCACTTCAGCCGCGCGTCCAGCATCAT
AGACGAACTCTTCCAGGACAGGTTCTTCACCCGGGAGCCCCAGGATACCTACCACTACC
TGCYCTTTCAGCCTGCCCCACCGGAGGCCTCATTTCTTCTTTCCCAAGTCCCGCATCGT
CCGCCGCCACAACTCCACGGGCTGCTGCGGATGAAGGACCAGTGTGACAAGTGCCGGGA
GATCTTGTCTGTGGACTGTTCCACCAACAACCCCTCCCAGGCTAAGCTGCGGCGGGAGC
TCGACCAGCACCCGCCAACAGAATTCATACGYGAAGGCGASGAMGACCGGACTGTGTGC
CGGGAGATCCGCTAVAACTCMACGGGCTGCTGCGGWTMAAGGACCAGTGTMARAAGCGG
GAGCTCGACGAATCCCTCCAGGTCGCTGAGAGGTTGACCAGMAAATACAACGAGCTGCT
WAAGTCCTACCAGTGGAAGATGRTCAACACCTCCTCCTTGCTGGAGCAGCTGWACGTAG
CAGTTTAACTGGGTGTCCCGGCTMGCAAACRTCACGCAAGGCGAAGACCAGTACTATCT
GCGGGTCACCACGGTGGCTTCCCACACTTCTGACTCGGACGTTCCTTCCGGTGTCACTG
AGGTGGTCGTGAAGCTCTTTGACTCTGATCCCATCACTGTGACGGTCCCTGTAGAAGTC
TCCAGGAAGAACCCTAAATTTATGGAGACCGTGGCGGAGAAAGCGCTGCAGGAATACCG

CWAAAAGCACCGGGAGGAGJ (GACCCTAGCTTTCTTGTACTAATAGTTGG

pXINsect-Dest38clusM228P

AACTTTATACAAAAAAGCAGGCTCGGCCACCI^ATGAAGACTCTGCTGCTGTATGTAG
GGCTGCTGCTGACCTGGRAAAATRGGCAGGTCCTGGGGGACCAAMCRGTCTCAAACAAT
AARCTCCAGGAAATRTCCAATCAAGGAAGTAAGTACGTCAATAAGGAAATTMAAAATDC
TGTCAMCGGGGTGAAACAAATAAARACTCTCATAGAARRRRCRRRCGRRGAGCGCVGGG
VGCTGCTCAGCRGCCTRGRGGRGGCCRGGGGGGGGGGGGGGGGTGCCCTGGGTGGGRCC
VGGGRGTCTGWGMCYDYGCTGADGGNGCTCCCYGGAGTGTGCGRTGGGGCCRTGGTGGC
CCTCTGGGGGGGGTGTGGGCSCTGCCTGGGGSGGGCCTGCGTGRGGTWCTRCGCRCGCG
TCTRCAGARGTGGCTCGGGCCTGGTTGGCCGCCAGCDTGAGGGGTTCCTGRGCCAGGGC
WCGCCCTTCWRCWTCWGGGTGRGWGGWGGCCGCGTCGRCTCCCTGCTGGAGRGCGAGGC
CGTCGTCTCRCACATRCWGGRWRTVGTGCAGGGCCMCTTCRRCCGCGCGTCCCGCAWCA
WRRRCGRGCTCTTCCSGGRCAGGTWCTCWCACCCCGGGGGCCCGGGGTACCTACCRCTR
CCTACCCTTCGGCCTGCCCCACCGGRGGCCTCACTTCTWCTTTCCCAAGTCCCGCATCG
TCCGCAGCTTGATGCCCTTCTCTCCGTACGAGCCCCTGAACTTCCACGCCATGTTCCAG
CCCTTCKTTGAGCCCATACACGAGGCTCAGCAGGCCATGGACATCCACTTCCACAGCCC
GGCCTTCCAGCACCCGCCAACAGAATTCATACGAGAAGGCGACGATGACCGGACTGTGT

GCCGGGAGAWCCGCCACAACTCCACGGGCTGCCTGCGGATGAAGGACCWGTGTGACAAG
TGCCGGGAGATCTTGTCTGTGGAKTGTTCCACCAACAACCCCTCCCAGGCTAAGCTGCG
GCGGGYGCTCGACGAATCCCTCCAGGTCGKTGAGAGGTTGACCAGAAAATACAACGAGC
TGCWAAAGTCCTACCAGTGGAAGATGCTCAACACCTCCTCCTAGCTGGAGCAGCTGAAC
GAGKAGTTTAACTGGGTGTKCCGGCTGGKAAACCTCACGCAAGGKGAAGACCAGAACTA
TCTGCGGGTCACAACGGTGGCTTCCCAKACWTATYAATCGGACGTWCCTTCCGGTGTKA
KTGAGGTGGTCGTGAAGCTCTTTGACTKTGATCCCATCACTGTGACGGTCCCTGTAGRA
AGTCCAGGAAGAACCCTAAATTTATGGAGACCGTGGCGGAGAAAGCGCTGCAGGAATAC
CGCAAAAAGCACCGGGAGGAG§(GACCCAGCTTTCTTGTARAAAGTTGG

pX!Nsect-Dest38clusL322P
AACTTTGTACAAAAAAGCAGGCTCGGCCACCATGJATGAAGACTCTGCTGCWGAAAWGTR
GGGCTGCTGCTGACCTGGGAGAGTGGGCAGGTCCTGGGGGACCAAACGGTCTCAGACAA
TRAGCT CCAGGAAATGT C C AAT C AGGGAAGT AAGTACGT C AAT AAGGAAATT CAAAATG
CTGTCAACGGGGTGAAACAGATAAAGACTCTCATAGAWAAAACAWACGAAGAGCGCAAG
ACACTGCTCAGCAACCTAGAAGAAGCCAAGAAGAAGAAAGAGGATGCCCTAAATGAGAC
CAGGGAATCAGAGACAAAGCTGAAGGAGCTCCCAGGAGTGTGCAATGAGACCATGATGG
CCCTCTGGGAAGAGTGTAAGCCCTGCCTGAHACARACCTGCATGAAGTTCTACGCACGC
GTCTGCAGAAGTGGCTCAGGCCTGGTTGGCCGCCAGCTTGAGGAGTTCCTGAACCAGAG
CTCGCCCTTCTACTTCTGGATGADTGGTGACCGCATCGACTCCCTGCTGGAGAACGACC
GGCAGCAGACGCACATGCTGGATGTCATGCAGGACCACTTCAGCCGCGCGTCCAGCATC
ATAGACGAGCTCTTCCAGGACAGGTTCTTCACCCGGGGAGCCCCAGGATACCTACCACT
ACCTGCMCTTCAGCCTGCCCCACGGAGCCTCACTTCTWCTTTCCCCAAGTCCCGCATCG
TCCGCAGCTTGATGCCCTTCTCTCCGTACGAGCCCCTGHACTTCCACGCCATGTTCCAS
CCCTTCCTTGAGWTGATARACGAGGRTCAGCAGGCRATGMACATCRACTTCCACAGCCC
GGCCTTCCAGCACCCGCCWARWGWATTRATACGAGAAGGCGACGATGACCGGACTGTGT
GCCGGGAGATCCGCCACAACTCCACGGGCTGCTGCGGATGAAGGACCAGTGTGACAAGT
GCCGGGAGWTCTTGTCTGTGGACTGTTCCACCAACAACCCCTCCCAGGCTAAGCTGCGG
CGGGAGCTCGACGAATCCCTCCAGGTCGCTGAGAGGTTGACCAGYAAATACAACGAGCC
CCTAAAGTCCTACCAGTGGAAGATGCTCAACACCTCCTCCTTGCTGGAGCAGCTGAACG
AGCAGTTTAACTGGGTGTCCCGGCTGGCAAACCTCACGCAAGGCGAAGACCAGTACTAT
CTGCGGGTCACCACGGTGGCTTCCCACACTTCTGACTCGGACGTTCCTTCCGGTGTCAC
TGAGGTGGTCGTGAAGCTCTTTGACTCTGATCCCATCACTGTGACGGTCCCTGTAGAAG
TCTCCAGGAAGAACCCTAAATTTATGGAGACCGTGGCGGAGAAAGCGCTGCAGGAATAC
CGCAAAAAGCATCCGGGAGGAG§ (GACCCAGCTWTCTTGTACAAAGTTGG

pXINsect-Dest38clusA413P

AAGTTTGTACAAAAAAGCAGGCTCGGCCACCf*||fATGAAGACTCTGCTGCTGTTTGT
GGCTGCTGCTGACCTGGGAGAGTGGGCAGGTCCTGGGGGGACCAAACGGTCTCAGACAA
TGAGCTCCAGGAAATGTCCAATCAGGGAAGTAAGTACGTCAATAAGGAAATTCAAAATG
CTGTCAACGGGGTGAAACAGATAAAGACTCTCATAGAAAANACAAACGAAGAGCGCAAG
ACACTGCTCAGCAACCTAGAAGAAGCCAAGAAGAMGAAAGAGGATGCCCTAAATGAGAC
CAGGGAATCAGAGACAAAGCTGAAGGAGCTCCCAGGAGTGTGCAATGAGACCATGATGG
CCCTCTGGGAAGAGTGTAAGCCCTGCCTGAAACAGACCTGCATGAAGTMCTACGCACGC
GTCTGCAGAAGTGGMTCAGGCCTGGTTGGCCGCCAGCTTGAGGAGTTCCTGAACCAGAG

CTCGCCCTTCTACTTCTGGATGARTGGTGACCGCATCGACTCCCTGCTGGAGAACGACC
GGCAGCAGACGCACATGCTGGATGTCATGCAGGACCACTTCAGCCGCGCGTCCAGCAMC
ATAGACGAGCTCTTCCAGGACAGGTTCTTCACCCGGGAGCCCCAGGATACCTACCACTA
CCTGCCCTTCAGCCTGCCCCACCGAGGCCTCACMTCTTCTTTCCCAAGTCCCGCATCGT
CCGCAGCTTGATGCCCTTCTCTCCGTACGAGCCCCTGHACTTCCACGCCATGTTCCASC
CCTTCCTTGAGWTGATARACGAGGRTCAGCAGGCRATGMACATCRACTTCCACAGCCCG
GCCTTCCAGCACCCGCCWARWGWATTRATACGAGAAGGCGACGATGACCGGACTGTGTG
CCGGGAGATCCGCCACAACTCCACGGGCTGCTGCGGATGAAGGACCAGTGTGACAAGTG
CCGGGAGHTCTTGTCTGTGGACTGTTCCACCHACAACCCCTCCCAGGCTAAGCTGCGGC
GGGAGCTCGACGAATCCCTCCAGGTCGCTGAGAGGTTGACCAGGAAATACAACGAGCTG
CTAAAGTCCTACCAGTGGAAGATGCTCAACACCTCCTCCTTGCTGGAGCAGCTGAACGA
GCAGTTTAACTGGGTGTCCCGGCTGGCAAACCTCACGCAAGGCGAAGACCAGTACTATC
TGCGGGTCACCACGGTGGCTTCCCACACTTCTGACTCGGACGTTCCTTCCGGTGTCACT
GAGGTGGTCGTGAAGCTCTTTGACTCTGATCCCATCACTGTGACGGTCCCTGTAGAAGT
CTCCAGGAAGAACCCTAAATTTATGGAGACCGTGCCCGAGAAAGCGCTGCAGGAATACC
GCAAAAAGCACCGGGAGGAGTGAGACCCAGCTVTCTTGTACAAAGTTGG
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